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Aims of Thesis and Abstract
Aims of Thesis
The continuing importance of thromboembolic disease as a cause of maternal
mortality and morbidity despite changes in obstetric clinical practice designed to
prevent thromboembolism in pregnancy, indicates a need for more information on
who is at particular risk, the best means and technique of diagnosing deep venous
thrombosis in pregnancy and appropriate strategies for prevention.
Ultrasound now offers a reproducible, accurate and non-invasive means of examining
vascular anatomy and function. In the field of obstetrics interest in ultrasound has
until recently been limited to examination of the fetus. However, with ultrasound
becoming established as the first line-investigation for suspected DVT in pregnancy ,
and showing promise as a screening tool, obstetricians are becoming aware of its
important role in maternal medicine. Interpretation of any test requires a knowledge
of what constitutes normality. Despite its place as the new 'Gold Standard' for DVT
in pregnancy, the effect of pregnancy itself on interpretation has been uncertain.
Ultrasound offers the means of quantifying the changes which occur in deep venous
anatomy and blood flow velocity in pregnancy, and enables the effect of interventions
on these parameters to be determined.
The three principal aims of the work presented in this thesis were:
1. To determine the incidence of venous thromboembolic disease in pregnancy in
Scotland, to assess how certain risk factors impact on this population and to
determine whether women considered to be at low to moderate risk may be sustaining
undetected subclinical DVT with implications for long-term morbidity.
2. To assess how pregnancy alters the anatomy and blood flow velocity within the
proximal deep veins of the leg, so that the normal appearances at different gestational
stages could be described, and thus aiding the ultrasound diagnosis of DVT in
pregnancy.
3. To investigate the impact of increasing gestation, alteration in posture, mode of
delivery and mechanical means of thromboprophylaxis on vessel size and dilatation
and flow velocity pattern ; factors which may influence the risk of thrombogenesis.
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Abstract
The thesis begins with a review of thromboembolic disease in pregnancy. The
physiological changes which render blood more prone to clot in pregnancy are
reviewed, and an overview of prevention, diagnosis and treatment of thromboembolic
disease in the pregnant woman is presented. The following chapter considers the
evidence for the role of venous stasis and vessel dilatation in initiating
thrombogenesis and examines how pregnancy may provide the haemodynamic,
anatomic and rheological conditions for thrombogenesis to occur.. There then follows
a discussion of duplex Doppler ultrasound as a means of quantifying changes in
venous anatomy and blood flow velocity and validity of the techniques employed are
considered. A reproducibility study carried out by the author and a colleague is then
presented, demonstrating good inter and intra-observer agreement for the techniques
employed.
In order to determine the incidence of recorded thromboembolic complications in
Scottish obstetric practice, a retrospective study of DVT and PE complicating
obstetrics in Scotland from 1982 to 1992 was conducted. Analysis of data concerning
over 700,000 maternities extracted from the SMR 2 database held by the Common
Services Agency for the National Health Service showed that age over 35 years and
emergency caesarean delivery were important risk factors for obstetric DVT and PTE.
The incidence of antenatal DVT and PTE was 0.615/1000 and 0.108/1000 maternities
respectively in those under 35 years of age and 1.216/1000 and 0.405/1000
maternities respectively in those over 35 years. Postnatal DVT occurred with an
incidence of 0.424/1000 after caesarean section and 0.173/1000 after vaginal delivery.
A prospective ultrasound screening study for asymptomatic DVT in the early
puerperium was performed in 140 women at low-moderate risk of DVT. No DVT
were detected. This suggests that puerperal DVT is rare in women at low to moderate
risk, and that undetected subclinical DVT are unlikely to be causing significant long-
term morbidity.
The effect of increasing gestation and posture on vessel diameter, flow velocity and
respiratory fluctuation in flow. In the supine position, vessel diameter increased and
flow velocity decreased with advancing gestation. These changes were most marked
in the common femoral vein. No significant gestational changes in respiratory flow
fluctuation were observed. Flow velocity was significantly slower in the left
compared to the right common femoral and popliteal veins, in keeping with the
observed increased incidence of left ileofemoral DVT in pregnancy. Adoption of the
left lateral position increased flow velocity in both legs throughout pregnancy and
postnatally. The deep venous system of the leg was studied with duplex Doppler
ultrasound in the early and late puerperium. Flow velocity was reduced in the left leg
and changes in vessel diameter and flow velocity were observed between the 4th and
42nd postnatal day. Although flow velocity was reduced in the common femoral vein
after caesarean section compared to vaginal delivery, no other differences were
observed.
The physiology of venous flow in the proximal deep veins of the leg was studied. A
pulsed Doppler ultrasound study of flow phasicity showed respiratory phasicity to be
present in 95% of subjects. In the supine position during pregnancy and the
puerperium, venous flow velocity was maximal on inspiration but on standing upright
it was maximal during expiration indicating that intra-abdominal pressure may
influence venous return.
Duplex Doppler ultrasound was used to study the effects of three types of stocking on
venous diameter, flow velocity and respiratory fluctuation in the supine, left lateral
and upright positions in non-pregnant women. Graduated stockings reduced vessel
diameter at the popliteal vein, but no other effects were observed. In contrast,
adoption of the left lateral position caused a significant reduction in vessel diameter
and increase in flow velocity.
In addition to providing novel information on the epidemiology of thromboembolic
disease in pregnancy, the data here presented address the effects of pregnancy,
postural changes and a common therapeutic intervention on deep venous flow and
may contribute to our understanding of the clinical pattern and pathophysiology of





Pulmonary thromboembolism remains a major cause of maternal mortality. The
increased risk associated with pregnancy is, in part, imposed by physiological
alterations in the coagulation and fibrinolysis systems, and these changes and their
impact are outlined in this chapter, which discusses the clinical context surrounding
the work presented later in this thesis. Risk factors for DVT are also considered and
the importance of appropriate thromboprophylaxis is emphasised. A clinical approach
to prevention and treatment of DVT is described, with reference to the particular
problems associated with pregnancy. In critically reviewing methods of DVT
diagnosis, ultrasound is shown to provide an appropriate methods for the
symptomatic pregnant patient. The diagnosis of pulmonary embolism is also
addressed.
1.1 Introduction
Pulmonary thromboembolism, along with pre-eclampsia, has remained a major cause
of maternal mortality over the last forty years (Department of Health, et al 1996). It
has persisted as a major cause of maternal mortality despite modern trends in obstetric
practice which have led to reduced periods of immobilisation, outpatient management
of pregnancy complications previously considered to require admission and earlier
discharge after delivery. The clinical diagnosis of deep venous thrombosis is
unreliable (Genton & Turpie 1980), and the physiological changes which take place
in pregnancy, such as peripheral oedema and venodilatation may make the early
recognition of DVT more difficult. In the most recent Confidential Enquiries into
Maternal Deaths (Department of Health et al 1994), 70% of those who had suffered a
fatal PTE had no documented clinical evidence of DVT. Similarly, the recently
published Report of the National Confidential Enquiry into Perioperative deaths
(DHSS 1993) found that in most of the 20% of perioperative deaths attributed to
PTE, the preceding DVT had not been diagnosed. (DHSS 1993). Given the
difficulties in detection of DVT, particularly in pregnancy, effective diagnostic
strategies are required. Identification of those at increased risk and the provision of
appropriate thromboprophylaxis may enable obstetricians and gynaecologists to
reduce the mortality and morbidity associated with thromboembolic disease.
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1.2 Physiological adaptation of the coagulation system in
pregnancy
Normal pregnancy is associated with major changes in the coagulation and
fibrinolytic systems. These have traditionally been thought to represent an adaptive
and preparatory mechanism for the haemostatic challenge of delivery and also to
maintain the placento-uterine interface during pregnancy. The overall effect from
these changes is an increased thrombotic potential which is most marked around term
and the immediate post-partum period.
Factor XIII, high molecular weight kininogen and prekallikrein increase in pregnancy
although reports on the latter have not been entirely consistent with some authors
reporting no change in prekallikrein levels (Hellgren & Blomback 1981, Sayama et al
1981, Adam et al 1985). Factor XI levels fall gradually through pregnancy reaching
their nadir at term (Hellgren & Blomback 1981). Factor IX remains static or
increases slightly (Beller & Ebert 1982). Both factor VIII coagulant activity and von
Willebrands factor antigen increase progressively as pregnancy advances (Hellgren &
Blomback 1981, Stirling et al 1984, Sorensen et al 1995). These increases in the two
components of the factor VIII complex appear to occur in parallel in the first half of
pregnancy, but then diverge due to a greater increase in von Willebrands factor
antigen. This increases by around twofold the ratio of von Willebrands factor antigen:
factor VIII coagulant activity (Hellgren and Blomback 1981, Inglis et al 1982,
Stirling et al 1984). Factor VII also increases in pregnancy (Stirling et al 1984, Beller
and Ebert 1982). Factor X increases while Factors II and V show do not change
(Stirling et al 1984, Hellgren & Blomback 1981). Fibrinogen increases substantially
and progressively with gestation and a significant change is evident from the first
trimester and an almost twofold increase over non-pregnant levels by term (Stirling et
al 1984, Hellgren & Blomback 1981). Factor XIII shows an initial increase but then
falls to normal non-pregnant values in late pregnancy (Persson et al 1980)
The endogenous inhibitor of coagulation antithrombin III was initially thought to
decrease in pregnancy; however, more recent studies show that levels do not appear to
change in pregnancy (Stirling et al 1984, Hellgren and Blomback 1981, Weiner &
Brandt 1982, Francalanci et al 1995). Although antithrombin III may increase
following delivery (Hellgren & Blomback 1981), this has not been a consistent
finding (Weenink et al 1982, Bremme et al 1992). Protein C levels remain constant
or increase slightly (Mannucci et al 1984, Malm et al 1988, Bremme et al 1992).
Protein S normally exists in plasma in two forms; the functionally active free protein
S and protein S complexed with C4b-binding protein which is functionally inactive.
Normally an equilibrium exists in plasma between these two forms. In normal
pregnancy there is a reduction in protein S activity and this appears to be due to a
reduction in total protein S as measured antigenically rather than a change in C4b-
binding protein (Comp et al 1986).
Fibrinolytic activity is impaired during pregnancy, but returns rapidly to normal
following delivery (Bonnar et al 1969,1970, Stirling et al 1984). This is due to
placentally derived plasminogen activator inhibitor type 2 (PAI-2) which is present in
substantial quantities during pregnancy (Booth et al 1988, Lecander & Astedt 1986,
Nilsson et al 1986). The endothelial derived inhibitors of plasminogen activator
(PAI-1 and PAI-2) increase in pregnancy (Bremme et al 1992, Ishii et al 1994,
Halligan et al 1994, Sorensen et al 1995). Increased levels of t-PA Ag have also been
reported (Kruithof et al 1987, Sorensen et al 1995, Ishii et al 1994). However, in
early pregnancy, t-PA activity has been shown to be close to the standard range seen
in non-pregnant women and to gradually decrease during later pregnancy, before
recovering to the normal range 48 hours after delivery (Ishii et al 1994). Plasminogen
increases during pregnancy (Bonnar et al 1969, Hellgren & Blomback 1981, Beller &
Ebert 1982) as does antiplasmin. Despite the reduction in fibrinolytic activity,
fibrinolysis cannot be completely shut down as FDPs remain present in the plasma
with several studies showing that FDPs increase as pregnancy progresses (Stirling et
al 1984, Thorburn et al 1982, Bonnar et al 1969, Woodfield et al 1968).
The activity of the fibrinolytic system in response to stimulation of fibrinolysis by
venous occlusion has been assessed in pregnancy. Total t-PA release is significantly
reduced in pregnancy with free t-PA remaining below the limit of detection of the
assay following occlusion (Ballegeer et al 1987). This is in contrast to the non¬
pregnant situation where both total and free t-PA increases significantly following
venous occlusion. These data suggest that t-PA release is impaired in pregnancy and
that free t-PA is rapidly inhibited, in keeping with the high levels of plasminogen
activator inhibitors noted in pregnancy (vide supra). Despite this impairment in the
response to venous occlusion, D-dimer fragment of cross-linked fibrin is substantially
increased in the first, second and third trimesters as compared to non-pregnant women
(Ballageer et al 1987, Bremme et al 1992, Francalanci et al 1995). This indicates that
fibrinolysis is still occurring and clearly is not impaired to the extent suggested by the
reduced levels of t-PA and increased PAI-1 and PAI-2.
Impaired fibrinolysis can be found in some patients with a history of deep venous
thrombosis (Isacson & Nilsson 1972) and the physiological impairment of fibrinolysis
seen in pregnancy may contribute to the increased thrombotic risk associated with
pregnancy. Overall, the data discussed in relation to changes in the coagulation and
fibrinolytic systems in pregnancy suggest that activation of both systems is occurring
with deposition of fibrin and subsequent fibrinolysis with increased levels of FDP's.
These changes are compatible with a compensated state of low grade disseminated
intravascular coagulation. This is supported by other studies where increased
fibrinopeptide A, FDP's and platelet release products have been found in normal
pregnancies indicating coagulation, fibrinolysis and in-vivo platelet activation
respectively (Gerbasi et al 1990), in keeping with compensated low grade
disseminated intravascular coagulation.
Platelet count does not change significantly during pregnancy (Stirling et al 1984,
Hellgren & Blomback 1981, Beller & Ebert 1982), although there may be a slight fall
towards the end of the third trimester (Fay et al 1983) in keeping with reports of a
trend towards a reduction in platelet lifespan (Rakoczi et al 1979, Wallenburg and
van Kessel 1978). The increase in mean platelet volume and volume distribution
width (Fay et al 1983, Sill et al 1985, Tygart et al 1986, Singer et al 1986) also
suggests that a compensated state of progressive platelet destruction occurs during the
third trimester. This may be supported by the enhanced platelet reactivity reported by
some studies in normal pregnancy (Morrison et al 1985, Burgess-Wilson et al 1986),
although others have reported that platelet reactivity is unchanged (Whigham et al
1978, Greer et al 1988). O'Brien et al (1986) have shown that circulating platelet
aggregates are increased in normal pregnancy, in keeping with enhanced reactivity in-
vivo, while ex-vivo platelet reactivity was simultaneously reduced. This may reflect a
degree of platelet exhaustion secondary to enhanced activation in-vivo. In-vivo
activation in late pregnancy is also supported by increased plasma levels of B-
thromboglobulin in the second and third trimester compared to the first trimester and
non-pregnant levels (Douglas et al 1982). Thus, normal pregnancy is associated with
a degree of enhanced platelet destruction which is compensated for by increased
production. Following the haemostatic challange of delivery, platelet count has been
thought to increase (Hellgren & Blomback 1981). However, more recent studies
suggest that the platelet count remains unchanged after uncomplicated vaginal
delivery and may be slightly reduced after normal and uncomplicated caesarean
section (Dahlstrom &Nesheim 1994).
The majority of the pregnancy related changes in the haemostatic systems revert to
normal following separation of the placenta. There is evidence of contact system
activation and platelet consumption immediately following delivery, then an increase
in fibrinogen, factor VIII:C and platelet count a few days later (Bonnar 1970,
Hellgren & Blomback 1981). The fibrinolytic system rapidly returns to normal in
keeping with the loss of the placental source of PAI-2 (Wiman et al 1984). The
normal non-pregnant state is regained by around 4 weeks after delivery.
1.3 Incidence ofDVT and PTE
Difficulties in diagnosing DVT in pregnancy have resulted in variations in the
reported incidence of deep venous thrombosis (DVT) and non-fatal PTE associated
with pregnancy. Clinical diagnosis has estimated the incidence of DVT in pregnancy
between 0.05% and 1.8% (Hiilesmaa 1960, Aaro & Juergens 1971, Coon et al 1973),
increasing to between 0.08 -1.2% following a vaginal delivery (Daniel et al 1967,
Husni et al 1967, Aaro & Juergens 1971, Flessa et al 1974), and to 2.2-3.0% (Husni et
al 1967, Hiilesmaa 1960) following caesarean section. A Swedish study which
confirmed the clinical diagnosis by objective means (plethysmography,
thermography, and venography) found an incidence of 0.07% during pregnancy
(Bergqvist et al 1983). The same group, using plethysmography, screened 169
women following caesarean section and found an incidence of DVT of 1.8%
(Bergqvist et al 1979). A retrospective review of 35,000 pregnancies at Queen
Charlottes Hospital, London, found an overall incidence of DVT and PTE of 0.09%
(Letsky & de Swiet, 1984). Further studies based on objective screening techniques
are required to clarify the true incidence ofDVT in pregnancy .
The young age of pregnant women renders chronic venous insufficiency arising from
DVT in pregnancy a significant cause of long-term morbidity. Studies of the
frequency of objectively diagnosed deep venous insufficiency in women with a
history of proven DVT in pregnancy have shown the prevalence of deep venous
insufficiency in the previously thrombosed leg to be 65% compared to 22% in the
healthy leg, the latter acting as a control (Lindhagen et al 1986). This frequency of
65% is significantly greater (Bergqvist et al 1992) than that found after postoperative
DVT diagnosed by radio-labelled fibrinogen uptake testing (32%) or after clinically
suspected acute DVT confirmed by venography (49%) (Lindhagen et al 1984, 1985).
1.4 Risk Factors for DVT
The risk of fatal PTE following caesarean section is greater than after vaginal delivery
and risk appears greater after an emergency procedure. This may be due to reduced
mobility, and trauma to pelvic veins at the time of operation. It is also likely that there
is an increased risk following forceps deliveries since one study has shown that 25%
of cases of thromboembolism occurred in complicated pregnancies which included
difficult forceps deliveries and prolonged labour (Aaro & Juergens 1974).
The Confidential Enquiries into Maternal Deaths for England and Wales show that
age and parity are important, with risk increasing more sharply with age, especially in
those over 35 years old, than with increasing parity. The risk of fatal PTE in a 40
year old para 4 being 263.6 per million maternities compared to 11.3 per million
maternities in a 20-24 year old para 4 (Department ofHealth 1989).
Restricted activity, often associated with hospitalisation and bed rest for
complications of pregnancy such as hypertension, is also an important risk factor
especially when the patient may have an increased likelihood of other risk factors
such as operative delivery. Obesity is undoubtedly an important risk factor for
DVT/PTE as such patients have impaired fibrinolytic activity, poor mobility and an
increased likelihood of venous stasis. The venous tone appears to be reduced in
pregnancy resulting in diminished flow prior to physical obstruction by the gravid
uterus, although physical obstruction of the inferior vena cava also occurs later in
pregnancy due to uterine size and may exacerbated by engagement of the fetal head
(Flessa et al 1974, Wright et al 1950).
If a surgical procedure is carried out during pregnancy or the puerperium, such as
post-partum sterilisation, then there is an increased risk of thrombotic problems.
Other risk factors include a hypertensive problem in pregnancy, excessive blood loss
(Department of Health 1989), sickle cell anaemia (Thomas et al 1982, Van Dinh et al
1982), dehydration and to have a blood group other than O (Jick et al 1969, Bergqvist
et al 1983). Hereditary thrombotic problems such as ATIII or protein C deficiency,
and acquired thrombotic problems such as lupus anticoagulant also place the patient
at increase risk and these are discussed below.
A previous history of a DVT during pregnancy increases the risk of a future
thrombosis both within and outwith pregnancy. The risk of recurrence during
pregnancy and the puerperium has been reported to be 15% and the risk of DVT not
pregnancy and the puerperium has been reported to be 15% and the risk of DVT not
associated with pregnancy, over a median follow up of over 10 years, reported to be
33% (Bergqvist et al 1992). These data are similar to those obtained from a
retrospective review of the literature (Bergqvist et al 1992) and other retrospective
studies (Tengborn et al 1989). However, de Swiet's group have reported 59
pregnancies in women with a history of thrombosis who received no anticoagulant
therapy antenatally (although intra-partum and post-partum prophylaxis was given).
None of these women had any thromboembolic complication (de Swiet et al 1987).
These figures suggest that the risk of recurrence during pregnancy in those not
receiving prophylaxis may be less than 5%.
1.5 Thromboprophylaxis
1.5.1 Heparin
The most commonly used mode of thromboprophylaxis in pregnancy is subcutaneous
heparin (Greer & de Swiet 1993). Since neither unfractionated standard heparin nor
low-molecular weight heparins cross the placenta (Flessa 1965, Forestier et al 1984,
1987, Andrew et al 1985, Omri et al 1989) or the breast, it is particularly suited in
these respects for use in pregnancy. While it might increase the risk of haemorrhage
in the mother and utero-placental bed, there is no risk of fetal haemorrhage per se or
of any teratogenic effect. There are, however, other risks associated with the use of
heparin in pregnancy, the most worrying of which is heparin induced osteoporosis.
Heparin induced osteoporosis has been reported in patients on long term heparin
therapy during pregnancy with resultant problems such as vertebral collapse (Hirsh
1991). This was initially thought to be an idiosyncratic phenomenon and it may be
that only a subgroup of patients are susceptible to the effect of heparin on bone
mineralisation (Ginsberg et al 1990). However, de Swiet et al (1983) have shown
objectively that the effects appear to be dose and duration related and that significant
bone demineralisation occurs in women taking subcutaneous heparin 20,000 i.u. daily
in pregnancy and 16,000 i.u. daily after delivery for greater than 22 weeks compared
to women on short term therapy (<7 weeks). In addition, an intermediate effect may
be seen in patients on therapy for 10-22 weeks (de Swiet et al 1983). There was no
correlation between loss of bone mass and symptoms which might be attributable to
this (de Swiet et al 1983). A recent prospective consecutive cohort study using bone-
densitometry to evaluate subclinical heparin-induced osteoporosis demonstrated a
significant decrease in mean femur bone density among those taking longterm
subcutaneous heparin prophylaxis (Barbour et al 1994). However, no dose-response
relationship could be demonstrated. Among 184 women receiving subcutaneous
heparin in the range of 13,000 to 40,000 i.u. over a mean duration of 25 weeks,
Dahlman (1993) demonstrated a 2.2% incidence of osteoporotic fractures. In this
study a dose relationship was evident, with those sustaining fractures receiving a
mean of 24,500 iu heparin/24 hours compared with an average of 19,100i.u. heparin
for the whole group. However, a vertebral fracture was sustained by one woman who
had received low dose prophylaxis (15,000 i.u. / 24 hours) for 7 weeks.
It is not known if low molecular weight (LMW) heparins will confer any benefit in
this regard. In animal studies, chronic dosing with unfractionated and low molecular
weight heparin given in comparable doses both resulted in osteoporosis of a similar
degree (Matzsch et al 1987). However, bone density scans performed after delivery of
11 patients who had received low molecular weight heparin thromboprophylaxis
throughout pregnancy and for at least 12 weeks postpartum showed normal mineral
mass (Melissari et al 1992).
Whether or not the osteoporosis induced by longterm heparin is reversible remains
unclear. Zimran et al (1986) suggested the effect may be reversible. However,
osteopenic effects could still be demonstrated up to two years after cessation of
treatment in de Swiet's study (de Swiet et al 1983) and a significant reduction in
femur bone densitometry was present six months after ceasing heparin prophylaxis in
Barbour's study (Barbour 1994).
Heparin can also cause thrombocytopaenia, allergic reactions and alopecia, but these
appear to be uncommon. The incidence of heparin induced thrombocytopaenia has
been estimated at between 0-30% (King & Kelton 1984). However, most recent
studies have reported an incidence of between 1 and 5%. Should this complication
develop heparin should be stopped and within several days the platelet count will
usually return to normal. An alternative anticoagulant may be required especially if a
thrombotic problem has developed. As these thrombotic problems are related to
platelet activation, anti-platelet therapy with aspirin may be of benefit (King & Kelton
1984). There have also been reports of LMW heparins being used successfully in
pregnancies complicated by heparin allergy and thrombocytopaenia (Harenberg et al
1987, Henny et al 1986) although it appears that severe heparin induced
thrombocytopaenia may also occur with heparinoids (van Besien et al 1991). In our
own practice we have successfully used enoxaparin for therapeutic anticoagulation in
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a patient with severe thrombosis and heparin induced thrombocytopenia (Macklon et
al 1995).
Previous studies suggested that heparin might be associated with an adverse fetal
outcome in up to one third of pregnancies associated with its use (Hall et al 1980).
This is surprising as heparin does not cross the placenta and bleeding complications
are not common enough to explain it. However, a recent literature review of 186
studies which reported 1325 pregnancies associated with anticoagulant therapy and
which took into account factors such as maternal co-morbid conditions, found that
heparin therapy was not associated with any adverse fetal or infant outcome
(Ginsberg et al 1989, Ginsberg 1991).
1.5.2 Warfarin
Warfarin also requires special consideration in pregnancy as it readily crosses the
placenta and is a known teratogen. It produces a specific warfarin embryopathy which
may occur following exposure to the drug in the first trimester, with the period
between 6 and 9 weeks gestation (Hall et al 1980) being the most vulnerable stage. It
is difficult to estimate the incidence of warfarin embryopathy as most studies have
been retrospective, however, an extensive recent literature review has placed the
incidence at 4.6% (45 of 970 pregnancies associated with oral anticoagulant therapy)
(Ginsberg et al 1989, Ginsberg 1991). The only prospective study of coumarin
anticoagulation in pregnancy was performed in patients with valvular heart disease
(Iturbe-Alessio et al 1986). This study showed an incidence of fetal abnormality of
almost 30% in infants exposed to a coumarin between 6 and 12 weeks gestation.
Furthermore, when heparin was substituted for warfarin between the 6th and 12th
weeks, none of the infants were found to have warfarin embryopathy. Thus, warfarin
embryopathy appears to be a significant but potentially preventable problem for
mothers requiring anticoagulation in pregnancy.
The warfarin embryopathy takes the form of abnormal bone and cartilage formation
termed chondrodysplasia punctata which is characterised by nasal and midface
hypoplasia, frontal bossing, short stature and stippled chondral calcification. Other
abnormalities have also been documented in association with warfarin therapy,
including microcephaly, central nervous system abnormalities, optic atrophy, cardiac
defects and the asplenia syndrome (Stevenson et al 1980, Cox et al 1977, Hall et al
1980, Ginsberg 1991). It should be noted, however, that central nervous system
abnormalities may occur with warfarin exposure at any stage of pregnancy (Hall et al
1980, Ginsberg 1991). The mechanism behind central nervous system abnormalities
is thought to be related to small intracerebral bleeds and subsequent scarring in-utero.
As the fetal liver enzyme systems are immature, the levels of vitamin K dependent
coagulation factors are low. Consequently, warfarin therapy maintained in the
therapeutic range in the mother poses the risk of excessive anticoagulation and
subsequent bleeding in the fetus. The incidence of CNS abnormalities has been
estimated at around 3% from retrospective studies (Hall et al 1980, Ginsberg 1991)
based on literature reviews. Among a group of 22 infants whose mothers took
warfarin during the second and third trimesters, no intellectual or developmental
difference was demonstrated when compared to matched controls (Chong et al 1984).
Chen et al (1982) found no developmental problems in infants exposed to warfarin in
the second and third trimester except in one infant with congenital hydrocephalus.
These latter two studies suggest that the incidence of CNS abnormalities may be
much lower than previously thought. The outcome of affected infants is variable due
to varying severity of the warfarin embryopathy syndrome. However, around 50% of
survivors with the embryopathy appear to do well while those with haemorrhages or
CNS abnormalities do poorly (Hall et al 1980).
The use of warfarin also places both mother and fetus at increased risk of
haemorrhagic complications in later pregnancy, during delivery and in the early post
partum period (de Swiet et al 1977). Early reports found a high incidence of fetal
intracerebral haemorrhage in late pregnancy (Villa Santa 1965). There is a substantial
risk of major haemorrhagic complications for both mother and fetus during delivery,
especially if this is carried out by operative means, even with optimal anticoagulant
control. As warfarin has such a long duration of action it will take several hours for
any reversal of anticoagulation to occur following parenteral vitamin K
administration, and fresh frozen plasma will be required to correct the haemostatic
defect in an emergency situation.
Warfarin has also been associated with an increase in spontaneous abortion rates
when administered in the first trimester, ranging from 28-44% (Salazar et al 1984,
Lutz et al 1978, Chen et al 1982). There is some evidence to suggest that if heparin is
substituted for coumarin derivatives the spontaneous abortion rate may be lessened.
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1.5.3 Low molecular weight heparins
Low molecular weight heparins may offer advantages over unfractionated heparins. A
recent multicentre, randomised, double blind study comparing a once daily
subcutaneous injection of 2500i.u. LMWH (Fragmin, Kabi Pharmacia) with twice
daily 5000i.u. subcutaneous unfractionated heparin in 3809 patients undergoing
major elective abdominal surgery found no difference in their thromboprophylactic
efficacy. However, the incidence of wound haematoma and severe bleeding was less
frequent in the group given the LMWH. Additionally, Leizorovicz et al (1992) have
shown the low molecular weight-heparin, enoxaparin (Rhone-Poulenc-Rorer, UK) to
have a bioavailability of 90% (compared to 10% for unfractionated heparin) in non¬
pregnant women and a longer elimination half-life than unfractionated heparin,
allowing once daily administration. With regard to osteoporosis, it is not known if
low molecular weight (LMW) heparins will confer any benefit. In animal studies,
chronic dosing with unfractionated and low molecular weight heparin given in
comparable doses both resulted in osteoporosis of a similar degree (Matzsch et al
1987). However, bone density scans performed after delivery of 11 patients who had
received low molecular weight heparin thromboprophylaxis antenatally showed
normal mineral mass (Melissari et al 1992).
The role of low molecular weight heparins (LMWH) in thromboprophylaxis in
pregnancy has yet to be established. Anecdotal reports of the successful use of these
compounds in pregnancy (Priollet et al 1986, Many et al 1992) have been followed
by larger studies. Sturridge et al (1994) reported a series of sixteen women treated
with enoxaparin. The 20mg dose failed to increase the anti-Xa levels to the
recommended level of 0.2 units/ml, and the higher dose of 40mg once daily was
recommended. Additionally, anti Xa activity was noted to fall in the second half of
pregnancy. In our own practice we have found that the low molecular weight-
heparin, enoxaparin (Rhone-Poulenc-Rorer, UK), has better bioavailability than
unfractionated heparin as determined by anti-Xa levels (unpublished data) and may be
satisfactory on a once daily dose. However, in the light of data currently available we
would recommend, at least until more experience is gained, that anti-Xa levels are
monitored and dosage adjusted to achieve satisfactory anti-Xa levels. In the




Dextran may also be considered for intra-partum or intra-operative prophylaxis
although its efficacy is perhaps uncertain, at least in non-pregnant surgical patients
(Turpie 1992). Its precise mode of action is not certain but may be due to
haemodilution and improved flow as well as its effects on the haemostatic system
which include anti-platelet effects, a fall in factor VIII and possibly enhanced
plasminogen activators (Bergqvist 1983). Its disadvantage is the small risk of
anaphalactoid reaction, but this can be markedly reduced by pre-treatment with the
low molecular weight hapten dextran (Bergqvist 1983), although widely used in
Europe it is not available in the UK. There is also evidence to suggest that heparin
and dextran may be associated with haemorrhagic problems if used together
(Bergqvist 1983).
1.5.5 Physical methods
Physical methods of prophylaxis such as intermittent calf compression or graduated
compression stockings are also of value intraoperatively and postoperatively
especially in the low risk situation or if combined with other thromboprophylactic
techniques (Turpie 1992). There is good evidence for their efficacy among ambulant
post-operative surgical patients (Scurr et al 1987). Their efficacy in providing
effective long-term thromboprophylaxis in pregnancy has not been evaluated. Further,
their mode of action remains uncertain.
1.5.6 The approach to thromboprophylaxis
Until recently, long term administration of anticoagulants was employed in the
antenatal period as the established prophylactic therapy for women with a past history
of thromboembolism occurring within or outwith pregnancy. However, the risk of
antenatal thromboembolism in these women is much lower than previously thought.
When this is balanced against the hazards of anticoagulation, prophylactic therapy is
questionable and perhaps is best reserved for those with recurrent severe problems,
congenital or acquired thrombophilia or those with post-phlebitic insufficiency.
Additionally, pregnancy is not contraindicated in women with such a history (Lowe et
al 1992). Some authorities, however, still advise prophylactic anticoagulant therapy
if the previous problem occurred in pregnancy, starting four to six weeks before the
gestation when the previous thromboembolic problem occurred (Hathaway & Bonnar
1987, Rutherford & Phelen 1986). A recent survey has shown that 52% of UK
obstetricians would still use prophylaxis ante-natally in women with a previous DVT
outwith pregnancy, rising to 81% if the previous DVT had occurred during pregnancy
and 97% if the patient had recurrent problems (Greer & de Swiet 1993). These
figures for those patients with a single episode of DVT reflect the controversy over
the need for prophylactic heparin in this group of patients. If subcutaneous heparin
prophylaxis is employed, then it should be used in a similar manner as chronic
therapy following a thromboembolic problem (see below). As thromboembolism is a
potentially fatal condition and prophylaxis is not without hazard, the various risks of
these problems should be discussed pre-pregnancy, or at least in early pregnancy,
with the patient, no matter which prophylactic philosophy is taken. All authorities do
agree, however, on postnatal prophylactic therapy in patients with a past history of
thromboembolism with 5,000 i.u. of heparin subcutaneously 8 hourly (or 7,500 i.u 12
hourly) switching to warfarin within 7-10 of delivery and continuing therapy for at
least 6 weeks (Lowe et al 1992, RCOG 1995). As previously stated, breast feeding is
not contraindicated with either heparin or warfarin.
Increasingly, short term prophylactic heparin is being used postpartum in patients
with significant risk factors such as operative delivery, obesity, age over 35 years old,
high parity and restricted activity prior to delivery (Lowe et al 1992). Such
prophylaxis must be encouraged if we wish to impact upon the morbidity and
mortality associated with DVT and PTE in the puerperium.
A further group of patients meriting special consideration with regards to
thromboprophylaxis in pregnancy are those with congenital or acquired
thrombophilia. The main congenital thrombophilias are deficiencies of the
endogenous inhibitors of coagulation ATIII, Protein C and Protein S although
abnormalities of fibrinolysis, hereditary dysfibrinogenaemias, and homocystinuria
may also be responsible for recurrent thromboembolism (Winter & Douglas 1991). In
recent years a further congenital thrombophilia, activated protein C (APC) resistance
has been identified. A point mutation at a cleavage site in factor Va makes the
altered form, known as factor V Leiden, inaccessible to activated protein C. The
prevalence of this condition among non-pregnant patients with DVT has been found
to be between 20% and 33% compared with a prevalence of around 5% in the general
population (Rosendaal et al 1994, Koster et al 1993, Svensson and Dhalback 1994).
APC resistance is therefore a major risk factor for venous thrombosis. Since it is far
more prevalent in the general population than the other known hereditary
thrombophilias, it is likely to be a significant factor underlying venous thrombosis in
pregnancy. While case reports of APC resistance in pregnancy have recently been
published (Cook et al 1994), insufficient information currently exists to enable the
formulation of guidelines on the management of affected women. In view of the
pregnancy associated changes in the coagulation system, pregnancy may act to
unmask thrombophilia in young women and an assessment of the need for
thromboprophylaxis in pregnancy and the puerperium should be made.
Prophylactic treatment, usually with subcutaneous heparin, appears to reduce the
incidence of thrombosis in AT III deficiency (Douglas et al 1990). The dose of
subcutaneous heparin should be adjusted to maintain the APTT 5-10 seconds above
the normal value on a sample taken immediately prior to heparin administration.
Monitoring of APTT and platelet count should be carried out at least fortnightly.
When delivery is imminent, the heparin is reduced to 5000 i.u. twice daily and ATIII
concentrate infused on alternate days to maintain the ATIII concentration greater than
80% of normal. Following delivery, ATIII infusions and heparin are continued for
seven days, then warfarin can be employed as the risk of postpartum haemorrhage
will have diminished by that time. Low molecular weight heparins have been
successfully employed for prophylaxis in ATIII deficient women (Henny et al 1986,
Manson et al 1991) and may be superior to unfractionated heparin (Manson et al
1991). However, further and more extensive evaluation of these compounds is
required in this situation. Warfarin should continue for 3 months or indefinitely if
there is a past history of thromboembolism. Oestrogen containing contraceptives
should be avoided as they are associated with thrombosis, but the progesterone only
pill appears suitable. Similarly, those women who carry the factor V Leiden mutation
are at additional risk of venous thrombosis while taking the oestrogen containing
contraceptive (Vandenbrouke et al 1994) and alternative contraceptive measures
should be advised.
The risk of thrombosis with Protein C and Protein S deficiency appears to be much
less than with ATIII deficiency, although superficial thrombophlebitis is more
common. Conard et al (1990) have reported on 93 pregnancies in 36 patients with
protein C deficiency and 44 pregnancies in 17 patients with protein S deficiency. In
the absence of anticoagulant therapy the incidence of thrombosis during pregnancy
was 7% and 0%, and during the puerperium 19% and 17% for protein C and protein S
deficiency respectively. While there is a clear case for prophylaxis in the puerperium,
the need for prophylaxis in pregnancy is less certain, especially in protein S
deficiency. However, all these conditions should be considered and preferably
evaluated prepregnancy in women with a previous history of thrombosis or
pregnancy problems.
The major acquired thrombophilic problem seen in pregnancy is lupus anticoagulant
or anticardiolipin antibody syndrome (Lubbe & Butler 1992). In obstetric medicine
lupus anticoagulant is associated not only with thrombotic problems but also with
recurrent fetal loss and intrauterine death (Nilsson et al, 1986), pre-eclampsia, growth
retardation and chorea gravidarum (Branch et al, 1985; Lubbe et al, 1984; Lubbe &
Walker, 1983). The aim of the 'traditional' treatment of lupus anticoagulant in
pregnancy was to suppress autoantibody production with steroids and inhibit platelet
function with aspirin. A coagulation test to assess lupus anticoagulant should be
monitored and when this returns to normal steroids may be reduced to a maintenance
dose. However, the use of steroids in this condition has recently come into question.
A combination of heparin (10,000 i.u. twice daily) and low dose aspirin may be as
effective as aspirin and steroids while avoiding the side effects of chronic steroid
therapy (Cowchuk et al 1992). In addition, it may be that aspirin alone, in the absence
of major maternal thromboembolic events, may be as good as combination therapy
for fetal outcome. However, more information in this area is urgently required in
order to guide treatment. Recently, the use of intravenous immunoglobulins and fish
oil derivatives has been reported to improve outcome, but these studies were
uncontrolled (Buckley 1994).
1.6 Treatment ofDVT
The administration of anticoagulant therapy to prevent further thromboembolic
complications and extension of any existing thrombus has been shown to reduce
mortality from DVT from 13% to 0.7% (Villa Santa 1965). The acute therapy for
DVT/PTE is heparin and this is no different in pregnancy. Most regimes employ
intravenous administration of a bolus of 5,000-10,000 i.u. followed by a continuous
infusion of 1,000-1,600 i.u. per hour for 5-10 days. Subcutaneous therapy may be a
satisfactory alternative to continuous intravenous therapy as it is a more practicable
treatment regime for patients and staff. The risk of haemorrhagic complications with
subcutaneous therapy does not appear to be any greater than with continuous
intravenous infusion (Andersson et al 1982, Hull et al 1986a) and the efficacy appears
to be equally good in terms of recurrent thromboembolism (Andersson et al 1982).
A variety of tests are available for monitoring heparin therapy. These include the
activated partial thromboplastin time (APTT), the heparin level measured by the
protamine sulphate neutralisation test (PSNT), the thrombin clotting time and factor
Xa inhibitory activity (anti-Xa). Perhaps the most commonly used of these is the
APTT. This should be maintained in the range 1.5-2 times the normal result since
animal and clinical studies have shown an APTT of <1.5 times the normal level to
be associated with thromboembolic recurrence while on therapy (Zucher & Cathay
1969, Basu et al 1972). The risk of haemorrhagic complications does not correlate
well with APTT however (Pitney et al 1970, Hirsh 1986) and haemorrhagic
complications appear to be related more to other factors such as heparin level or an
underlying haemorrhagic tendency. The anti-platelet effects of unfractionated heparin
may also contribute to the haemorrhagic effects of high heparin levels. In some
patients with venous thrombosis, very high doses of heparin are required - in excess
of 50000 i.u./day, to prolong the APTT by 1.5-2 times the normal mean. Such
patients are often termed heparin resistant. It has been shown that the anticoagulant
effect of heparin is markedly decreased in late pregnancy with approximately 1.5
times as much heparin being required in pregnancy to double the APTT compared to
the non-pregnant situation (Whitfield et al 1983). This phenomenon may be related to
high concentrations of procoagulant factors particularly factor VIII (Hirsh 1986) and
the increased plasma volume (Bonnar 1976) found in late pregnancy. Because of
these difficulties some workers suggest that the PSNT is more useful (Letsky and de
Swiet 1984) as a monitoring test in pregnancy. This test calculates the heparin
concentration from the amount of protamine sulphate required to neutralise the effect
of heparin on the thrombin clotting time (therapeutic range 0.6-1.0 i.u./ml).
Following the acute phase of therapy, chronic anticoagulation is required. In view of
the problems of warfarin in pregnancy (see above) heparin is preferable. This is
given as 10,000 i.u. heparin twice daily subcutaneously and can be administered in a
small volume if a concentrated heparin solution (50,000 i.u./ml) is employed.
Monitoring is rarely necessary unless larger doses are being used or in special
situations such as antithrombin III deficiency where it may be important to ensure that
adequate heparin levels have been obtained. Since such low dose heparin does not
affect the conventional coagulation tests, therapy is monitored by the anti-Xa activity
method of Denson and Bonnar (1973), and levels should be maintained at less than
0.4 u/ml. At such levels, there appears to be no risk of bleeding in labour (Hathaway
& Bonnar 1987) and blood loss during caesarean section performed following
subcutaneous low dose heparin is no different from that following placebo (Hill et al
1988). In the puerperium, the heparin dosage can be reduced to 7500 i.u. twice daily
subcutaneously as recommended by de Swiet (1985) or 5000 i.u. three time a day. In
view of the risk of haemorrhage if warfarin is employed in the early puerperium,
heparin should be continued for at least 7-10 days. After this time warfarin may
safely be used. In the case of an antenatal thrombosis, treatment should be continued
throughout pregnancy and for at least six weeks following delivery as it takes some
time for the "physiological coagulopathy" of pregnancy to disappear. Six weeks
therapy seems satisfactory for a simple post partum DVT but a longer period of three
months or more may be required in the case of a PTE or a very extensive DVT.
If warfarin is employed, it should be started approximately three days prior to
stopping heparin, due to the time required for its maximal effect to occur. Various
regimes exist for warfarin loading. A satisfactory one is 20 mg on the first day of
warfarin therapy, 10 mg on the second day, then stop the heparin and maintain
anticoagulation with a maintenance dose of warfarin which should be titrated against
the prothrombin time which is the most satisfactory test for warfarin's anticoagulant
effect. The heparin should not be stopped until the prothrombin time is in the
therapeutic range (2.0-4.0 times the normal control plasma).
Should heparin therapy fail to prevent recurrent thromboembolism despite adequate
anticoagulation, or if there is extension of clot into the common iliac veins or inferior
vena cava itself, the insertion of a vena cava filter may be required to prevent PTE.
These filters are inserted into the inferior vena cava via the femoral or jugular veins
and lodged below the renal veins, although in pregnancy or in the presence of
extensive thrombus reaching the region of the renal veins they may be sited between
the renal veins and the intrahepatic section of the inferior vena cava. The Cardial
filter has been used successfully in pregnancy (Narayan et al 1992) and is probably




The importance of accurate diagnosis ofDVT in pregnancy cannot be overstressed as
the presence of a DVT places the woman at substantial risk of PTE, while
anticoagulant therapy without a firm diagnosis may subject the woman to unnecessary
and potentially dangerous anticoagulant therapy. The most common clinical features
are pain, tenderness, swelling, oedema, Homan's sign, a change in leg colour and
temperature, and a palpable thrombosed vein. Over 80% of DVT in pregnancy are
left sided (Lindhagen et al 1986). However, the clinical diagnosis of DVT is
unreliable having both a low sensitivity and a low specificity with less than 50% of
cases of DVT including those involving major proximal veins being recognisable
clinically, while venography substantiates the diagnosis in only about 40% of patients
with clinical findings compatible with DVT (Genton & Turpie 1980, Ramsey 1983).
It is also noteworthy that the majority of women dying from PTE had no clinical
evidence of DVT yet thrombus was found in leg and pelvic veins at post-mortem
(Department of Health et al 1991). Objective diagnosis is therefore essential. Despite
this, a survey among general physicians in Scotland in 1982 showed that 47% were
diagnosing (and presumably treating) DVT on clinical diagnosis alone (Prentice et al
1982) and obstetricians may have been no different. Ramsay (1983) has estimated,
that by using clinical diagnostic criteria alone, that 2 patients out of every 3 would
receive anticoagulants unnecessarily. The causes of "pseudothrombo-phlebitis"
include ruptured Bakers cyst, muscular injury and cellulitis, although the presence of
such diagnoses does not exclude DVT as a Bakers cyst and DVT not uncommonly
coexist (Belch et al 1981).
In view of the low sensitivity and specificity of clinical diagnosis outlined above it is
crucial that an objective assessment of DVT is performed particularly in the pregnant
patient. Perhaps the biggest contribution the clinician can make is to be aware of the
presence of risk factors and alert to the possibility of the diagnosis which should not
depend on clinical examination alone to establish or refute the presence of
thrombosis.
1.7.2 Venography
Venography remains the "gold standard" of the objective tests for DVT. It is an
invasive technique but has the greatest degree of sensitivity and specificity of all the
objective tests, and is the technique against which other techniques are compared. In
the hands of a skilled radiologist it will probably detect up to 95% of peripheral
thrombi (Browse, 1978). However, a number of studies have recently demonstrated
considerable inter-observer variation in the evaluation of venograms in non-pregnant
patients with suspected DVT (Lea Thomas et al 1991), in thromboprophylactic
studies (Wille-Jorgansen et al 1992, Couson et al 1993) and in the evaluation of
phlebographic changes produced by thrombolytic therapy (Bounameaux et al 1992).
Furthermore, at least 10% of contrast venograms performed in non-pregnant subjects
are inadequate for interpretation (Huisman et al 1986). There are also risks associated
with venography. These include pain at the time of injection of contrast,
hypersensitivity to the medium, or rarely extravasation of the medium resulting in
damage to the skin of the foot. Thrombosis can occur secondary to venography due
to the irritant effects of the hyperosmolar media on the venous endothelium and may
be lessened by elevating the legs and flushing the legs with isotonic saline or by
giving a single dose of heparin after the examination, although studies have not
confirmed the effectiveness of the latter option (Bettman & Paulin 1977, Cranley
1975). Lowering the osmolality of contrast media will reduce the irritant effects and
subsequent DVT formation (Bettman & Paulin, 1977) although it will not be
abolished. The use of a non-ionic low osmolality medium has been shown not be
provoke thrombosis compared to an ionic hyperosmolar medium (Albrechtsson &
Olsson 1979).
There has been a reluctance to employ venography in pregnancy because of the
radiation hazard to the fetus. A 2.4-fold increase in the risk of childhood cancer has
been associated with prenatal X-ray exposure (plain films of the abdomen or
pelvimetry) during the third trimester (Harvey et al 1985). However, this problem can
be alleviated by performing limited venography, where the uterus is be shielded so
that the direct radiation dose to the fetus is small and less than with X-ray pelvimetry
(Laros & Alger 1979). The risks of unwarranted anticoagulation must also be
considered. Where clinically indicated, such in severe thrombotic problems,
venography should still be employed if it is deemed necessary for optimal patient
management.
1.7.3 Impedance plethysmography
Impedance plethysmography (IPG) is non-invasive, indirectly measuring changes in
the volume of a limb by the change in electrical resistance across it. Following
inflation of a thigh cuff the venous outflow of the limb is occluded. In the absence of
any obstruction to venous flow, release of the cuff will result in a rapid outflow of
blood and an associated change in electrical resistance as measured between 2
electrodes placed round the limb. In the presence of venous thrombosis the rate of
emptying will be reduced. In the non-pregnant this technique has been shown to have
a sensitivity ranging from 63% to 95% and a specificity of 83% to 96% in the
detection of proximal occlusive venous thrombi (Ramchandani et al 1985, Hull et al,
1984, Anderson et al 1993). Up to 80% of false positive tests may be attributed to the
presence of non-vascular space occupying lesions (such as Baker's cysts) which act to
reduce the rate of venous drainage from the limb (Huisman et al, 1986) and cannot be
differentiated by IPG. However, despite the physiological changes in venous flow in
pregnancy due to reduced venous tone, and obstruction to flow by the gravid uterus,
this technique can still be successfully employed in pregnancy provided the
physiological changes are taken into account (Clarke-Pearson & Jolovsek, 1981). In
view of the risk of false positives result from external compression, however, it would
seem prudent to confirm the diagnosis by venography or ultrasound. The main
disadvantage of this technique is its very poor sensitivity in detecting calf vein
thrombosis (Hull et al, 1976) and non occlusive thrombi. While this technique may
still have a role in screening it has been largely superseded by the increased
availability of ultrasound imaging.
1.7.4 125i-Fibrin0gen scanning
This technique is now only of historical interest and has no place for screening or
diagnosis in the pregnant or post-partum situation. In pregnancy, radio-iodine may
cross the placenta and the breast and accumulate in the fetal or neonatal thyroid. In
the non-lactating mother it has been used post-partum as employed by Friend &
Kakkar (1970). The mother's thyroid can be protected by the concomitant
administration of potassium iodide to prevent uptake of radioactive iodine. A recent
review has shown many of the studies demonstrating the accuracy of this technique to
be flawed (Lensing & Hirsh 1993); in many of the published studies on surgical and
orthopaedic patients, interpretation of scan results was not carried out independently
of venogram results, with which the technique was compared. In those studies where
independent interpretation was documented, therefore minimising bias, a sensitivity
of 55% was estimated. Lensing & Hirsh (1993) have therefore called into question the
validity of the many studies which used 125j_ Fibrinogen scanning as the test of
efficacy when evaluating thromboprophylactic agents. Concern over the true accuracy
of the technique and the theoretical possibility of viral transmission has led to the test
being withdrawn from clinical use.
1.7.5 Other diagnostic techniques
Liquid crystal contact thermography has also recently undergone evaluation as non¬
invasive screening methods for DVT after general surgery. However, the sensitivity
and specificity of the technique is poor (Bounameaux et al 1992). The effect of
pregnancy on the peripheral microvasculature further reduces the specificity of the
technique and its use has not become established. Recently the measurement of D-
Dimer in plasma has been found to aid the diagnosis of suspected DVT and PTE
(Bounameaux et al 1989, 1992) and may provide a useful test to exclude the presence
of DVT or PTE or aid the diagnosis where other investigations such as the
ventilation/perfusion lung scan is equivocal. Although this technique has not be
assessed in a pregnant population, it may still provide assistance with the diagnosis
in this situation, at least in the absence of other complications, such as severe pre¬
eclampsia or major haemorrhage with disseminated intravascular coagulation. This
technique is worthy of further evaluation in pregnancy.
Isotope venography using radiolabeled albumin platelets or red blood cells (Lisbona
et al 1982) has been used in the non-pregnant however these techniques have not been
fully evaluated and in view of the radiation hazards are unlikely to find any place in
the diagnosis of DVT in pregnancy.
A technique with greater promise in pregnancy is that of light-reflection rheography
which has been shown to be as accurate as other non-invasive tests in the diagnosis of
deep venous thrombosis in non-pregnant patients (Thomas 1991, Mitrani 1989). This
non-invasive method uses light emitting diodes and a sensor to measure light
reflected from the skin surface. The intensity of the reflected light establishes a
graphic pattern that indirectly quantifies parameters of venous function by measuring
changes in the microcirculation. A recent study indicated the utility of the technique
in pregnancy if the sitting position is adopted, as this prevents artefactual effects
secondary to the presence of the gravid uterus (Allbert at al 1991). Further assessment
of this technique in pregnancy and the puerperium is required.
1.7.6 Ultrasound techniques
In recent years, several ultrasound techniques have been applied as a quick non¬
invasive means of assessing venous thromboembolic disease and it has now become
the first choice investigation for DVT in pregnancy.
Continuous wave Doppler ultrasound
Continuous wave Doppler imaging is the most basic technique and involves the use of
a hand-held pencil-like device, the probe of which contains two transducers. One
continuously sends sound waves while the other continuously receives a signal. It
lacks any focusing ability, has no range resolution and does not permit interrogation
of any particular vessel. However, the femoral and popliteal veins can be assessed by
evaluating three Doppler parameters; (1) Spontaneous venous flow, which is easily
detected in large vessels, (2) Phasic variation of venous flow occurring during the
respiratory cycle, (3) Augmentation of flow which occurs when a more distal part of
the leg is compressed. This indicates patency between the point of compression and
the sampling site. Meaningful results are difficult to achieve with continuous-wave
Doppler. Non-occlusive thrombosis may not alter blood flow sufficiently to affect the
signal. The overall sensitivity and specificity in testing the symptomatic patient are
inadequate to maintain widespread use of the technique when compared to real-time
ultrasound (Nix et al, 1989, George et al 1990).
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Duplex Doppler ultrasound
The combination of real-time imaging with pulsed Doppler (duplex scanning) enables
visualisation and sampling of the Doppler characteristics of a specific vessel by
placing the range gate within the vessel lumen. The physical principles underlying the
application of Doppler ultrasound to blood flow assessment are discussed in Chapter
2 but in essence, this equipment pulses the Doppler signal, which controls the range
or depth in tissue that is sampled by altering the length of time the system waits after
sending a pulse to record the Doppler information. A completely absent signal or a
continuous but non-variable signal is interpreted as abnormal, the latter indicating
proximal obstruction or collateralisation of venous flow (Plate 1.1).
Thrombus Visualisation.
Direct real-time visualisation of thrombus is possible (Sullivan et al. 1984, Aitken &
Godden, 1987) (Plate 1.2) but of little clinical use. Clot echogenicity is variable,
dependent on transducer frequency, age of clot and extent of the thrombolytic
process. The echogenicity of a clot does not indicate whether it is acute nor does it
permit assessment of the age of the clot (Murphy et al 1990). Additionally, slow
flowing blood can appear sufficiently echogenic to mimic the appearance of the clot
(Machi et al 1983).
Valsalva Manoeuvre
The normal physiological response of the femoral vein to the Valsalva manoeuvre is a
50-200% increase in vessel diameter. If thrombus is present the vessel demonstrates a
limited or absent response. This finding is effective in the upper femoral region but
the response rapidly diminishes in the more distal parts of the leg. Excellent patient
co-operation is required for adequate performance of this technique (Effeney et al
1984). Although a normal increase in vein diameter excludes DVT, an abnormal
response is not specific for thrombus and may be due to extrinsic causes of vessel
compression or to congestive cardiac failure. The gravid uterus does not appear to
prevent the valsalva response at the femoral vein and it has been described as a
diagnostic method in pregnancy (Duddy & McHugo 1991).
Venous compression
The compression technique for venous clot continues to constitute the principal
method of ultrasound assessment for DVT. The deep veins may be examined from
the level of the inguinal ligament to the bifurcation of the popliteal vein as it extends
into the tibial and peroneal veins (Aitken & Godden 1987). The femoral veins are best
evaluated in the supine position while the popliteal veins may be examined in the
decubitus position, with the patient lying prone with the legs flexed 20°, or by
elevating the foot and leg and scanning from below (Cronan 1993). The gain should
be set so that normal vessels appear free of internal echoes. This can be achieved by
determining that the accompanying artery is free of internal noise. The vessel should
first be examined in the longitudinal axis to localise the vein but compression is best
applied in the transverse axis since the transducer will not roll off the vessel.
Compression should be applied sufficient only to dimple the overlying skin. If the
artery is compressed, excessive pressure has been used. The lumen of a thrombus-free
vein will completely collapse on compression (Plate 1.3), while DVT will prevent co¬
aptation of the venous wall (Cronan et al 1987). In the symptomatic patient, clot
usually extends over one or more venous segments (Markel et al 1992) so continuous
compression assessment over every millimetre of the vessels length is unnecessary.
The confirmation of normal compressibility at 2cm intervals may be interpreted as a
thrombus free vessel (Cronan 1993). In the area of the inguinal ligament and in the
adductor canal, complete compression of the vessel is difficult without applying
additional, and possibly painful, compressive force. If uncertainty as to the
compressibility of a deep vessel remains, the opposite leg can be examined as a
control. Alternatively, patency can be determined using pulsed Doppler or colour
Doppler techniques. Despite these limitations, compression ultrasound has been
extensively validated against venography. If the results of a series of studies are
pooled a sensitivity of 95% for detecting lower extremity DVT and a specificity of
98% can be demonstrated (Cronan et al 1987, Naidich et al 1988, Raghavendra et al
1984, Raghavendra et al 1986, Cronan et al 1988, Sullivan et al 1984, Duazat et al
1986, Vogel et al, 1987, Appelman et al 1987, Langsfield et al 1987, Aitken
&Godden 1987, George et al 1987, Oliver 1988, O'Leary et al 1988, White et al 1989,
Lensing et al 1989, Monreal et al 1989, Habscheid et al 1990, Mussarakis et al 1990).
Assessing outcome after a negative compression ultrasound scan also demonstrates
the reliability of the technique (Vaccaro et al 1990, Sarpa et al 1989). Recently, a
large prospective randomised trial comparing serial compression ultrasonography
with serial impedance plethysmography for the diagnosis of DVT using contrast
venography as a reference has confirmed the positive predictive value of an abnormal
ultrasound test to be 94% compared to 83% for impedance plethysmography. In non¬
pregnant patients with repeatedly normal results, the incidence of venous
thromboembolism during the six-month follow-up period was 1.5% for compression
ultrasound and 2.5% for serial impedance plethysmography (Heijboer et al 1993).
Although there are no comparative studies in the literature on the use of compression
ultrasound in pregnancy, it is now being successfully employed for DVT diagnosis in
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pregnancy (Greer et al, 1990, Polak & Wilkinson 1991). It can also be combined
with pulsed Doppler ultrasound and Doppler colour flow mapping to facilitate the
diagnosis of thrombus.
Colour Doppler ultrasound
Colour Doppler ultrasound uses computer processing to assess multiple gates
simultaneously. The entire real-time image can be interrogated for Doppler shifts
(Mitchell 1990). Moving blood produces a Doppler shift dependent on blood flow
velocity and the angle subtended by the ultrasound beam (the Doppler angle). Flow is
assigned a colour based on direction and a shade based on Doppler frequency shift. A
normal vein should fill with colour whereas thrombus is represented as a filling defect
(Plate 1.4). If the colour gain is set to high, colour may appear outside the vessel
wall, making detection of mural thrombus difficult. The value of complete colour
filling of the vessel lumen to exclude thrombus appears to reside principally in the
reduction in time required to assess the veins, and in the ability to identify and
examine smaller veins for thrombus (Rose et al 1990, Mattos et al 1992).
1.7.7 Calf vein thrombus
The clinical importance of calf vein thrombi remains controversial. There is now a
considerable body of evidence suggesting that significant emboli do not embolise
from isolated calf veins (Meibers et al 1988, Cohen et al 1988, Philbrick & Becker
1988, Moser & Le Moine 1981). Venogram and duplex ultrasound studies have
indicated that 10-20% of calf vein thromboses propagate proximally (Meibers et al
1988, Philbrick & Becker 1988). Thus calf vein DVT contribute only a small
proportion of DVT causing PTE. However, if PTE is to be prevented then treatment
of isolated calf vein thrombi should be considered (Havig 1977), particularly as the
relationship between calf vein thrombi and postphlebitic syndrome remains uncertain
(Lagerstedt et al 1985, Lohr et al 1991). In the pregnant patient, isolated calf vein
thrombi appear uncommon as most clinically significant thrombi are found in the
ileofemoral segment in pregnancy (Bergqvist & Hedner 1981). However, should calf
symptoms persist after a negative proximal leg assessment, the possibility of proximal
extension into the popliteal vein should be considered and the veins assessed 3-5 days
later (Huisman et al 1986), although only 5% of those offered return for follow up
examination (Cronan et al 1988). More recently, imaging of the calf veins with
colour flow Doppler has been reported (Polak et al 1989). Blood flow is often very
slow in the small veins of the calf and slow-flow Doppler capabilities are required.
Asking the patient to adopt a sitting position and the use of augmentation can aid
vessel visualisation. Using these techniques, the sensitivity for detection of clot can
approach 85% (Yucel 1991).
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1.8 Diagnosis of pulmonary thromboembolism
The signs and symptoms of PTE depend on the number and size of the emboli and
arise from mis-matching of ventilation and perfusion, reduced cardiac output due to
arterial obstruction, and infarction or collapse of lung segments. Clinical features are
non-specific and just as in the non-pregnant include dyspnoea, pleurisy, haemoptysis,
chest pain, abdominal pain, hypertension, fever, collapse and sudden death. The
differential diagnosis will include chest infection, pneumothorax, aspiration, amniotic
fluid embolism and myocardial infarction. Like DVT, the bedside diagnosis of PTE
is unreliable. The classic triad of dyspnoea, pleuritic pain and haemoptysis is present
in only a fifth of patients with major PTE (Wenger et al, 1972) and pulmonary
embolus is diagnosed in less than one third of episodes (Windebank, 1987). In view
of these non-specific symptoms the clinician must remain vigilant to the possibility of
PTE. Traditionally, initial investigations include ECG, chest X-ray and blood gases.
However, these tests are of no diagnostic value for PTE (Robin, 1977). They may
initially be normal and the ECG may show changes resulting from the effects of
pregnancy itself on the heart in the absence of PTE. The main use of these tests is in
helping to exclude other pathology. Chest X-rays, ECG and arterial blood gases not
in keeping with the diagnosis of PTE were the principal reasons for treatment not
being given in many of the cases in the Confidential Enquiries (Department of Health
et al, 1991) yet symptoms or signs such as dyspnoea, chest pain, hyperventilation and
cyanosis were present. A ventilation-perfusion isotope lung scan should be obtained
if PTE is suspected. The radiation dose to the fetus is low. A ventilation perfusion
mismatch is suggestive of PTE. A normal result effectively excludes the possibility
of PTE. An abnormal result showing normal ventilation and a perfusion defect which
is segmental or larger is size is diagnostic of PTE (Windebank, 1987). With smaller
defects the diagnosis is far from certain (McBride et al, 1986; Hull et al, 1986b) as
other conditions can cause sub-segmental mis-match. In addition matched defects do
not always indicate a chest problem other than PTE, as one third of patients with
matched defects have been shown to have PTE (Windebank, 1987). In patients in
whom the ventilation-perfusion scan shows sub-segmental mismatching then
ultrasound imaging of the deep veins or venography should be performed as this may
help reach a decision regarding treatment (Genton & Turpie, 1980). Although since
one third of patients with PTE have no evidence of DVT (Hull et al 1986b), a
negative bilateral lower limb compression ultrasound study cannot exclude PTE
(Sciff 1987).
1.9 Ultrasound in assessing chronic venous disease
Old thrombus may mimic the appearance of acute thrombus when imaged with
ultrasound. In most cases of acute thrombus, however, resolution of the of thrombus
occurs during the first 6 months. After 6 months, approximately 48% of the veins
have demonstrable abnormalities on ultrasound examination and 52% appear
completely normal (Cronan & Leen 1989). The abnormalities described include a
small proportion (14%) that appear completely occluded. A larger percentage of veins
show partial recanalisation with a residual clot organised along the vessel wall (Sevitt
et al 1973) which being thickened resists compression. When the vein is compressed,
the residual lumen collapses, but the original vein walls remain separate, resulting in
an appearance consistent with that of acute non-occlusive thrombus. Ultrasound
assessment of venous diameter can aid in determining the age of thrombus. Whereas
acute thrombus causes dilatation of the vessel often to twice the size of the adjacent
artery (Murphy et al 1990), in the presence of old thrombus, the vein is of similar size
to the adjacent artery. The presence of collateral vessels, while indicating chronic
disease does not exclude acute on chronic disease. Colour Doppler may be of
assistance in assessing the true thickness of the vessel wall when partial occlusion by
an acute thrombus is suspected but in difficult cases serial ultrasound examinations to
look for changes suggestive of acute DVT or venography may be required.
1.10 Interpretation of venous ultrasound in pregnancy
The assessment of ultrasound techniques in pregnancy has been limited. Little data
exist on the normal changes in pregnancy and the puerperium and how they may
alter the anatomy of the deep veins of the leg and the flow characteristics as detected
by Doppler. Interpretation, particularly in late pregnancy may therefore be difficult. In
view of its non-invasiveness, safety and high degree of sensitivity and specificity
ultrasound is now the first choice, first line diagnostic technique for DVT in
pregnancy. A better understanding of the interpretation of deep venous ultrasound in
pregnancy is therefore essential.
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1.11 Conclusion
Thromboembolism contributes substantially to maternal mortality and morbidity but
the true incidence in pregnancy and the puerperium is uncertain. The clinician must
be aware of the risk factors for thromboembolism which are often present in patients
who go on to develop DVT or PTE. The risk can be reduced by thromboprophylaxis
with agents such as low dose heparin, and graduated compression stockings and the
wider use of such prophylaxis in high and moderate risk situations associated with
pregnancy should be encouraged. Furthermore, the clinician must be alert to the
possible diagnosis of thromboembolism in pregnancy or the puerperium and utilise
objective diagnostic investigations such as ultrasound examination.
Plate 1.1 Occlusive thrombus is present in the vessel shown. The Doppler flow
signal from the sampled region is consistent with absent flow.
Plate 1.2 Echogenic thrombus is seen to distend the CFV, imaged in the
transverse section.
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Plate 1.3 The lumen of the CFV, imaged in transverse section (a) has collapsed
on application of compression, indicating a thrombus free segment (b).
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Plate 1.4 Colour flow is seen to fill the artery adjacent to the vein which




Venous haemodynamics in pregnancy;
thrombogenesis and prophylaxis
Summary
Clinical and epidemiological evidence points to the role of venous stasis as an
initiating factor in thrombogenesis. Mechanisms by which stasis may lead to
thrombus formation include the accumulation of clotting factors, hypoxia leading to
endothelial damage and altered shear forces. Venous dilatation may occur under the
same conditions associated with stasis and can cause damage to the endothelium and
basement membrane sufficient to expose thrombogenic tissues. The literature relating
to the effects of pregnancy on deep venous anatomy and flow suggests that reduced
venous flow velocity may result from increasing venous distension, both of which
may predispose to thrombus formation. Little contemporary data quantifying these
changes is available however. Pregnancy associated alterations in blood flow
rheology may also play a role, although it is probably the combination of these
physiological changes which act to increase the pregnant womans risk of
thromboembolic disease. The efficacy of physical means of thromboprophylaxis
further support the role of stasis and vessel dilatation in initiating thrombogenesis,
although their precise means of action remains uncertain.
2.1 Introduction
In 1856 Virchow presented his classic triad, stating that changes in blood elements
(hypercoagulable state), reduced flow velocity (stasis), and vein wall injury combined
to create a setting that promotes thrombus formation. It has been known for over 200
years , however, that static blood left for many hours in isolated veins does not clot
(Hewson 1771, Lister 1863) and contemporary studies have demonstrated that simple
stasis alone is not associated with thrombus formation (Thomas et al 1985, Aronson
& Thomas 1985). Yet the crucial role of stasis in enabling the initiation of
thrombogenesis is borne out by clinical and epidemiological evidence. A study of 2
groups of spinal cord injury patients, one with paralysis and the other without
demonstrated a 100% incidence of deep venous thrombosis in the paralysed group,
but none in the non-paralysed patients (Myllynen et al 1985), and in a study of acute
stroke patients, the paralysed limbs had a 63% rate of thrombosis as compared to only
7% in the non-paralysed limb (Warlow et al 1976). Autopsy studies show a
relationship between bedrest and venous thrombosis (Sevitt & Gallagher 1961), and
demonstrate the soleal sinuses to be the principal site of venous thrombogenesis
(Gibbs, 1957). Additionally, post-operative patients have been shown to be at higher
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risk during the period of immobility (Gallus 1976) while devices designed to reduce
venous stasis have been demonstrated to be effective in preventing post-operative
venous thrombosis (Caprini et al 1988).
2.2 Stasis and thrombogenesis
Several theories have been put forward to explain how stasis may lead to
thrombogenesis. Mammen (1992) has postulated that stasis permits prolonged
interaction between the prothrombotic coagulation proteins with a lack of dilution and
clearance by free flowing blood of activated clotting factors, which may accumulate
locally, while blood coagulation inhibitors are locally consumed. Autocatalytic
activation of the coagulation may then occur, leading to further local
hypercoagulation (Davie et al, 1979).
Alternatively, stasis may cause local hypoxaemia which itself results in endothelial
damage. When flow is restored, the damage may attract phagocytic blood cells which
become attached to the damaged endothelium (Malone 1977). However, Thomas
(1983) found no evidence that the vessel wall changes, produced by venous stasis, led
to platelet adhesion and aggregation or thrombus formation. Although Schaub (1984)
was able to demonstrate that stasis of blood can lead to leukocyte adhesion, the
resultant endothelial damage and exposure of subendothelial collagen previously
described by Stewart et al (1974), only occurred after prolonged (>24 hours) stasis.
Although leukocyte adhesion to and migration through the endothelium appears to be
a rapid phenomenon, the resultant thrombosis is slow to develop. Leukocyte
migration almost certainly occurs during venous thrombogenesis but is probably not
causative.
The presence in venous valve pockets of nidi of aggregated platelets and leukocytes
in postmortem specimens has been demonstrated (Sevitt 1974 &1978), and they are
likely sites of thrombus initiation. Other workers have shown that blood within the
valve pockets becomes rapidly hypoxic during induction of stasis (Hamer et al, 1981).
Further evidence for the importance of the venous valve pockets was put forward by
Karino and Motomiya (1984) who demonstrated the existence of a profoundly
stagnant region in the deepest portion of the pockets, where a secondary vortex with
low red cell concentration appears to occur. Finding that fluid circulated in these areas
at extremely low velocities, with the creation of a very low shear field, they showed
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the potential of the secondary vortex to act as an automatic trap for large cellular
aggregates. These may then propagate with resultant thrombogenesis.
The shear forces acting in the presence of flowing blood also merit consideration in
the context of thrombogenesis. Blood flow through large, straight venous segments
has been shown to be parabolic. That is, the velocity is maximal at the centreline and
decreases to zero at the vessel wall. In such conditions, platelets concentrate close to
the vessel wall, while red blood cells are predominantly centrally located (Eckstein et
al, 1988). The shear rate in this context describes the rate at which fluid velocity
changes as one moves radially. This rate is taken to be zero at the centreline and
maximal at the vessel wall (Eckstein et al 1988). The shear stress is the product of the
shear rate and the blood viscosity, and reflects the force per unit area in a direction
tangential to the vessel wall (Goldsmith & Turitto, 1986). However, at low shear
rates, such as those present in large veins, blood behaves as a non-Newtonian fluid in
that its viscosity is dependent on shear rate, being higher at lower rates. In general,
low flow rates and low shear rates occur in the proximal leg veins. Low flow and
shear rates will tend to increase viscosity, further exacerbating local stasis, and thus
predisposing to the initiation of and propagation of venous thrombosis.
Other workers have thrown further light on how shear forces may influence
thrombogenesis. While unstirred platelets do nor spontaneously aggregate, the
application of shear stresses to platelet suspensions can induce aggregation without
the addition of agonists (Peterson et al 1987). Shear stresses can also influence the
nature of platelet surface agonist receptors (Ikeda et al, 1991). Recently Noris et al
(1995) showed that the synthesis of the potent vasoactive mediator, nitric oxide (NO)
by cultured endothelial cells, can be modulated by different flow conditions, with
laminar shear stress being associated with an upregulation of NO synthase mRNA
and NO production. Their findings suggest that constant release of NO by the
vascular endothelium under laminar shear stress may have a physiological role in
maintaining the non-thrombogenicity of the vascular wall. Further, it has been
demonstrated that fluid shear stress can stimulate secretion of tissue plasminogen
activator by cultured human endothelial cells, while plasminogen activator inhibitor
type 1 secretion remains unstimulated (Diamond et al 1990).
Recent work on orthopaedic patients suggests that alterations in deep venous diameter
may also play a role in bringing about the conditions in which thrombus formation
might occur. Although direct injury to the vessel wall may occur locally in patients
undergoing orthopaedic procedures, the commonest sites for DVT are the more
distant veins which are not directly damaged. Endothelial lesions distant to the
operative site have been demonstrated in canine models (Stewart et al 1983, Schaub et
al 1978). These endothelial lesions occurred as multiple microtears at the junction of
tributaries with large veins, such as the femoral veins, and were found to be infiltrated
with leukocytes and platelets, thus serving as potential initiation sites for thrombus.
Anatomic studies have shown that these junction sites are areas of structural weakness
and the possibility therefore arises that dilation of the vein wall may occur beyond
the ability of the endothelium and basement membrane to maintain their integrity at
these points, resulting in intimal mpture and collagen exposure. In 1987 Stewart et al
showed that dilatation of the vessel beyond a critical point was associated with an
increased incidence of venous lesions in a canine model of total hip replacement.
Subsequently, Camerota et al (1987) demonstrated that intraoperative venodilatation
occurred distant to the operative site in human subjects undergoing total hip
replacement. Patients in whom postoperative DVT developed had a mean operative
venodilatation in the contralateral cephalic vein of 28.9% ± 3.9% compared to 11.6%
± 1.6% in those in whom DVT did not develop. Further evidence for the importance
of venous dilatation was provided by the finding that the administration of a
venotonic agent resulted in less operative venodilatation and a lower incidence of
DVT.
2.3 The Effects of Pregnancy
2.3.1 Venous blood flow and anatomy.
The effect of pregnancy on deep venous flow conditions has been a topic of research
interest throughout this century. In 1924, Klee measured the blood flow during
pregnancy using the flourescein method of Koch (1922). He found the circulation
time to be prolonged in pregnancy with the greatest slowing of blood flow occurring
in the eighth month. Only a single observation was made on each of 100 women in
the final trimester of pregnancy. Other studies failed to confirm these findings
however. Spitzer (1933), using decholin, found the velocity of blood flow to be the
same in the pregnant and non-pregnant states, as did Landt and Benjamin(1936). The
cyanide method of Robb and Weiss (1933), which used the nasal flaring response to
the central arrival of peripherally injected sodium cyanide to determine flow velocity,
was employed by Cohen and Thomson (1936) who carried out 100 measurements on
37 pregnant women. They found the average velocity of blood flow in the upper limb
to be normal in the first trimester, increased in the second trimester of gestation
beginning with the seventeenth week, and remained increased until the thirty-fifth
week, decreasing again before term. Other similar studies measuring flow times in the
upper limb confirmed these findings. Venous pressure studies have also
demonstrated marked alterations in the leg veins in pregnancy. McLennan (1943)
carried out serial venous pressure studies in pregnancy, inserting needles into the
antecubital and femoral veins of both normal and pregnant subjects and recorded
intravenous pressures with a manometer. While no gestational changes were
observed in the arms, a gradual and sustained elevation in venous pressure was
observed in the legs as pregnancy advanced, becoming first apparent at the beginning
of the second trimester. Wright et al (1950), injecting saline labelled with 24Na into
the dorsum of the foot and timing its appearance at the groin with a Geiger counter,
demonstrated parallel changes in blood flow in the leg veins with advancing
gestation. The first appreciable increase in foot-groin flow times also occurred at the
beginning of the second trimester. Plethysmography studies examining primarily the
effect of pregnancy and the oral contraceptive pill on venous distensability also
provided further data on lower limb venous blood flow velocity (Goodrich & Wood
1964). In these studies, the mean flow velocity within the examined limb was
calculated by dividing the blood flow though the limb (derived from the water
plethysmography) by the cross sectional area of the limb. By these rather crude
means, a reduction in venous flow velocity was observed in the calf in the third
trimester. Using continuous wave Doppler techniques, Ikard et al (1971) found a
reduction in femoral venous flow velocity with advancing gestation and in relation to
maternal position and Schlunk & Goeltner (1974) observed a reduction in venous
blood flow velocity of 43% at term. The described studies provided limited
information as to the changes occurring in individual vessels and further studies of
blood flow velocity in pregnancy were limited by the need for an accurate, non¬
invasive technique which enabled scrutiny of individual vessels.
In 1988, Baumann et al published data on femoral vein diameter and flow velocities
in pregnancy obtained using duplex Doppler ultrasound techniques. Measuring the
diameter of the femoral vein of 21 subjects at 4 weekly intervals between 20 weeks
gestation and 12 weeks postpartum, they observed an increase in mean femoral vein
diameter from 10.8mm at 20 weeks to 11.9mm at 39 weeks, falling to 7.5mm at 12
weeks postpartum. A reduction in time averaged flow velocity was found to be
already present at the beginning of the second trimester, but no further gestation
dependent changes were observed.
Reduction in venous bloodflow velocity may be related to increasing venous
distensability and pressure and reduced arterial inflow. Venous distensability
increases throughout pregnancy (Clark-Pearson & Jelovsek 1981, Goodrich & Wood
1964). This increase occurs early in pregnancy due to decreased venous tone. During
pregnancy, venous capacity can increase by up to 50%, with a marked rise in the first
and second trimester, but little further increase in the third trimester (Clarke-Pearson
& Jelovsek 1981)
Little further contemporary data exists on the normal alterations in venous diameter
which occur in pregnancy. However, it can be postulated that venous dilatation
occurring as a response to pregnancy associated changes in smooth muscle tone and
increased venous pressure secondary to the effects of the gravid uterus on venous
return from the deep leg veins, might result in progressive venous dilatation sufficient
to cause microtears at the junctions of tributaries with the common femoral vein, thus
exposing thrombogenic subendothelial collagen, and initiating thrombogenesis.
2.3.2 Rheology
Pregnancy is associated with a fall in whole blood viscosity secondary to
haemodilution of cellular blood components (Lowe 1992). This usually outweighs
increases in plasma viscosity (Inglis et al 1982, Huisman et al 1987) and red cell
aggregation arising as a result of the rise in plasma fibrinogen (see Chapter 1) until
the third trimester, when increases in low shear whole blood viscosity are observed
(Lowe 1992) As described earlier, however, lower flow velocity and shear rates can
result in local increases in blood viscosity, increasing its resistance to flow. While
there are no reported studies of the relationship between blood viscosity and venous
thromboembolism in pregnancy, increases in blood viscosity under low shear and
low flow conditions may contribute to deep venous thrombosis (Lowe 1984).
2.4 Stasis, venous dilatation and thromboprophylaxis.
Whatever the precise mechanisms by which stasis leads to thrombosis, the efficacy of
physical means of thromboprophylaxis underline its importance. The mostly widely
used physical means of thromboprophylaxis today are graduated compression
stockings and several groups have demonstrated their efficacy in preventing post¬
operative DVT (Scurr et al 1977, Allan et al 1983, Jeffery & Nicolaides 1990). Early
studies on the effect of graduated compression on venous haemodynamics indicated
that their thromboprophylactic effect resulted from an increase in flow velocity within
the deep veins of the legs (Sigel et al, 1973). This work provided further clinical
evidence for the importance of haemodynamics in thrombogenesis. In recent years,
however, the means by which compression stockings prevent thrombosis has come
under further examination and while the mechanisms remain uncertain, it appears that
they may exert their prophylactic effect by means other than preventing stasis.
Coleridge et al have demonstrated that venous distension occurs in lower limb veins
during surgical procedures (1991), potentially resulting in the exposure of
thrombogenic subendothelial collagen and that intraoperative venous distension can
be corrected by the application of graduated compression stockings. The mechanism
by which graduated compression stockings effect thromboprophylaxis remains an
area of uncertainty and is discussed further in a later chapter. Pneumatic
compression has also been demonstrated to be effective in preventing DVT
(Nicolaides et al 1983) and recent studies using modern duplex ultrasound
methodology suggest their principal effect is to increase deep venous flow velocity
(Keith et al 1991). However, other studies have also demonstrated a relative
activation of the fibrinolytic system during the use of intermittent compression boots
(Guyton et al 1985). Further, there is evidence that pneumatic compression and
compression stockings provide a synergistic thromboprophylactic effect, as
demonstrated in the studies of Scurr et al (1987) and Nicolaides et al (1983) who
showed a reduction in the incidence of postoperative DVT to 1 % and 4% respectively
when this combination was used. Intermittent pneumatic compression is now widely
used to provide intra-operative thromboprophylaxis to women undergoing caesarean
section and graduated compression stockings have become an important means of
providing thromboprophylaxis in pregnancy and the puerperium. While the evidence
for their efficacy in the surgical patients is strong, no studies have yet been published
demonstrating their efficacy in preventing DVT in the pregnant and puerperal patient.
2.5 Conclusion
While haemostasis alone has not been shown to cause DVT, the role of
haemodynamics in initiating or preventing thrombogenesis can be seen to be crucial
both from consideration of the potential effects of haemostasis on the local
microenvironment at the vessel wall, and from the clinical evidence reviewed above.
Pregnancy is a period of increased risk for DVT, and this may be due in part to
gestational changes in deep venous anatomy and haemodynamics. However there is
little contemporary data which describes or quantifies these changes.
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Chapter 3
Ultrasound in the study of blood flow velocity
and vessel size
Summary
Since the discovery of the Doppler effect the application of the Doppler principle to
ultrasound equipment in the clinical setting has lead to the development of duplex
Doppler ultrasound as a non-invasive means of measuring blood flow velocity,
volume flow and vessel size. Pulsed wave Doppler ultrasound allows flow velocity
measurements to be made in discrete vessels by Fast Fourier transformation of the
Doppler shift detected form a vessel imaged in real-time. True velocity measurements
are, however, subject to many potential sources of error. The angle of insonation to
that of direction of flow should be minimised and corrected for in calculations of flow
velocity. Wall thump artefacts should be minimised by appropriate filter settings.
Time average velocity processors are available on most modern ultrasound machines,
but are subject to several sources of error. When measuring flow velocity in large
vessels with established parabolic flow, there are theoretical advantages in measuring
the time averaged maximum flow velocity, although this technique is also prone to
certain errors. Transverse imaging of the vessel and measurement of the internal
vessel diameter appears to be an accurate and reproducible technique. Calculation of
volume flow requires measurement of vessel cross sectional area which is more prone
to error. This combined with the difficulties in accurately measuring time average
flow velocity in the context of the presented studies renders volume flow
measurement unsuitable, and given the relative advantages and disadvantages of the
techniques described, the measurements presented in this thesis are of time averaged
maximum velocity and cross sectional vessel internal diameter.
3.1 Introduction
Reliable and accurate in-vivo observations of venous anatomy and flow may be
recorded using invasive techniques such as direct operative vessel visualisation and
the application of mechanical callipers and electromagnetic flow meters to the
exposed vessels. Such techniques are clearly not applicable to human physiological
studies in pregnancy, where non-invasive, reliable, accurate and reproducible methods
are required. Duplex Doppler ultrasound provides a non-invasive means by which
deep vessels can be scrutinised for anatomy and flow. This chapter begins with a
description of the Doppler effect and its development as a means of velocity
measurement. The technical aspects and limitations of Doppler ultrasound as applied
to ultrasound measurement of blood flow velocity are then addressed, and this is
followed by a discussion of real-time ultrasound as a means of measuring vessel size.
56
3.2 Principles of Doppler Ultrasound
3.2.1 The Doppler Effect
The utilisation of the Doppler effect has enabled modern ultrasound machines to
provide a means of non-invasively quantifying blood flow velocity. This has
revolutionised the study of circulatory physiology and clinical vascular investigation.
The Doppler effect was described by Christian Johanne Doppler, an Austrian
professor of mathematics and geometry. In 1843 he postulated that the observed
frequency of light or soundwaves depends on the relative motion of the wave source
and the observer, thus explaining the shifts in red light from binary stars. He indicated
how the observed frequency could be derived mathematically. It was however, a
dutchman, BuysBallot who was responsible for the first experimental test of the
theory. Working in Utrecht in 1845, he used the newly completed Amsterdam to
Utrecht railway line to demonstrate that the pitch of a horn played by a traveller on a
moving railway carriage was perceived by a stationary observer to increase as the
train approached. The change in pitch became greater as the angle between the
railway track and the observer's line of sight became more acute. The variation of the
pitch produced by the motion verified Doppler's equations (BuysBallot, 1845,
Jonkman, 1980). A short time after this PJ Curie discovered the piezo-electric
properties of certain materials, which resonated when subjected to voltage. Curie's
pupil, Langevin, used this property of certain ceramics to produce ultrasound which
had its first practical application in the detection of submarines in the first world war.
The first diagnostic application was described in Austria to visualise intracranial
structures using a transmission technique (Dussik 1942). Rapid advances continued
through the second world war but it was not until 1957 that the possibility of
combining the Doppler effect with ultrasound to identify moving structures was
investigated (Satomura 1957). Soon after, the application of ultrasound to obstetrics
was established by Ian Donald and his colleagues in Glasgow who produced the first
contact B mode scanner. At the same time, Callagan, Rowland & Goldman (1964)
and Johnson et al (1965) were working to develop the ultrasonic flow meter to detect
fetal heart action. In recent years, technical developments have enabled precision
imaging and measurements. However the principles governing all ultrasound Doppler
machines remain the same.
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3.2.2 The Doppler Principle
The perceived frequency of sound depends on the number of wavefronts which reach
the ear per second. The difference between the emitted frequency and the perceived
frequency is called the Doppler shift. Movement of the reflecting object towards the
sound source results in an apparent increase in the frequency of reflected sound.
Movement away from the source results in an apparent decrease. Echoes reflected
from stationary boundaries are received at the emitted frequency, but ultrasonic waves
reflected from moving particles, such as red blood cells, undergo Doppler shift that is
proportional to the velocity at which the particles are moving.
The Doppler shift (f d)is given by the formula:
fd = 2 x Fo x V x cos 0
C
= the frequency of the emitted ultrasound
= the velocity of the moving target
= the angle between the ultrasound beam and the direction of
= the velocity of sound in tissue, which is approximately
1540 metres/second
If the Doppler beam is at right angles to the vessel being investigated, no Doppler
shift will be recorded, as the cosine of 90 degrees is 0. The size of the Doppler shift
increases as the angle of insonation approaches 0 degrees (maximum positive Doppler
shift) or 180 degrees (maximum negative Doppler shift). Doppler shifts obtained
from flowing blood are in the order of 0-5 kHz, which is within the audible range.
As the Doppler shift is directly proportional to the cosine of the angle of insonation,
this angle must be known with accuracy in order to determine the velocity. Errors in






smaller the angle of insonation, the smaller the error in estimating velocity. The rise
in error with increasing angle of insonation is exponential. Angles greater than 85°
will cause significant errors (more than 20%) in velocity calculation (Griffin et al,
1983).
Errors in measuring flow velocity may also arise from assumptions related to
refraction, the speed of sound in tissue and the speed of sound in blood. For clinical
blood velocity measurements, the net error arising from refraction effects is estimated
to be between a 2% and 8% overestimation of the actual velocity (Kremkau 1990,
Christopher et al 1995).
3.2.3 The Doppler Spectrum
When ultrasound strikes blood it is scattered by the erythrocytes. This scattering is
very weak in comparison with that from tissue, as inspection of any ultrasonic image
of a vessel will indicate. The 'sample volume' of a Doppler system is the region from
which the instrument can receive Doppler shifted echoes. Depending on the design of
the machine, it may be as small as 3-4 mm in depth and width, or it may be
considerably larger. Since the red cells are in general independent and randomly
distributed within the sample volume, their Doppler shifted signals add together
randomly to produce the final signal which is detected by the Doppler machine. This
process gives the Doppler signal its characteristic 'noise-like' quality.
A further consideration in understanding the nature of a Doppler signal is the fact that
the red cells within the sample volume do not, in general, all travel at the same
velocity. This gives rise to a 'spectrum' of Doppler shifts, reflecting the range of
velocities present in the sample volume.
The dynamics of blood flow have been analysed extensively, both theoretically and
experimentally, and it has been shown that the distribution of blood velocity across
the diameter of a vessel is complex and highly variable (McDonald, 1974; O'Rourke,
1982). Among other factors, this distribution often called the 'velocity profile'
depends on the viscosity of the blood, the time variation of the flow, the presence or
absence of turbulence, and any branching or curvature of the vessel.
In a straight non-elastic pipe with an ideal fluid flowing at a constant rate without
turbulence, the velocity profile is parabolic, with the maximum velocity being in the
centre and with the blood at the vessel walls scarcely moving. This distribution,
referred to as 'laminar flow', is considered to be a reasonable approximation for steady
(venous) flow in a relatively straight section of a vessel at points proximal to the
entrance of tributaries and in the absence of local pathology.
3.3 Application of ultrasound to flow velocity measurement
3.3.1 Continuous wave Doppler ultrasound
The simplest type of Doppler machine is a continuous wave (CW) Doppler. Here, two
separate transducers are used, one to transmit continuously at a fixed frequency, the
other to act as a receiver for the back scattered signals. The sample volume of this
device is simply the area of overlap of the transmitted beam and the beam pattern of
the receiving transducer. In general this sample volume is large. As a consequence,
CW Dopplers have relatively poor spatial selectivity, particularly in depth. While this
may appear to a severe disadvantage for many applications, it does mean that they can
be used 'blind' without imaging guidance, since the positioning of the probe is not as
critical as in the systems with better spatial selectivity.
3.3.2 Pulsed wave Doppler ultrasound
A more complex form of Doppler instrument is pulsed Doppler. This uses the
relationship between the depth of a scatterer and the time taken for its echo to arrive
at the transducer. The transmitted signal consists of a short burst of ultrasound,
containing 3-20 cycles at a fixed frequency. Generally the same transducer then acts
as a receiver, picking up the back scattered echoes that arise as the transmitted energy
travels through the body.
After the weak echo signals have been amplified, a 'range gate' circuit selectively lets
through the Doppler shift detector only those echoes which arrive at a given time
delay after the transmit burst. This ensures that the signals originate from scatterers,
such as erythrocytes, at a fixed depth, with that depth being determined by the time
delay between the transmit time and the opening of the range gate. In fact, the sample
volume has a finite extent in depth; this is determined by the number of cycles in the
transmit burst and the length of time for which the range gate is open. The width of a
sample volume is simply the width of the ultrasound beam at that depth.
In view of the limitations of continuous wave ultrasound, especially because of the
poor spatial selectivity at depth, deep vessels such as the femoral vein, are better
scrutinised using pulsed Doppler systems. As the ultrasound has to travel to the vessel
and back, a depth limitation is imposed, since all information from one pulse must be
received prior to the next pulse being emitted. The maximum pulsed repetition
frequency (PRF) is given by the formula:
PRF (Hz) = (CxD) / 2
where C is the velocity of sound in tissue (generally assumed to be 1540
metres/second) and D is the depth of the structure being investigated.
In addition, if the PRF is less than half the Doppler shifted frequency, an artefact
known as aliasing occurs. This phenomenon is readily recognised as the peaks of the
Doppler shifted waveform fold round and appear in the lower channel. Aliasing may
result in substantial underestimation of systolic velocities (Teague et al, 1985).
Although techniques have been developed to reduce frequency aliasing, it is still a
significant problem in some applications. A number of machines provide the
possibility of switching to continuous wave Doppler when aliasing cannot be
eliminated, since CW Doppler does not suffer from this limitation. Aliasing
constitutes less of a problem when measuring venous blood flow, as the velocities are
considerably lower, and unlikely to exceed the PRF of a pulsed wave Doppler
machine.
3.3.3 Doppler signal processing
While aural monitoring of the signal can be part of the examination, providing the
operator with feedback regarding the quality and nature of the signal, spectral
analysis by means of the fast Fourier transform (FFT) has become established as the
method of choice for analysing and displaying the signals, and virtually all equipment
now provides this option. The FFT is a high speed algorithm which computes the
spectral content of a sampled signal by transforming incoming Doppler signals from
the time domain to the frequency domain in real time. The analyser first samples and
digitizes the audio- frequency, time domain signal with a sampling rate sufficient to
prevent aliasing (usually 20 to 200MHz, corresponding to sample lengths of 50 to 5
ms) and then displays the information on a rolling screen. The spectral display shows
the signal in considerable detail indicating the frequency components of the Doppler
spectrum, the relative intensity of these components and their time variation.
Various derived values may also be available, including the peak and instantaneous
mean frequencies, and time average maximum values. Variation in flow patterns can
be readily observed, such as occurs in venous flow during the respiratory and cardiac
cycles.
Duplex Doppler ultrasound also provides a non-invasive means of quantifying venous
flow velocity. There are however different means of analysing the Doppler spectrum
in order to extract information about flow velocity in the scrutinised vessel. The two
principal means are calculation of the time-average velocity (TAV), achieved by
computation of the mean Doppler frequency, and the time averaged maximum flow
velocity (TAMV), calculated from the maximum frequency envelope of the Doppler
waveform. Both are subject to machine based and observer based sources of error.
Machine based errors may be systematic or random, or a combination of both (Gill
1985). Random machine-based errors are difficult to differentiate from random
observer errors, so machine based error are usually considered to be systematic. These
errors are difficult to measure in-vivo (Gill 1985). However, the potential machine
based errors associated with TAMV and TAV measurement are discussed below.
3.3.4 Measurement of Time Average Velocity
Most modern ultrasound machines contain software which allows computation of the
mean frequency over a given time. Under ideal conditions, this derived frequency is
proportional to the mean velocity of flow within the scrutinised vessel. If the angle
between the subtended ultrasound beam and the axis of the blood vessel is known, the
mean flow velocity can be calculated.
If a true mean velocity within a vessel is to be calculated, then analyses of the
Doppler frequencies at every point across the vessel diameter is required. The sample
volume should include the entire lumen of the vessel, both axially and laterally. In
reality, this may not be attainable (Evans 1982). Duplex scanners usually use the
same beam for Doppler ultrasound as for real-time imaging, and the beam is made
narrow at its focus in order to improve lateral resolution of the real-time image. Even
low frequency (eg: 2MHz) transducers produce a beam width whose lateral extent is
small compared with the diameter of large vessels such as the common femoral vein
(Burns & Jaffe 1995). Cobbald et al (1983) and Evans (1985) have demonstrated that
the use of an ultrasound beam that is narrower than a blood vessel containing a
parabolic velocity profile may cause an over-estimation of the mean velocity of up to
33% as the lower frequencies at the lateral edges of the vessel may be excluded from
the computation of the mean frequency. In addition, the differential rates of beam
attenuation in soft tissues and blood mean that echoes returning from different parts
of the blood vessel may undergo different rates of attenuation if they traverse
different proportions of soft tissue and blood. Signals from the centre of the vessel are
stronger than those at the lateral edges of the vessel where the beam traverses more
soft tissue and less blood. Higher velocities obtained at the centre of the vessel are
therefore accentuated and the effective beam width is reduced (Cobbald et al 1983)
therefore accentuating the higher velocities at the centre of the vessel.
The recorded Doppler spectrum comprises not only the moving blood but also the
pulsating vessel wall. Vessel wall motion is low in frequency, but is high in intensity
(Reneman 1981). Doppler devices therefore contain high pass filters designed to
remove high amplitude low-frequency signals which can arise from movement of
vessel walls. These filters will however, not only remove unwanted noise but will also
reject low frequency signals, thus biasing the mean frequency estimate upwards. The
margin of error thus introduced has been shown to be around 3%. (Gill 1979).
A further important limitation of mean frequency calculation is the inability of the
processor to distinguish between signal and noise. This is of particular importance
when the signal to noise ratio is reduced, as may occur when the Doppler angle is
large. Unless noise is removed from the spectrum, the mean velocity calculation will
be biased by the inclusion of non-signal derived frequencies.
Many of these limitations do not, however, apply to the calculation of maximum
frequencies.
3.3.5 Measurement of Time Averaged Maximum Velocity
Many modern ultrasound machines also contain processors which can automatically
extract the maximum frequency envelope from the Fast Fourier Transformed
spectrum. Knowledge of the angle between the subtended beam and the direction of
flow at the centre of the vessel enables calculation of the maximum velocity. In many
instances, the maximum frequency envelope is manually traced on screen by the
operator. In neither case is the calculation of maximum frequency and hence
maximum flow velocity prone to the same errors described in relation to the
calculation of the time averaged mean velocity as derived by mean frequency
processors. In relation to the effect of non-uniform insonation discussed above,
provided some part of the ultrasound beam passes through the part of the vessel
containing the maximum velocity (the central segment in veins containing parabolic
flow) then the output will not be significantly influenced by the shape of the
ultrasound beam or the ratio of the beam width to the vessel diameter. Further,
differential attenuation of the ultrasound beam between blood and tissue is of less
importance since the effective ultrasound beam shape is not critical to the ability to
recognise and analyse maximum frequency shifts within the vessel.
With respect to the effect of wall filters, provided the maximum frequency in the
Doppler signal does not fall below the frequency of the filter, the calculation of time
averaged maximum velocity from the maximum frequency will be unaffected by its
action; again, in contrast to the derivation of mean velocity by the mean frequency
processor. However, given the low flow velocities present within large veins, it is
important that the wall filter is set as low as is practical in order to avoid removal of
the maximum frequencies themselves.
A further major advantage of calculating time averaged maximum velocities is their
relative immunity to noise. Provided the signal can be visually differentiated from
background noise, then the effect of noise can be virtually eliminated from the
velocity calculations. The human eye is very sensitive to pattern recognition, and
allows an operator to monitor the performance of an automatic maximum frequency
follower if installed in the machine. The threshold level can be adjusted to ensure that
it follows the required signal (Prytherch & Evans 1985).
A source of error that is more likely to affect maximum than mean velocity
calculation is that imposed by intrinsic spectral broadening (ISB). Intrinsic spectral
broadening does not affect the mean frequency of a spectrum because the broadening
is symmetrical. However since the effect of ISB is to blur the Doppler spectrum, it
will not fall off rapidly at the frequency corresponding to maximum flow, but will fall
off gradually, depending on the amount of ISB present. This may make determination
of the true maximum frequency within the spectrum difficult to judge with certainty
(Biascom et al, 1986).
In determining which means of spectrum analyses to use to measure venous flow
velocity in the presented studies, consideration was given to the above advantages
and disadvantages of each method. For volumetric blood flow measurements, the
calculation of time-averaged mean velocity using a mean frequency processor has
been the usual method of choice. For velocity calculations however, the technique
least sensitive to noise and other distorting influences is the calculation of time
averaged maximum flow velocity from analyses ofmaximum Doppler shifts.
When larger vessels are interrogated, accurate sampling of the complete vessel is
difficult to achieve. In addition, different segments of a vessel may have different
flow characteristics. Sampling the middle third of the vessel lumen will minimise
errors arising from incorrect assumptions over the form of flow and avoid the
difficulties in sampling larger vessels. Clearly the time averaged flow velocity cannot
then be calculated as a only a proportion of the flowing blood is sampled. However, it
is reasonable to assume that the maximum flow velocities will be present in the
middle third of the lumen. Additionally, if only the mid-lumen is sampled, wall
thump artefacts (discussed below) are reduced.
Measurement of the TAMV is therefore recommended as the better technique for
velocity measurement when the velocity profile is established, parabolic and
relatively non-pulsatile, and the maximum velocities can be assumed to occur in the
middle segment of the vessel (Burns & Jaffe 1985, Evans et al 1989, Tortoli et al
1994). Such is the case in large veins at points distant to the entry of tributaries. The
accuracy of TAMV as a means of measuring flow velocity has been verified
experimentally. Li et al (1993) employed a computer-controlled string phantom to
compare Doppler measured TAMV with actual mean flow velocity in a straight tube
under pulsatile and non-pulsatile flow conditions. The TAMV was found to be within
5% of the actual velocity. Error arising from spectral broadening was less than 3%.
Although few studies report the clinical reproducibility of duplex Doppler TAMV
measurement in the deep leg veins, data derived from other venous measurements
indicate that good inter- and intra- observer agreement can be obtained using this
technique (Lomas 1994).
3.3.6 Measurement of volume flow
The potential of Duplex Doppler ultrasound to provide a non-invasive means of
measuring volume flow has been explored by many workers (Gill 1979, 1982, Eik-
Nes et al 1984, Gill et al 1984, Evans 1986). In order to calculate volume flow, the
blood vessel is visualised, allowing the accurate placement of the Doppler sample
volume to totally encompass the vessel while avoiding signals from adjacent
structures. The angle between the ultrasound beam and the axis of the blood vessel is
measured, as is the area of the vessel. The mean velocity of flow parallel to the vessel
axis is calculated and multiplied by the cross sectional area to give the mean
volumetric flow.
The errors which may arise in the calculation of mean velocity vessel cross sectional
area (discussed below) can be reduced to 6% for certain arterial measurements by
careful attention to technique (Gill, 1985). However, for smaller vessels, accurate
measurement of vessel size is difficult, and for larger vessels, uniform insonation
becomes progressively more difficult to achieve.
In view of the increased potential for error in volumetric flow measurement, the
author elected to measure flow velocity only, and after consideration of the previously
discussed advantages and disadvantages of time average mean velocity and time
averaged maximum velocity measurements, the latter method was elected for the
presented studies.
3.3.7 Measurement ofWall Shear Rate
Given the important role played by wall shear stress and shear rate in the pathogenesis
of venous thrombosis (see Chapter 2), the ability to quantitate wall shear rate using
pulsed Doppler ultrasound is of great potential interest. Hughes and How (1993) have
described the calculation of wall shear rate using a 20MHz Doppler system to obtain
steady flow velocity profiles in cylindrical tubes. Comparing the obtained wall shear
rates with those expected from theoretical considerations, an average error in
measured wall shear rate was obtained, of 46% measured velocity profiles. Carrying
out similar studies under conditions of pulsatile flow, error in wall shear rate
calculations of 28% were reported by the same authors (1994). At the time of
designing the studies presented in this thesis, the means of measuring wall shear rates
in-vivo with Doppler ultrasound were not available. This technique requires further
development and refinement before meaningful clinical measurements can be made.
3.4 Ultrasound Measurement of Vessel Size.
The ability of modern ultrasound machines to image deep blood vessels combined
with on-board software allowing the use of superimposed 'callipers' offers the
possibility of non-invasive and accurate vessel diameter measurement. This technique
has found widespread use in echocardiography, vascular surgery and obstetrics, where
the ability to measure the size of fetal vessels is of considerable importance in the
field of prenatal diagnosis. In view of the potential clinical utility of vessel size
measurement, the technique has been subject to examination of its accuracy and
reproducibility.
There are several potential sources of error which may affect the accuracy of vessel
size measurement using ultrasound techniques. Imaging the vessel in the sagittal
plane introduces the potential for underestimation of the vessels diameter as the
transducer may slide from the central, widest section of the vessel, producing a false
image of the true vessel size. This potential for error can be removed by imaging the
vessel in the transverse plane, where the maximal diameter can readily be determined.
Because of the low intra-luminal pressure and relatively thin walls, veins collapse
readily on the application of external pressure. Indeed, this property constitutes the
basis for ultrasound techniques in the diagnosis or exclusion of deep venous
thrombosis (see Chapter 1). Superficial vessels are particularly vulnerable to
compression by the application of an ultrasound transducer to the skin and this may
result in artefactual reduction in measured diameter by the technique itself. To
overcome this, some workers have used apparatus designed to hold the transducer
against the skin while applying minimal pressure (Camerota et al 1989). While such
devices have found use in anaesthetised paralysed patients, they are of less
practicality in the conscious patient. Other workers have shown that such devices may
not be required if careful technique is employed (Buchbinder et al, 1987). The liberal
application of sonic gel allows excellent sonic transmission with minimal direct
contact between the transducer and the skin. Suitable images for analysis can be
obtained by withdrawing pressure on the applied transducer to the point at which
sonic contact is lost and then gently reapplying the transducer to the minimal pressure
required for return of the image.
Measurements of arterial diameters are complicated by the changes in vessel diameter
that occur during the cardiac cycle. Some authors have advocated taking the mean of
several measurements to minimise uncertainty as to the 'true' diameter (Evans et al
1989). Eik-Nes et al (1984) attempted to overcome this potential uncertainty in
arterial measurements by taking the mean of 10 on-screen measurements of randomly
frozen images.
More recent developments in the field of non-invasive vessel diameter measurement
include an ultrasound phase-locked echo-tracking system which has been shown to
allow the measurement of pulsatile vessel diameter changes. (Hansen et al, 1993). In
addition Magnetic Resonance Imaging (MRI) has been shown to be a valuable tool in
measuring vessel diameters that alter with cardiac pulsation. The importance of
pulsatile changes in vessel diameter as a source of measurement error is questionable
however. At the femoral artery radial dilatation during systole is small
(McDonald1974) and M Mode ultrasound studies of pregnant patients have
demonstrated this to be in the order of 5% regardless of gestational age . No
significant systole related radial dilatation was demonstrated in the CFV, SFV or
popliteal vein (Baumann et al, 1988).
The reproducibility and accuracy of real-time ultrasound measurement as compared
to direct methods of vessel measurement has been established by many studies. In a
prospective study undertaken to assess the reliability of ultrasound imaging of the
greater saphenous vein, Buchbinder et al (1987) performed pre-operative imaging on
15 patients prior to saphenous bypass, and compared the ultrasound measurements
with intraoperative findings. In addition to reporting 100% accuracy in the detection
and location of valve sites, they found the actual venous diameter to be consistently
within 0.5mm of that measured by realtime ultrasound. Using realtime ultrasound
they were also able to demonstrate the correct anatomic location of the vein in all
patients.
The superficial location of the greater saphenous vein in the proximal leg renders it
more vulnerable to compression during ultrasound measurement than the deeper lying
CFV, SFV and popliteal veins. The accuracy of the technique in the hands of
Buchbinder et al demonstrates that with careful technique, errors in measurement
caused by vessel compression can be minimised. Head & Brown (1995) have further
validated ultrasound vessel diameter measurement in 100 patients undergoing
coronary artery bypass grafting. They demonstrated a close correlation between
imaged and in-vivo measurements. However, a non-statistically significant increase in
the in-vivo measurement was noted, possibly reflecting comparison of the internal
diameter measured by ultrasonography to the external diameter measured at
operation. This difference was observed to be of a similar magnitude at all levels of
the saphenous vein. Of further interest was the absence of differences found in vein
measurements based on age, sex, diabetes or obesity, or in measurements obtained by
five observers. Real-time ultrasound would therefore appear to be an accurate and
reproducible means of non-invasive vessel measurement.
In-vivo versus in-vitro comparison of real-time ultrasound has further confirmed the
accuracy of the technique. Rasmussen (1987) has measured fetal vessels in-vivo and
in-vitro preparations and reported a close correlation in results, describing an under
estimation of vessel diameter of only 1.1% in-vivo.
The above described studies relate to simple vessel diameter measurement. However,
vessel area is the important parameter for those wishing to measure volume blood
flow. While vessel area can be calculated from vessel diameter by applying the
formula:
Vessel Area =(11 x vessel diameter/2)2
several assumptions are
made which may not be applicable in vivo. The first is that the vessel concerned is
circular in cross section. Veins are usually oval in cross section and errors may
therefore enter the calculation.
Inter- and intra- observer error has been shown to be non-significant in the
measurement of the diameter of the superficial femoral vein. Studies assessing the
reproducibility of vessel area measurements have shown less clear results. Ellis et al
(1992) have studied the inter- and intra-observer error arising in measurements of the
external vessel diameter, luminal diameter and internal diameter (the diameter within
the internal elastic lamina) in both longitudinal and cross sectional views of the
common femoral arteries. They also assessed the reproducibility of cross sectional
area measurements. They found cross sectional and longitudinal diameter
measurements to be similarly reproducible, with measurement of the internal diameter
showing the greatest inter- and intra- observer agreement (limits of agreement;-0.67
to +0.25mm). They concluded that a real difference in vessel diameter of greater than
0.86mm would be required to enable detection by different observers. This
represented a change of less than 10% in the measured vessel. Cross sectional area
measurements, however, showed a wide variation with limits of agreement ranging
from -25.4% to +30.2%, demonstrating the inferior reliability and reproducibility of
vessel area measurements.
3.5 Conclusion
All ultrasound methods of measuring vessel size and blood flow velocity are subject
to error, the principal sources of which have been discussed in this chapter.
Appropriate selection and careful use of technique can reduce the impact of these
errors. For the studies presented in this thesis the technique deemed most suitable for
flow velocity measurement was time averaged maximum velocity (TAMV). Volume
flow measurements were not attempted. In view of the reported reproducibility of
internal diameter measurements, and the above described data demonstrating the
accuracy of the ultrasound diameter measurements, this method was selected for the
studies presented in this thesis. Systematic errors are of less importance when serial
measurements at the same site are made to detect changes in vessel size or flow
velocity rather than absolute values. Similarly, random observer based errors can be
reduced if all observations are carried out by the same observer under the same
experimental conditions. However, in order to assess the reliability of transverse
sectional diameter and flow velocity measurements as measured by the author using
the ultrasound machine to be employed for the presented studies, a study was
undertaken by the author together with a consultant radiologist with expertise in
vascular ultrasound to assess the inter- and intra-observer error of measurement of
deep leg veins using our own ultrasound machine (Acuson 128). These data are
presented in Chapter 4.
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A reproducibility study is presented where-in the inter and intra-observer variation
between ultrasound measurements of cross-sectional vessel diameter and time
averaged maximum velocity were calculated. Using Pearson's Coefficient of
Correlation, the inter-observer variability for these measurement techniques was
found to be good with correlation coefficients of 0.96 for vessel diameter and 0.90 for
time averaged maximum flow velocity. At an interval of one hour between
measurements, the intra-observer agreement was also good with correlation
coefficients of 0.89 for vessel diameter and 0.87 for flow velocity measurements. At
an interval of 10 days the respective correlation coefficients were 0.71 and 0.77.
Physiological alterations in hormonal status of the female subjects examined may
underlie the difference in levels of agreement obtained at 1 hour and 10 days (mean)
intervals. The presented data indicate that the techniques employed are reproducible.
4.1 Introduction
The reproducibility of realtime ultrasound measurement of venous diameter and
duplex Doppler measurement of time averaged maximum velocity has undergone
previous evaluation, as discussed in the previous chapter. However, most of the
studies addressing the reproducibility of vessel measurement and duplex Doppler
flow velocity have been carried out in vessels other than those studied in the work
presented in this thesis.
In order to assess the reproducibility of the methods employed by the author, studies
were carried out into the inter-observer and intra-observer reproducibility of
transverse section vessel diameter measurement with real-time ultrasound and time
averaged maximum flow velocity measurement using duplex Doppler ultrasound.
4.2 Methods
4.2.1 Inter-observer variation
10 healthy women of low parity at different stages of pregnancy (range of gestation:
24-39 weeks, mean: 33 weeks) were recruited for this study. None had any previous
history of thromboembolic disease. Each woman rested in the semi-recumbent
position for 15 minutes prior to the scans being performed. The following protocol
was followed by two observers, each blinded to the measurements of the other. Both
observers were experienced in duplex Doppler ultrasound. The first observer was the
author (NM) and the second (AR) a consultant radiologist with a special interest in
vascular ultrasound.
With the subject lying supine and with her back raised at an angle of 15°, the right
common femoral vein was imaged in the longitudinal axis, at a point on the common
femoral vein 2 cm below the junction with the long saphenous vein. The image was
frozen after minimising the transducer pressure near to the point of losing contact.
The distance between the inner aspects of the anterior and posterior vessel walls was
recorded and the mean of three measurements calculated. The Doppler gate was then
placed across the middle third of the vessel lumen, and a spectral Doppler recording
of the flow wave form was made over a period of 15 seconds of quiet respiration. In
order to minimise velocity calculation errors from the Doppler shift, the angle of
insonance was electronically steered to subtend an angle less than 60° to the axis of
flow and the velocities measured were angle corrected by aligning the cursor to the
direction of flow. These measurements were then repeated at the popliteal vein, distal
to its junction with the short saphenous tributary. All measurements were recorded
directly by each observer, who was blinded to the results of the other observer at the
time of performing the measurements.
The inter-observer variation was assessed by calculating Pearson's Correlation
Coefficient between the sets of data obtained by each observer. Calculations were
performed using the SPSS Statistics Programme for Windows.
4.2.2 Intra-observer variation
For the first part of the study, 8 subjects were recruited. The subjects were non¬
smoking members of staff and none were pregnant or had any history of
thromboembolic disease or other significant medical history. Each subject was
allowed to rest in the semi-supine position for 15 minutes prior to undergoing the
same measurements as described above, with the same technique. The values
obtained were recorded directly from the screen at the time of measurement. After an
interval of at least one hour, the same protocol was followed on each subject by the
same observer (NM), and the results again recorded directly at the time of
measurement. In order to further test the reproducibility in the author's hands, the
protocol was repeated on 10 further subjects similarly recruited, with a mean interval
of 10 days (range 8-11 days) between observations, by the same observer. On each
occasion the observer was blinded to the previously obtained measurements.
The intra-observer variation was assessed by calculating Pearson's Correlation
Coefficient between the sets of data obtained by the same author observer.
Calculations were performed using the SPSS Statistics Programme for Windows. The
coefficients of variation between the measurements carried out at an interval of 1 hour
were calculated, as were the coefficients of variation between the measurements
carried out more than a week apart.
4.3 Results
4.3.1 Inter-observer variation
The mean measurements obtained by each observer for each parameter are shown in
Table 4.1, The correlation coefficient between observers for vessel diameter
measurement was 0.964 and that for time averaged maximum flow velocity was
0.904. These studies demonstrate good reproducibility for TAMV and vessel
diameter measurements in the patients studied.
4.3.2 Intra-observer variation
Two sets of data were obtained. Table 4.2 show the mean results obtained on each
subject from the first examination and that carried out 1 hour later. Table 4.3 shows
the data obtained when the interval between measurements was more than a week.
The correlation coefficient for vessel diameter between the examinations made at an
interval of 1 hour was 0.89, while that for measurement of time averaged maximum
flow velocity was 0.87.
When the measurements were carried out at a mean interval of 10 days, the level of
agreement was found to be less good, with correlation coefficients for vessel
diameter measurement and TAMV measurement of 0.71 and 0.77 respectively.
4.4 Discussion
A coefficient of correlation value of greater than 0.8 indicates a good agreement
between observations, while that above 0.9 indicates very good agreement (Altman
1991).
We have demonstrated very good inter-observer agreement for the techniques of
vessel diameter and maximum flow velocity measurement. Our findings in this regard
are consistent with previous studies assessing similar techniques on other vessels
(Rasmussen 1987, Lomas et al 1994, see Chapter 3). The results for inter-observer
agreement were similar to those obtained for intra-observer agreement. However, the
slightly higher coefficients of correlation obtained between observers may reflect the
closer temporal proximity of the measurements as these were carried out
consecutively. Transient alterations in vessel size and flow velocity were less likely to
occur than in the intra-observer study, where intervals of 1 hour and a mean of 10
days occurred between observations. The lower level of intra-observer agreement
seen at 10 day intervals may reflect a true weakness in the reproducibility of the
techniques employed. However, given the good reproducibility observed in the 1 hour
study, a more likely explanation may underlie the lower coefficient of correlation
observed for both vessel diameter and maximum flow velocity at a 10 day interval:
the compliance of the veins has been shown to alter in pregnancy and in women
taking the oral contraceptive pill (Goodrich & Wood 1969, Clarke-Pearson &
Jelovsek, 1981) and a changing hormonal milieu has been proposed as the cause. The
subject groups for the intra-observer studies consisted of non-pregnant pre¬
menopausal women. Over a 10 day period, cyclical changes in the oestrogen and
progestogen levels occur and may affect venous compliance and hence capacitance,
diameter and blood flow velocity. This variable, related to the menstrual cycle may be
reflected in the results obtained. Clearly, such a variable is unlikely to exert a
significant influence at an interval of 1 hour, and resultant agreement between
measurements by the same observer is unlikely to be thus affected. The significance
of these findings for the interpretation of the data presented in later chapters is two
fold. Firstly, the technique employed for measuring vessel diameter and blood flow
velocity has been demonstrated to have good reproducibility. Secondly, any trend
revealed in the change of these measured parameters with gestation is less likely to
be a chance event, since the poorer correlation coefficient observed over periods of
around 10 days would tend to conceal such a trend.
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4.5 Conclusion
The techniques employed in the ultrasound studies presented in this thesis appear to
have good reproducibility in the author's hands on the equipment employed.
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Table 4.1
The three values obtained by two observers (NM and AR) for vessel diameter (d) in
mm and time averaged maximum flow velocity (v) in cm/sec at the common femoral
(CFV), superficial femoral (SFV) and popliteal veins (POP) in five patients are given
below.
Patient Parameter NM1 NM2 NM3 AR1 AR2 AR3
1 CFVd 15.5 16.2 15.5 14.3 14.2 14.8
1 SFVd 8.0 8.0 8.3 7.6 7.5 7.5
1 POPd 7.8 7.7 7.5 7.1 6.9 6.8
1 CFVv 7.3 7.1 7.1 8.9 8.6 10.0
1 SFVv 6.5 5.8 5.4 4.6 5.6 6.2
1 POPv 4.6 4.4 4.4 5.6 5.4 5.3
2 CFVd 12.8 12.0 12.3 11.9 11.5 12.6
2 SFVd 9.9 9.9 9.9 8.1 8.1 8.0
2 POPd 4.9 4.8 5.6 5.9 5.6 5.7
2 CFVv 12.1 12.4 12.0 17.6 15.4 17.4
2 SFVv 5.1 4.3 3.5 6.1 3.3 3.3
2 POPv 5.1 6.1 4.8 7.0 7.0 5.1
3 CFVd 11.8 12.3 12.0 17.6 15.4 17.4
3 SFVd 8.3 8.3 8.2 8.4 9.0 8.4
3 POPd 7.3 7.6 7.3 6.8 7.2 6.9
3 CFVv 6.0 4.5 4.8 5. 3.9 4.7
3 SFVv 2.8 2.9 2.6 3.6 3.0 3.3
3 POPv 3.5 2.9 3.2 3.7 2.3 3.3
4 CFVd 7.8 7.1 7.0 8.5 8.0 7.6
4 SFVd 7.3 7.3 7.2 7.5 7.8 7.8
4 POPd 4.6 4.9 4.7 5.8 6.2 4.7
4 CFVv 15.7 13.9 12.2 16.1 15.2 11.2
4 SFVv 5.1 5.5 4.5 7.6 7.0 7.1
4 POPv 4.9 3.7 3.6 5.6 5.6 5.8
5 CFVd 12.5 12 11.7 12.3 12.3 12.3
5 SFVd 8.2 7.7 7.6 8.5 7.9 7.4
5 POPd - - - - - -
5 CFVv 13.0 12.4 10.5 11.1 9.5 9.1
5 SFVv 6.2 6.3 6.2 5.5 5.2 4.8
5 POPv - - - - - -
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Table 4.2
The initial three values obtained by one observer (NM) for vessel diameter (Dl) in
mm and time averaged maximum flow velocity (VI) in cm/sec and those obtained
after an interval of one hour (D2 and V2) at the common femoral (CFV) and
popliteal veins (POP) in eight subjects are given below.
CFV POP
Subject Dl D2 VI V2 Dl D2 VI V2
1 10.0 10.2 4.6 5.2 6.1 6.3 1.3 3.0
1 10.5 10.0 4.0 5.6 6.5 5.6 2.5 2.4
1 11.3 10.2 3.0 4.7 5.5 6.2 1.4 1.8
2 9.9 10.7 7.1 5.8 6.0 6.9 2.7 2.2
2 9.9 10.7 6.6 5.5 6.1 6.9 2.1 2.5
2 9.5 11.0 5.6 5.6 6.1 6.9 2.3 2.5
3 10.9 11.0 5.0 6.0 5.2 5.2 3.1 3.8
3 10.9 10.9 5.0 6.5 5.2 4.9 3.4 4.7
3 10.2 10.9 5.0 6.5 5.3 5.0 2.8 4.6
4 11.8 11.5 4.7 5.3 5.9 5.4 4.3 5.8
4 11.9 11.0 5.0 6.1 5.9 5.6 4.4 5.3
4 12.5 11.8 4.5 4.8 5.9 5.6 4.3 5.8
5 13.3 12.5 6.3 7.4 5.2 5.1 3.8 3.9
5 13.2 13.5 5.6 5.9 5.5 5.6 3.8 4.2
5 13.7 13.5 4.5 5.9 5.3 6.4 3.8 4.4
6 9.4 9.9 9.3 7.7 5.5 5.6 5.3 4.4
6 9.3 10.2 9.9 7.7 5.9 5.9 5.1 5.4
6 9.8 10.4 11.6 8.0 5.4 5.4 5.0 5.1
7 14.8 14.4 4.4 4.9 7.4 6.8 2.7 2.0
7 14.5 14.6 3.7 4.3 7.0 6.8 2.2 1.7
7 14.4 15.1 4.6 4.3 7.5 7.9 2.2 2.1
8 11.3 11.2 7.5 7.4 6.5 7.2 7.7 6.9
8 11.8 11.5 9.2 7.9 7.1 7.8 9.8 8.1
8 11.8 11.7 9.4 7.0 6.9 7.3 7.9 6.1
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Table 4.3
The initial three values obtained by one observer (NM) for vessel diameter (Dl) in
mm and time averaged maximum flow velocity (VI) in cm/sec and those obtained
after a mean interval of 10 days (D2 and V2) at the common femoral (CFV) and
popliteal veins (POP) in ten subjects are given below.
CFV POP
Subject Dl D2 VI V2 Dl D2 VI V2
1 10.7 7.9 8.2 12.5 5.2 4.8 3.7 3.4
1 11.5 8.5 9.1 9.3 5.6 5.4 2.9 3.3
1 10.9 8.2 10.0 6.8 5.0 5.1 2.1 2.7
2 9.5 8.5 5.5 7.5 3.9 4.4 5.3 6.7
2 9.1 8.7 5.8 6.6 4.2 4.8 5.2 5.1
2 9.1 7.9 9.6 9.7 4.1 4.5 4.3 5.5
3 6.3 7.0 25.0 21.6 4.5 4.7 6.5 4.9
3 6.0 6.4 27.9 19.4 4.6 5.0 5.0 4.3
3 5.8 5.8 27.5 19.4 5.0 4.6 3.5 3.8
4 8.4 8.6 14.8 11.1 5.9 5.8 5.0 7.1
4 8.0 8.5 13.0 11.8 6.1 5.8 6.5 7.3
4 7.3 8.5 13.8 11.4 6.0 5.6 6.1 7.3
5 11.2 9.1 12.0 14.0 7.0 6.8 6.0 4.6
5 11.4 9.1 11.5 14.7 6.7 6.3 6.4 4.8
5 11.3 9.7 11.8 15.3 6.5 6.6 5.7 6.7
6 9.3 8.2 9.1 9.9 5.8 3.2 9.3 7.0
6 7.9 8.1 4.5 9.5 4.8 3.2 7.4 7.6
6 8.1 8.0 9.0 9.6 4.8 3.2 6.5 8.3
7 7.8 6.4 14.5 15.9 5.4 5.3 3.1 4.7
7 7.3 6.9 12.9 15.1 5.7 5.4 3.9 3.1
7 7.4 6.5 13.7 12.3 5.8 5.6 3.4 3.0
8 8.9 9.7 12.7 14.8 5.4 5.3 5.2 7.3
8 10.0 10.0 11.3 14.5 5.1 5.0 4.8 7.0
8 10.1 9.5 12.3 16.1 4.9 5.3 6.4 6.1
9 12.6 8.4 12.8 13.2 4.8 4.8 4.0 4.5
9 12.5 8.2 13.5 12.1 5.0 5.0 4.3 4.1
9 12.5 8.1 12.6 12.5 5.0 5.0 5.0 4.5
10 11.6 9.0 5.7 10.1 5.1 5.1 3.3 3.9
10 11.0 9.0 5.7 10.1 5.1 5.1 3.3 3.9





In this chapter the practical procedures carried out in order to obtain the ultrasound
derived data presented in later chapters are described. All the studies were carried out
by the author in the same Ultrasound Unit, employing the same ultrasound apparatus.
All subjects were recruited from the staff and patients of the hospital in which the
studies were performed. The ultrasound machine settings were set as advised in the
manual supplied with the machine as appropriate for peripheral venous studies.
Protocols for patient preparation, scan performance and data collection were designed
and are described below.
5.1 Introduction
The studies presented in chapters 7 to 11 of this thesis were performed in the
Ultrasound Department of Glasgow Royal Maternity Hospital. Full ethical approval
was obtained from the Hospital Ethics Committee prior to commencing the studies.
A 5 MHz linear array transducer, suitable for vascular studies, was purchased using
monies from the grant awarded to Professor Greer and the author. This was coupled
to an Acuson 128 ultrasound machine with real-time, spectral Doppler and colour
Doppler facilities made available to the author by the Ultrasound Department.
5.2 Recruitment
Subjects were recruited from four main sources.
A. Women were seen by the author at their booking visit. After carrying out the
booking procedure, those with a singleton pregnancy and no complicated past
obstetric history or medical history were informed about the study and invited to take
part. No other exclusion criteria were applied. Full informed consent was obtained,
and arrangements were made for shared antenatal care between the author and the
woman's GP.
B. A small number of antenatal patients with a history of DVT in pregnancy were
referred to the author at booking by their consultant for screening throughout
pregnancy. Full informed consent to the study was obtained, and a protocol for scans
was offered similar to those antenatal subjects with no history of DVT.
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C. The subjects entered solely into post-natal studies were recruited directly from
the postnatal wards. Women who were suffering postnatal complications limiting
their mobility were excluded, as were any with a complicated medical history. No
other restrictive criteria were applied, and full informed consent was obtained on the
third or fourth post-operative day, the day of the first scan.
D. Subjects entered into the study into support stockings were recruited from
among staff. This group was restricted to the following criteria:
- no previous history of DVT
- no risk factors for DVT
- no current medical illness
Full informed consent was obtained.
5.3 Ultrasound Scanning Equipment and Settings
5.3.1 Transducer
A 5 MHz linear array transducer (L 558 Acuson, Mountain View, Calif.) was
employed for all studies. The linear array format is the preferred type for peripheral
vascular studies as it is possible to place the entire transducer face on the patient.
Additionally, colour flow mapping is not altered artefactually by relative changes in
flow direction with respect to the subtended beam, in a vessel running parallel to the
skin surface as may occur when employing the sector array format.
5.3.2 Machine Settings
The following parameters were set to enhance venous imaging prior to each scan. The
settings were stored in the system software. All power settings were set at levels less
than or equal to the acoustic output guidelines for "Peripheral Vessel" of the United
States Food and Drug Administration (FDA).
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Real time 2D image
Transmit Power: -9bB; equivalent to SPTA
<2.9mW/cm2 (minimum output)
Log compression (grey scale dynamic range): 45 decibels (midrange setting)
Postprocessing curve: Low contrast (level 2)
Preprocessing: Moderately sharp border (level 1)
Image persistence: Moderate (level 3)
Spectral Doppler Mode
Doppler Power (SPTA): 718mW/cm2 (Standard setting)
Log compression: 25dB (a dynamic range displaying reduced extraneous
signals or noise)
Postprocessing: (D curve) Linear relationship between echo amplitude
and displayed pixel intensity.
Wall thump filter 50MHz
Colour Doppler Imaging Mode
Transmit power (SPTA): 345 mW/cm2
Preprocessing: High colour resolution (level 0)
Persistence: Moderate temporal averaging of colour samples (level 1)
Postprocessing: Velocity only colour map (level V5)
Velocity filter: For low velocities (level 2)
5.4 Subject Preparation
In order to allow the effects of recent ambulation on venous flow to diminish, all
subjects rested for 20 minutes on the examination couch in a semi-supine recumbent
position (back tilted to 45 degrees). In pregnant patients, urinalysis was carried out,
a blood pressure recording was taken and a fetal scan was performed during this rest
period. In order to reduce environmental effects on peripheral venous dilatation, the
examination room was maintained at a temperature between 22-25°C.
The back rest was then adjusted to apply 15 degrees of reverse Trendelenberg tilt, and
sonic coupling gel applied to the skin over the femoral triangle. The subject was
asked to externally rotate the leg at the hip, thus exposing the femoral triangle to easy
access with the transducer. The CFV and SFV were examined with the subject thus
positioned (Plates 5.1 & 5.2). In order to examine the popliteal vein without causing
collapse of the vessel, the subject was asked to flex the knee slightly while
maintaining a degree of external rotation at the hip (Plates 5.3).
5.5 Vessel diameter measurements
The tranducer was applied to the skin over the common femoral vein at the junction
with the long saphenous tributary, imaging the vessels in longitudinal section. The
CFV was identified by its position medial and deep to the visibly pulsing common
femoral artery (CFA), its junction anteriorly with the great saphenous tributary, its
diameter (the largest of these vessels) and, if visible, the distal to proximal streaming
artefact indicating venous blood flow within the vessel. If doubt persisted as to the
identification of the CFV, the vessels of the femoral triangle were scrutinised with
colour Doppler. This clearly demonstrated pulsatile flow in the CFA. A real-time
ultrasound examination was made of structures in the vicinity of the CFV such as
lymph nodes, to exclude causes of extraneous vessel compression. By means of
gentle manipulation of the transducer and angle of insonation, a view of the CFV at
its maximum diameter was obtained. The transducer was then rotated through 90
degrees to obtain a transverse view of the vessel.
The close proximity of the CFV to the skin, coupled with its readiness to collapse on
application of pressure by the transducer made accurate assessment of the distance
between the posterior and anterior vessel walls difficult. In order to minimise
compression artefacts, once a maximal diameter had been imaged, the transducer was
gradually lifted from the point of application until the image was lost. The lightest
pressure to obtain an image was then applied, and the image frozen. The distance
between the inner aspect of the anterior wall and the inner aspect of the posterior wall
of the CFV was then measured at a point 1 cm distal to the saphenofemoral junction
(Plate 5.4). Where the deep circumflex tributary joined immediately posterior to this
point, the diameter was measured immediately distal to the latter junction. This
procedure and measurement was repeated twice and three transverse diameter
assessments were recorded.
Continuing the imaging in the longitudinal view, compression was applied until
dimpling of the overlying skin occurred, and the posterior and anterior walls of the
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CFV was examined. Complete obliteration of the vessel lumen was interpreted as
thrombus free segment as discussed in chapter 1.
5.6 Flow velocity measurements
The time averaged maximum flow velocity (TAMV) was chosen as the best means of
assessing venous flow velocity. In order to avoid the effect of shearing effects on
calculating the flow velocity, the pulsed Doppler gate was placed so as to interrogate
flow velocity in the middle third of the vessel lumen in all cases. This had the
additional benefit ofminimising wall thump artefacts (Plate 5.5) (see Chapter 3).
Distal to the saphenofemoral junction, the CFV runs a parallel course to the skin. A
combination of electronic beam steering and manual angling of the transducer was
applied to reduce the angle of insonation to the direction of venous flow as much as
possible below 60° without distorting the vessel under scrutiny (Plate 5.5). If the
angle subtended to the direction of blood flow was greater than 60 degrees, the
measured data regarding venous flow velocity was discarded.
The angle of insonation was reduced to less than 60 degrees by means of the
techniques described earlier, and the flow direction indicator on the screen was lined
up parallel to the direction of blood flow. Flow direction was most accurately
assessed when the streaming artefact was visible. If not present, then the direction of
flow was assumed to be in parallel to the axis of the vessel. The flow through the gate
as indicated by a realtime spectral representation on screen was then recorded onto
video tape for later analysis. Each recording continued until a 15 second period of
technically acceptable wavefroms were obtained. Analysis of the wavefrom was
performed by measuring the maximum flow velocity and minimum flow velocity
during each 15 second period (Plate 5.6). The outline of the spectral representation
of the waveform was then traced onto the screen and a built in soft-ware package
used to calculate the TAMV of the 15 second period (Plate 5.7). The VVI was
calculated as described earlier. Mean values for the TAMV and VVI obtained over
three consecutive 15 second periods were recorded.
A realtime image of the vessel under examination was then obtained in the
longitudinal axis and flow through the vessel was imaged using colour Doppler. The
angle subtended by the ultrasound beam was maintained below 60° to the direction of
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blood flow either by manual manipulation of the transducer or by electronically
steering the beam.
On achieving a colour Doppler image the colour gain was increased to the point
where spontaneous flow was seen to fill the insonated segment of vein, while
preventing artefactual extravascular colour signals from enlarging the perceived
diameters of the vessel. Evidence of spontaneous venous blood flow filling the vessel
lumen was recorded, as was fluctuation of flow velocities associated with respiration.
If venous flow velocities were below the range of detection of ultrasound machine
(less than 0.9cm/sec), no colour signal was detected during spontaneous respiration,
and flow was then augmented by means of gentle manual compression of the
ipsilateral calf. If no thrombus occluded the vessel between the calf and CFV, a
colour signal filled the vein with colour confirming patency of the vessel. Moving
distally from the CFV, every part of the CFV and SFV was thus examined down to
the distal segment of the popliteal vein. Further methodological details are described
as they apply to the studies reported in the following chapters.
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Plate 5.1 The transducer is placed over the CFV in the longitudinal axis,
after the leg has been externally rotated at the hip.
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Plate 5.2 The transducer is positioned in the longitudinal axis, at the point
where it emerges from the adductor canal.
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Plate 5.3 Collapse of the popliteal vein on application of the transducer is
prevented by a moderate degree of knee flexion.
Plate 5.4
The vessel diameter is measured between the two callipers shown.
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Plate 5.5 The Doppler gate is placed to interrogate flow velocity in the middle
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Plate 5.6 The maximum and minimum flow velocities are measured using on¬
screen callipers.
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The incidence and pattern of thromboembolic complications in obstetric and
gynaecological patients in Scotland between 1981 and 1992 was investigated by
analysing I.C.D. coded data retrieved from the SMR1 and SMR2 database. The effect
of mode of delivery and maternal age over 35 on risk of thromboembolism in
pregnancy was also assessed. 0.076% of gynaecological episodes were subsequently
complicated by thromboembolic events. 19% of those suffering thromboembolic
complications within 2 weeks of discharge were referred back to gynaecology. The
incidence of deep venous thrombosis (DVT) in those under 35 years and over 35
years was 0.615/1000 maternities and 1.216/1000 maternities respectively. Respective
figures for postnatal DVT were 0.304/1000 and 0.720/1000 and for pulmonary
thromboembolism (PTE), 0.108/1000 and 0.405/1000. In both age groups, emergency
caesarean section was associated with a higher incidence of DVT than elective
caesarean section and vaginal delivery.
6.1 Introduction
In response to concern over the continuing major contribution of venous
thromboembolism to obstetric mortality and morbidity, guidelines covering the
assessment for and appropriate institution of thromboprophylaxis have recently been
published (THRIFT Consensus Group 1992, RCOG 1995). However many
obstetricians do not prescribe thromboprophylaxis to patients at risk because of the
perceived low incidence of thromboembolic disease in their practice (Greer & De
Swiet 1993). Information concerning the risks of DVT associated with pregnancy
(Letsky and De Swiet, 1984) is available but the true incidence of thromboembolic
complications in pregnancy remains unclear. Apart from a recent study employing
duplex Doppler ultrasound which found no cases of DVT among 140 asymptomatic
women at low to moderate risk screened in the early puerperium (Macklon & Greer
1995), no other accurate contemporary data based on objective screening techniques
has been published. In order to assess the incidence of recorded thromboembolic
complications in obstetric practice in Scotland, we analysed data for the years 1981 to
1992 provided by the Information and Statistics Division of the Common Services
Agency for the National Health Service in Scotland.
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6.2 Methods
Data were extracted from the SMR 2 database (Obstetrics) held by the Information
and Statistics Division of the Common Services Agency for the National Health
Service in Scotland. The data related to all patients treated in Scottish hospitals and
covered the inclusive period of 1983 -1992. Thus data concerning over 700,000
maternities were analysed. Analyses on specified ICD9 codes were carried out for
specific thromboembolic complications:
Data relating to the above thromboembolic complications were obtained with
information regarding mode of delivery (elective caesarean section, emergency
caesarean section or vaginal delivery) and patient age (under 35 years, 35 years and
over). All postnatal admissions for thromboembolic complications were to obstetric
units and these data were also stratified for age. The obstetrical data were analysed
using chi-squared tests for statistical significance between rates of thrombotic events
per 10,000 deliveries.
6.3 Results
During the period 1983 to 1992 inclusive, there were 645,663 recorded maternities in
Scotland. 44,410 were to women over the age of 35 years; 6.88% of the total number
of maternities. The proportion of maternities to women over 35 rose significantly over
the study period, however, from 6.25% in 1983 to 8.5% in 1992 (Figure 6a). 89,618
caesarean sections were recorded over the 10 year period, constituting a caesarean
section rate of 13.88%. Among those over 35 the rate of caesarean section was
20.77% compared to 13.37% in those under 35. 37.7% of the caesarean sections were
performed as elective procedures, although this figure rose to 47.87% in those over 35
years of age, probably reflecting repeat elective procedures.
The figures obtained and the relevant denominators for the numbers of antenatal and
postnatal DVTs, PTE and superficial thromboses over the 10 year period are given
Superficial Thrombophlebitis
Antepartum Deep Venous Thrombosis







in Table 6.1, which also shows the annual incidences of each thrombotic event per
1000 maternities.
The incidence of antenatal DVT was 0.615/1000 maternities in those under 35 years
of age but was significantly higher in those aged over 35 years of age where the
incidence was 1.216/1000 (p<0.005) (Figure 6b). A similar age related effect was
seen in those presenting with DVT postnatally, with a rate of 0.304/1000 maternities
under 35 years and 0.72/1000 over 35 years (p<0.005). Age over 35 was also
associated with a significantly greater risk of pulmonary thrombembolism (PTE),
occurring with an incidence of 0.405/1000 maternities as opposed to 0.108/1000 in
those under 35 years ( p<0.05). A similar age related increase was observed for
superficial thrombosis with an incidence of 1.67/1000 under 35 years and 5.38/1000
over 35 years (p<0.005).
In summary, age over 35 years was associated with a near doubling in the incidence
of deep venous thrombosis and pulmonary thromboembolism, and an increase by a
factor of three in the incidence of superficial thrombosis.
The incidence of postnatal DVT was affected by mode of delivery. Delivery by
caesarean section was associated with a rate of 0.424/1000 compared to a rate of
0.173/1000 following vaginal delivery. Emergency caesarean section was associated
with a higher postnatal DVT rate than elective caesarean section in both the under 35
age group (0.431/1000 vs. 0.238/1000 respectively, p<0.005) and the over 35 age
group (1.248/1000 vs 0.680/1000, p<0.005) (Figure 6c). While caesarean delivery
was associated with a higher incidence of PTE than vaginal delivery in both age
groups (Table 6.2 and Figure 6d), a significantly higher incidence associated with
emergency versus elective caesarean section was only demonstrated in the over 35
age group. The association with mode of delivery of superficial thrombosis was in
marked contrast to that seen with DVT and PTE in that the highest incidence in both
age groups were associated with vaginal delivery (Table 6.2). The data for postnatal
readmissions showed that 38% of postnatal DVTs and 22% of cases of PTE presented
after discharge from hospital.
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6.4 Discussion
The data presented requires a substantial degree of caution in its interpretation as it is
not known to what extent objective tests were employed to reach the diagnoses.
Obstetricians remain reluctant to use the traditional 'gold standard' objective test,
contrast venography, because of the perceived risk to the fetus. Despite poor
sensitivity and specificity, clinical diagnosis may often be relied upon in the absence
of the availability of non-invasive tests such as compression ultrasound, and the
clinical signs arising from conditions such as popliteal cysts or groin
lymphadenopathy may be misinterpreted and misdiagnosed. Given the poor reliability
of clinical diagnosis (Genton & Turpie 1980) and that 70% of those who suffer a fatal
PTE have no previous documented evidence of DVT (Department of Health et al
1994), it is unlikely that the data presented represent the true incidence of DVT. In
addition, women with a thromboembolic complication may go unrecognised both in
hospital and the community. These data remain of value, however as they reflect the
incidence of these conditions as diagnosed under current clinical practice. In addition,
such data may be required to guide practice with regard to diagnosis and prevention
of thrombotic complications. Thus, this study maybe of value, particularly as there is
a paucity of published information in this field, and because of the large numbers
analysed.
The appropriate degree of thromboprophylaxis in individual cases is normally
determined by the presence of certain risk factors for thromboembolic disease. In
obstetrics, previous guidelines have advised that age over 35 years be considered a
risk factor, but this was considered by many to be an arbitrary 'cut off. Our data
clearly demonstrate this factor to be associated with a significant increase in the
incidence of antenatal and postnatal DVT, pulmonary embolism and superficial
thrombosis. Delivery by caesarean section has been demonstrated to increase the risk
of PTE, and this risk is considered to be greatest after an emergency procedure. The
presented data support this view. It is interesting to note, however, that the incidence
of DVT after emergency caesarean section in women under 35 years of age was
similar to that after a vaginal delivery and less than that after elective caesarean
section in women over 35 years . Age over 35 may, therefore, be a more important
risk factor than mode of delivery. While superficial thrombosis is not considered to
put the patient at immediate risk of PTE, it is considered a risk factor for the
development of DVT. The increased incidence in reported cases of superficial
thrombosis after vaginal delivery in both age groups when compared to delivery by
caesarean section may reflect an influence on the interpretation of leg signs such as
calf tenderness by knowledge of the relative risk ofDVT associated with the mode of
delivery; clinicians may take signs suggestive of DVT more seriously in patients who
have undergone emergency caesarean section than in those who have delivered
vaginally. Unless clinical suspicion is tested objectively, incorrect diagnoses may be
reported.
In the recent Confidential Enquiries into Maternal Deaths in the U.K. 46% of fatal
cases of PTE occurred after delivery (DHSS et al 1994). A significant proportion of
the reported cases of postnatal DVT and PTE analysed here, presented after discharge
from hospital. Vigilance during the puerperium is difficult, and the responsibility for
this falls, in part, to those providing community based postnatal care. However,
correct identification of those at risk and appropriate thromboprophylaxis prior to and
following discharge, may help to reduce the number suffering potentially fatal
thromboembolic events in the late puerperium.
6.5 Conclusion
Thromboembolic disease is frequently encountered by individual obstetricians and
gynaecologists, but the consequences of a missed diagnosis can be grave. The data
presented provides information as to why the condition is perceived to be rare in
clinical practice, and highlights high risk groups for targeting appropriate
thromboprophylaxis.
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Table 6.1 The annual incidence of antenatal DVT (AN DVT), postnatal DVT
(PN DVT), PTE and superficial thrombosis (Sup. Thromb.) in women aged under
35 years and 35 years or over in Scotland, 1983 to 1992.
Rates per 1000 maternities
Year Age Maternities AN PN PTE Superficial AN PN PTE Sup.
(Years) DVT DVT Thromb. DVT DVT
Thromb.
1983 <35 59964 47 18 6 151 0.784 0.300 0.100 2.518
1983 >35 3982 5 2 3 35 1.256 0.502 0.753 8.790
1984 <35 60214 43 15 10 123 0.714 0.249 0.166 2.043
1984 >35 3991 11 1 4 28 2.756 0.251 1.002 7.016
1985 <35 60874 23 9 3 97 0.378 0.148 0.049 1.593
1985 >35 4081 3 4 2 28 0.735 0.980 0.490 6.861
1986 <35 60535 36 14 6 100 0.595 0.231 0.099 1.652
1986 >35 4159 3 4 0 26 0.721 0.962 0.000 6.252
1987 <35 60842 56 18 4 97 0.92 0.296 0.066 1.594
1987 >35 4084 3 1 3 19 0.735 0.245 0.735 4.652
1988 <35 61051 35 12 6 83 0.573 0.197 0.098 1.360
1988 >35 4381 5 4 0 15 1.141 0.913 0.000 3.424
1989 <35 58556 38 28 11 90 0.649 0.478 0.188 1.537
1989 >35 4424 9 6 1 13 2.034 1.356 0.226 2.939
1990 <35 59878 38 26 7 84 0.635 0.434 0.117 1.403
1990 >35 4686 7 4 2 25 1.494 0.854 0.427 5.335
1991 <35 60556 21 28 5 88 0.347 0.462 0.083 1.453
1991 >35 5183 3 3 1 25 0.579 0.579 0.193 4.823
1992 <35 58783 33 15 7 108 0.561 0.255 0.119 1.837
1992 >35 5439 5 3 2 25 0.919 0.552 0.368 4.596
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Table 6.2 The influence of mode of delivery on the incidence of postnatal
DVT (PN DVT), superficial thrombosis (Sup. Thromb.) and PTE in
women aged below 35 years and 35 years and over in Scotland, 1983 to
1992.
Rates per 1000 deliveries


















Emergency C/S <35 51031 22 41 14
Emergency C/S >35 4808 6 12 5
0.431 0.803 0.274
1.248 2.496 1.040
Vaginal Delivery <35 520853 82 910 23 0.157 1.747 0.044
Vaginal Delivery >35 35187 14 203 6 0.398 5.769 0.171
Figure 6a. The number of maternities in those over 35 years of age as a
proportion of all maternities in Scotland over the years 1983-1992.
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Figure 6b The effect of age on the incidence of antenatal DVT,
postnatal DVT and PTE.
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Figure 6c The effect of mode of delivery on the incidence of
postnatal DVT in women under 35 years of age , over 35









Figure 6d The effect of mode of delivery on the incidence of PTE


















The objective of this study was to investigate gestational and postural changes in
diameter and blood flow in the proximal deep leg veins during pregnancy. 24
healthy women with uncomplicated singleton pregnancies were recruited to this
longitudinal, prospective observational study. Realtime and duplex Doppler
ultrasound assessments of the vessel diameter, flow velocity and respiratory flow
fluctuation in the proximal deep leg veins of women were serially measured from the
first trimester of pregnancy to six weeks postnatally. An increase in vessel diameter
and a fall in flow velocity with increasing gestation was observed. However, no
change in venous flow variation was demonstrated. After delivery these effects were
seen to reverse. Flow velocity was slower in the left than the right legs, but on
adoption of the left lateral position an increase in flow velocity and venous flow
variation was observed in both legs during pregnancy. These data are consistent with
the observed increase in incidence and pattern of deep venous thrombosis in
pregnancy and may aid in the interpretation of duplex Doppler ultrasound
examinations for deep venous thrombosis in pregnancy. Postural changes should be
part of this evaluation. The gravid uterus may not be the sole cause for postural
changes in deep venous flow velocity.
7.1 Introduction
Thromboembolic disease remains a major cause of maternal mortality (DHSS 1994).
Clinical diagnosis of deep venous thrombosis (DVT) has been shown to be insensitive
and nonspecific (Genton & Turpie 1980) and objective means of diagnosing DVT are
normally required. Venography remains the 'gold standard' test, but is avoided in
pregnancy because of the perceived radiation risk to the fetus. In recent years, real
time ultrasound has been shown to be of use in pregnancy (Greer et al 1990, Polak et
al 1991) and, with the aid of duplex and colour Doppler, is now considered to be the
first line investigation for suspected DVT in pregnancy. However, alteration of
venous flow occurs in pregnancy (Wright et al 1954). The interpretation of ultrasound
examination of the deep veins of the leg has therefore been hampered by a lack of
information regarding the normal gestational changes in the deep venous system.
Thus, the aim of this study was to follow longitudinally the gestational alterations in
vessel diameter, flow velocity and respiratory variation in flow (termed the Venous
Variation Index (VVI)) using duplex Doppler ultrasound. In addition the effects of
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adopting the supine, left lateral and upright postures on these same indices from early
pregnancy to the late puerperium were serially examined.
7.2 Methods
24 subjects were recruited on attendance for booking at the antenatal clinic.
Inclusion criteria were a viable singleton pregnancy on booking ultrasound scan and
no obstetric risk factors. 20 subjects had no past history of thromboembolic disease
and 4 had a previous history of DVT in pregnancy. The median gestation at which
they entered the study was 12 weeks (8-24). The median age of the subjects was 25
years (18-34) and parity ranged from 0 to 2. Each subject underwent a duplex
Doppler ultrasound scan of both legs by means of the technique described below at
the time of the booking visit and at approximately monthly intervals throughout
pregnancy. Further scans were carried out 4 days and 6 weeks postnatally. The
following method was employed for each scan.
Prior to each scan, each subject was allowed to rest supine for 15 minutes. The
ultrasound examinations were carried out using an Acuson 128 Ultrasound scanner
(Acuson, Mountain View, Calif.) equipped with spectral and colour Doppler
facilities, and a 5 MHz linear array transducer. The room temperature was maintained
between 22 and 25°C. With the subject lying supine with 15° of head up tilt, the right
common femoral vein was imaged in the longitudinal axis, at a point on the common
femoral vein 2 cm below the junction with the long saphenous vein. The image was
frozen after minimising the transducer pressure near to the point of losing contact.
The distance between the inner aspects of the anterior and posterior vessel walls was
recorded and the mean of three measurements calculated. The Doppler gate was then
placed across the middle third of the vessel lumen, and a spectral Doppler recording
of the flow wave form was made over a period of 15 seconds of quiet respiration. In
order to minimise velocity calculation errors from the Doppler shift, the angle of
insonance was electronically steered to subtend an angle less than 60° to the axis of
flow and the velocities measured were angle corrected by aligning the cursor to the
direction of flow. The wave form recording was then analysed for maximum and
minimum flow velocities, time averaged maximum velocity (TAMV) over 15
seconds, and for the presence of respiratory and cardiac fluctuation. The degree of
flow fluctuation with respiration was calculated by dividing the difference between
maximum and minimum velocity by the TAMV, giving the Venous Variation Index
(VVI), a measure of venous 'pulsitility'. These measurements were repeated at the
superficial femoral vein proximal to its exit from the adductor canal, and at the
popliteal vein, distal to its junction with the short saphenous tributary. This protocol
was repeated in the left leg. The subject then adopted the left lateral position and the
same measurements were carried out at the left and right common femoral vein.
Prior to statistical analysis the data were assigned to one of nine gestational 'stages'
depending on gestation or postpartum date at which it was collected. The grouped
data were pooled and then analysed for variance by means of a repeated
measurements model which allows for variation among patients and for correlated
errors across time.
7.3 Results
7.3.1 The semisupine position.
Vessel Diameter
Analysis of the data relating to diameter of the CFV, SFV and popliteal vein
demonstrated no significant difference between the legs and the data were pooled
across legs for further analysis. The CFV diameter at booking measured 9.1mm
(SEM± 0.3mm) and was found to increase throughout pregnancy to a maximum of
12.7mm (± 0.2mm) between 36 weeks gestation and delivery. By the fourth
postpartum day the mean diameter had fallen to 9.8 mm (± 0.2mm) and a further fall
to a mean of 9.0mm (±0.2mm) was recorded 6 weeks postnatally. The presence of
changes over time was highly significant (p<0.001). A similar but less marked
gestational pattern was observed at the superficial femoral vein, rising from a mean
diameter at booking of 7.7mm (±0.3mm) to a maximum of 8.4mm (± 0.2mm) in the
late third trimester before falling to a diameter of 7.5mm (±0.2mm) postnatally.
Again, the presence of changes over time was highly significant (p<0.001). At the
popliteal vein a similar marked pattern was again observed with the rise in diameter
occurring from 5.8mm (+0.2mm) at booking to 6.8mm (± 0.2mm) prior to delivery




Analysis of the data in the right and left legs showed the time averaged maximum
flow velocity (TAMV) to be significantly slower in the left than in the right CFV and
popliteal veins. The gestational fall in TAMV demonstrated a similar pattern in both
limbs. At the right CFV a mean TAMV of 14.8cm/s (SEM±2.0cm/s) was recorded at
booking, falling by over 60% to 4.5cm/s (±0.4cm/s) by the mid third trimester
(p<0.001). A similar pattern was seen in the left CFV where the fall was from
11.2cm/s (±1.2cm) to 4.9cm/s (±0.5cm/s). The difference in TAMV between the right
and left CFV was demonstrated in early pregnancy and six weeks postnatally (Figure
7a) when significant increases in flow velocity were seen in both right and left legs to
15.0cm/s (±0.8cm/s) and 13.4cm/s (±0.7cm/s) respectively (p<0.01). The popliteal
vein demonstrated similar changes with gestation (Figure 7a). Here, the fall in flow
velocity appeared complete by the mid second trimester and showed no significant
further increase until delivery had occurred. Although a similar trend was evident at
the SFV, the gestational changes in flow velocity were less marked and did not reach
statistical significance.
Venous variation index
While there was a suggestion of a slight gestationally related reduction in VVI
(Figure 7b) the observed changes failed to reach statistical significance in any of the
vessels examined and no significant difference between the right and left legs was
demonstrated.
7.3.2 Left lateral position
On adopting the left lateral position, clear differences were recorded in vessel
diameter, flow velocity and VVI when compared with the supine position and these
changes were evident at most gestational and postnatal stages.
Vessel Diameter
In contrast to the semi-supine position, differences in vessel diameter were evident
between the left and right CFV in the left lateral position, and the data were analysed
separately. At the right CFV adoption of the left lateral position resulted in a fall in
diameter from 9.0mm (±0.4mm) to 7.9mm (±1.7mm) at booking. In contrast to the
semi-supine position, no significant gestational changes in right CFV were recorded
in the left lateral position until delivery when a significant fall in diameter from
5.9mm (±0.6mm) prenatally to 4.8mm (±0.3mm) was observed. The postural
difference in diameter was therefore observed to increase slightly as gestation
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advanced (Figure 7c) A statistically significant fall in diameter was also observed in
the left leg on adoption of left lateral position (p<0.01) but this fall was significantly
less than that observed in the right CFV (p<0.01) (Figure 7c). The postnatal
measurements showed a reversal in this relationship, with an increase in diameter
being recorded at the left CFV on adoption of the left lateral position (Figure 7c).
Time averaged maximum flow velocity
Adoption of the left lateral position resulted in an increase in flow velocity in the right
CFV which while clearly evident throughout pregnancy became more marked after
delivery (p<0.001). (Figure 7d). In the left CFV, the adoption of the left lateral
position resulted in a rise in flow velocity over the semi-supine position from mid-
pregnancy. However, the left lateral position was associated with a fall in flow
velocity when measured postnatally (Figure 7d).
Venous Variation Index
The adoption of the left lateral position resulted in a significant increase in VVI in
both the right and left CFV during pregnancy (p<0.01). However, after delivery no
significant changes was demonstrated in the right CFV on altering posture whereas in
the left CFV, adopting the left lateral position the postnatal phase resulted in a more
profound increase in VVI than was observed during pregnancy (Figure 7e).
7.4 Discussion
The development of duplex Doppler ultrasound techniques as a noninvasive, accurate
and reliable means of measuring blood flow velocity has enabled a review of the
previously held assumptions concerning the effects of pregnancy on the
cardiovascular system. In vitro and in-vivo studies on the venous system have shown
Doppler ultrasound to be capable of accurate measurement of flow velocity (see
Chapter 3) and the technique has been validated in the arterial system by comparison
with the Fick principle, showing high correlation in the measurement of cardiac
output in non-pregnant patients undergoing cardiac catheterisation (Robson et al,
1987). Several studies have since been published demonstrating the effects of
pregnancy on cardiac output (Robson et al 1989).
Early studies of the venous system in pregnancy indicated that the pressure in the
femoral vein increased through gestation to a maximum at term, by which time it had
Ill
doubled (McLennan 1943). The flow rate studies of Wright (1954) indicated a
parallel effect, with a doubling in the time taken for saline labelled with 24Na
injected into a vein on the dorsum of the foot to be detected by a counter at the groin.
Unlike previous studies which assessed venous flow in the limb as a whole, we have
specifically examined the proximal deep venous collecting system of the leg and our
findings suggest that the gestational changes in the deep leg veins maybe more
profound. A feature of our results was the variable degree to which the different
vessels altered with advancing gestational age. When measured in the supine
position, an increase in diameter was detected from the early second trimester in all
three vessels (CFV, SFV and POP). However, these changes were most marked in the
CFV. Similarly, while a fall in flow velocity was demonstrated in all three vessels
from the second trimester, this was again most profound in the CFV where a
reduction of more than 60% in flow velocity was observed from the first trimester
to term. Such a reduction in flow velocity is likely to result in relative stasis of the
blood. Additionally, marked vessel distension may result in damage to the
endothelium and the exposure of the blood to subendothelial collagen and triggering
of the extrinsic pathway of coagulation (Stewart et al 1987). Further, increased
stretch of endothelial cells may cause activation of prothrombotic changes on the
endothelium (Bodin et al 1994). Thus the CFV in late pregnancy may provide more
favourable conditions for thrombus formation than the more distal deep veins of the
leg. These findings are consistent with the observations that in contrast to the
nonpregnant state where thrombus formation is thought to begin in the soleal sinuses
of the calf, in pregnancy, the ileofemoral segment of the deep venous system is the
commonest site of thrombus formation (Berqvist & Hedner 1981).
In the nonpregnant, 55% of DVT affect the left leg. In pregnancy, this predominance
rises to 85% (Lindhagen et al 1986). This is thought to be due to the compression of
the left iliac vein by the right iliac artery and the ovarian artery which crosses the vein
on the left side only. The presented findings confirm that flow velocity is
significantly slower in the left leg when measured in the supine position. This
difference was also evident in the left lateral position. The observed difference in
flow velocity between the left and right legs may explain the increased risk of DVT
on the left side.
The adoption of the left lateral position had striking effects on CFV diameter, flow
velocity and VVI which were not confined to the third trimester. Previous studies
have demonstrated a clear compressive effect of the gravid uterus on the inferior vena
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cava in late pregnancy and it may be completely occluded in the supine position, with
venous return being diverted through the ascending lumber veins (Kerr et al 1964).
Adoption of the left lateral position relieves the observed obstruction in the inferior
vena cava, and is recommended in late pregnancy to prevent the 'caval syndrome'.
These data suggest that the 'lifting' of the gravid uterus off the IVC, while
contributing to the improvement in venous return, may not be the principal
mechanism by which venous return is increased on adoption of the left lateral position
and that other abdominal organs, such as the liver, may have a postural dependent
effect on flow in the IVC. The minimal effect of advancing gestation on the VVI in
the supine position suggests a limited dampening effect of the gravid uterus on the
transmission of respiratory changes in thoracic pressure. This is in contrast to the
marked increase in VVI seen in both the left and right CFV on adoption of the left
lateral position. This positional increase in VVI may provide a means of increasing
the specificity of reduced respiratory fluctuation in flow as an indicator of proximal
DVT. Additionally, we have demonstrated that adoption of the left lateral position
results in a greater increase in flow velocity in the right CFV than that observed after
the application of graduated support stockings in non-pregnant women (Macklon &
Greer 1995). The observed increase in flow velocity in both the left and right CFV in
the left lateral position in pregnancy may therefore provide the basis of a simple
thromboprophylactic manoeuvre for those at increased risk of thromboembolic
disease, with implications for the care of the patient following delivery by caesarean
section, a recognised risk factor for DVT (Macklon & Greer 1996).
7.5 Conclusion
Duplex Doppler and colour Doppler ultrasound are now established as the first line
method of diagnosis for suspected DVT in pregnancy. The physiological changes
which take place in the deep veins of the leg during and after pregnancy have been
elucidated and may aid in the interpretation of venous ultrasound examinations. Our
data have confirmed the profound changes in the diameter and flow velocity and
pattern within the deep veins of the leg on adoption of the left lateral position, and
have shown that these effects are not confined to late pregnancy. The gravid uterus
appears not to be the only factor underlying postural alterations in venous return. The
alterations in venous flow characteristics described on adoption of the left lateral
position may also aid in the diagnosis or exclusion of suspected DVT. The left lateral
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Figure 7a Top Panel: The gestational changes in diameter in the left and right
CFV, SFV and popliteal veins.
Bottom Panel: The TAMV in the right and left CFV and popliteal
vein. D+4 and D+42 indicate the 4th and 42nd postnatal day
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Figure 7b Gestational changes in the venous variation index
(VVI) in the CFV, SFV and popliteal vein (POP)
Data shown are mean (SE).
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Figure 7c Gestational changes in the diameter of the right and left
CFV as measured in the left lateral position, compared with
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Figure 7d The effect of adopting the left lateral position on flow velocity
in the right and the left CFV from 20 weeks gestation to 42
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Figure 7e The venous variation index (VVI) in the left and
right CFV in the supine (mean values) and left
lateral position from 25 weeks gestation to 42 postnatal
days. Data shown are mean (SE).
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Chapter 8




The objective of this study was to determine the vessel wall diameter and blood flow
velocity within the proximal deep venous system of the leg in the puerperium and
compare these parameters with respect to the left versus right leg, 4th versus 42nd
postnatal day and vaginal versus caesarean delivery. A reduction in vessel diameter
and an increase in flow velocity was observed between the 4th and 42nd postnatal
day. Vessel diameter was greater and flow velocity was reduced in the left as
compared to the right leg. In those delivered by caesarean section, a trend towards
reduced flow velocity in the proximal deep leg veins was observed when compared to
those delivered vaginally. These data suggest possible physiological mechanisms
behind previous clinical observations relating to the period of greatest risk of DVT in
the puerperium, the relative preponderance of left sided DVT and the risk of DVT
associated with caesarean section.
8.1 Introduction
Pulmonary thromboembolism remains the major cause of maternal mortality (DHSS
et al 1996). The puerperium is considered to be the period of greatest risk from
pregnancy associated thromboembolism, and guidelines have recently been published
in the U.K. for the administration of thromboprophylaxis to those at risk (RCOG
1995). In the review of reported thromboembolic complications of pregnancy and the
puerperium in Scotland presented in Chapter 6, 38% of postnatal DVT and 22% of
postnatal PTE presented after discharge from hospital while caesarean section was
associated with a reported incidence of DVT more than double that after vaginal
delivery (Macklon & Greer 1996). The physiological response to pregnancy results in
thrombogenic alterations to the blood coagulation system and relative stasis of blood
in the deep leg veins. The third component of Virchow's classical pathophysiological
triad for thrombosis (1856), vascular damage, may then arise from vessel distension
and endothelial tearing (Stewart et al 1987). Knowledge of the changes in deep
venous flow in the legs after delivery may be of value not only to our understanding
of the pathophysiology of venous thromboembolic disease in the puerperium, but also
in the design of future thromboprophylactic practice. We employed duplex Doppler
ultrasound techniques to study the diameter and blood flow velocity in the proximal
deep leg veins. Data for left versus right leg, 4th versus 42nd postnatal day and
vaginal versus caesarean delivery were compared.
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8.2 Methods
The approval of the local Research Ethics Committee was obtained prior to
commencement of the study. Subjects were recruited from the postnatal wards of the
maternity unit in which the study was carried out. Inclusion criteria included delivery
by spontaneous vertex delivery (SVD) or by caesarean section for obstetric reasons
such as fetal distress, breech presentation, and previous caesarean section.
Postpartum heparin thromboprophylaxis received in line with our unit protocol was
not considered an exclusion criterion, but women with a history of pre-eclampsia or
major antepartum haemorrhage were excluded from the study. Given the previously
demonstrated sensitivity of the measurement technique proposed, it was considered
that clinically meaningful differences in the studied parameters would be evident in a
combined sample size of 40 subjects. Complete data was obtained from 20 who had
been delivered by SVD and 22 who had been delivered by caesarean section, of
which 12 had undergone emergency delivery. The mean parity in each group was 1.
The mean age in the caesarean group was 28 years as opposed to 26 in the SVD group
but this small difference was not considered significant.
The subject preparation and methods employed were as previously described. All
measurements were made with the patient lying supine with a 15° head up position.
The diameter and blood flow velocity (measured as the time averaged maximum
velocity, (TAMV)) were recorded at the common femoral vein, superficial femoral
vein and popliteal veins according to the previously described protocol.
Measurements were performed in both legs on the 4th and again on the 42nd
postnatal day.
The data were found to be normally distributed. The data were subjected to two factor
analysis of variance and tested for significance using Fishers Protected LSD test.
p<0.05 was taken to indicate a statistically significant result.
8.3 Results
8.3.1 Effect of time
Between 4th and 42nd postnatal day, there was a mean reduction in the diameter of
all vessels except the left SFV. However, only the CFV showed a statistically
significant reduction . An increase in flow velocity was seen in all vessels between
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the 4th and the 42nd postnatal day. Again, however, statistical significance was only
demonstrated at the CFV (Table 8.1).
8.3.2 Difference between left and right legs
Comparison of the vessel diameter and flow velocity demonstrated significant
differences between the left and right legs. The mean diameter of the left CFV was
significantly greater than that of the right CFV. Conversely, the flow velocity was
lower in the left CFV than in the right, although the difference did not reach statistical
significance. While a similar trend was demonstrated at the level of the SFV, the
differences between left and right did not reach significance. At the popliteal vein,
however, the vessel diameter in the left leg was significantly greater and the flow
velocity significantly slower than that demonstrated in the right leg (Table 8.1).
8.3.3 Effect of mode of delivery
A trend towards reduced flow velocity at the CFV and SFV was observed in those
delivered by caesarean section (Table 8.2). However, the influence of mode of
delivery on vessel diameter and flow velocity did not reach statistical significance at
any of the venous segments studied.
8.4 Discussion
Our data indicate that following discharge from hospital, most women retain a degree
of stasis within the proximal deep veins of the leg. This may contribute to the ongoing
risk of thromboembolism in the puerperium and reflect persistent increased vessel
wall compliance (Clarke-Pearson & Jelovsek 1981) or relaxation of vascular smooth
muscle in the continuing presence of hormonal factors. It is not certain to what extent
observations made on the 42nd postnatal day reflect the non-pregnant situation.
However, in Chapter 7 it was demonstrated that by the 42nd postnatal day, deep
venous diameter and flow velocity have returned to levels observed in early
pregnancy .
Between the 4th and 42nd day, the most profound changes in deep venous diameter
and flow velocity were seen in the CFV. Our data suggest that the CFV is the segment
of the deep venous system of the leg most affected by the physiological and
mechanical stresses provided by pregnancy and delivery. Why this should be the case
is not clear. The superficial position of the vessel leaves it relatively unsupported
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compared to the superficial femoral vein where changes in compliance of the vessel
wall and venous pressure may not result in changes readily detected with ultrasound.
Additionally, any observed effect of the uterus on venous flow will decrease as the
distance between the vessel and the pelvis increases. These data are consistent,
however, with the observation that most pregnancy related DVT are ileofemoral in
origin, reflecting these thrombogenic alterations in the CFV, rather than of calf vein
origin as is the case outside pregnancy (Bergqvist & Hedner 1983, Polak &
Wilkinson 1991).
Thrombosis tends to occur more frequently in the left leg than in the right in both
pregnant and non-pregnant patients (Markel et al 1992). In Chapter 7 blood flow
within the deep veins of the leg was shown to be slower in the left leg during
pregnancy supporting the suggestion that relative stasis in the left leg may account
for the observed predominance of left sided DVT in pregnancy (Lindhagen et al
1986). The data presented here demonstrate the presence of relative stasis in the deep
veins of the left leg in the early puerperium and six weeks after delivery. The
increased diameter and reduced flow velocity on the left side would appear to indicate
the presence of a proximal obstruction. One factor that may contribute to this is the
compression of the left common iliac vein by the right common iliac artery. (Cockett
& Thomas 1965). In addition, venous webs have been reported to form more
commonly at the left than the right iliac vein (Ferris et al 1983) and changes in the
left iliac vein itself have been described in post-mortem studies, further supporting
this as a potential site for the development of acute DVT (Krumbhaar & Ehrich
1942). Hormonal factors may contribute to the pregnancy associated increase in left
sided predominance, since the effect has been observed to be related to oestrogen
dose in users of higher oestrogen-containing oral contraceptives (Bergqvist et al,
1982). A trend towards relative stasis in the proximal deep leg veins was observed in
those who had undergone caesarean delivery, suggesting that the increased incidence
ofDVT observed after caesarean section may be due in part to relative stasis.
8.5 Conclusion
These data suggest possible physiological mechanisms behind previous clinical
observations relating to the period of greatest risk of DVT in the puerperium, the
relative preponderance of left sided DVT and the risk of DVT associated with
caesarean section. Current thromboprophylactic guidelines tend to advise the
institution of prophylactic measures only until the patient is mobilised or discharged.
The presented data suggest that this approach may merit review. This is further
supported by the data presented in Chapter 6 showing that a high proportion of cases
of thromboembolism present after discharge and data from the Confidential Enquiry
which shows that many fatal cases of PTE occur between 7 and 42 days postnatally
(DHSS et al 1996). It may therefore be advisable that those women receiving
thromboprophylaxis should continue to use this following discharge. For example,
anti-thromboembolic stockings may be indicated for at least six weeks postnatally,
particularly following caesarean delivery.
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Table 8.1
Vessel diameter and time averaged maximum flow velocity (TAMV) are given for the
right (R) and left (L) common femoral vein (CFV), superficial femoral vein (SFV)
and popliteal vein (POP) on the 4th and 42nd postnatal day. The statistical
significance of the differences between the 4th and 42nd day (4 v 42) and the right
and left leg (R v L) are given as p values.
p value
Vessel Day 4 Day 42 4 v 42 R v L
Diameter R CFV 9.6(0.2) 8.6(0.3) 0.02 0.02
mm(SEM) L CFV 9.9(0.2) 9.4(0.2)
R SFV 7.6(0.2) 7.3(0.3) 0.85 0.07
L SFV 7.7(0.2) 7.9(0.2)
R POP 5.4(0.2) 5.0(0.4) 0.30 0.03
L POP 5.8(0.2) 5.7(0.2)
TAMV R CFV 10.6(0.6) 13.9(0.7) 0.04 0.07
cm/s(SEM) L CFV 10.0(0.6) 12.0(0.7)
R SFV 5.4(0.4) 6.2(0.5) 0.15 0.17
L SFV 5.1(0.3) 5.5(0.4)
R POP 5.9(0.4) 7.0(0.5) 0.06 0.04
L POP 5.3(0.4) 5.9(0.5)
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Table 8.2
Mean vessel diameter and flow velocity (TAMV) at the common femoral vein (CFV),
superficial femoral vein (SFV) and popliteal vein (POP) on the 4th and 42nd postnatal
day are given for the group delivered by spontaneous vertex delivery (SVD) and the
group delivered by caesarean section (C/S). The statistical significance of the
differences between the groups delivered by SVD and C/S (SVD v C/S) are given as
p values.
p value
Vessel Dav SVD C/S SVD v C/S
Diameter CFV 4 9.7(0.2) 9.7(0.2) 0.44
mm(SEM) CFV 42 9.2(0.2) 8.8(0.2)
SFV 4 7.7(0.2) 7.6(0.3) 0.76
SFV 42 7.5(0.2) 7.7(0.2)
POP 4 5.4(0.2) 5.7(0.4) 0.33
POP 42 5.3(0.2) 5.4(0.2)
TAMV CFV 4 10.4(0.6) 10.3(0.7) 0.27
cm/s(SEM) CFV 42 13.7(0.5) 12.3(0.4)
SFV 4 5.4(0.4) 5.1(0.3) 0.36
SFV 42 6.3(0.3) 5.5(0.5)
POP 4 5.9(0.4) 7.0(0.5) 0.29
POP 42 6.1(0.4) 6.8(0.5)
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Chapter 9
Deep venous flow and posture;




Fluctuation in deep venous flow velocity with respiration may be an important means
by which early thrombi are removed form valve pockets. The duplex Doppler study
presented shows this phasicity of flow to be present throughout pregnancy. While
adoption of the upright posture does not remove respiratory fluctuation, it does result
in a reversal in the phase of respiration. These findings indicate the importance of
caval occlusion in altering venous return to the chest. Fluctuations in deep venous
flow velocity with the cardiac cycle are rarely seen in normal pregnancy.
9.1 Introduction
In pregnancy, the gravid uterus has been shown to cause collapse of the IVC in the
supine position (Kerr et al 1962). The data presented in chapter 7 indicates that when
present, the amplitude of respiratory phasicity of venous flow in the deep leg veins
is not significantly altered even in late pregnancy. As previously discussed this may
have implications for the ultrasound diagnosis of proximal occlusive DVT.
Respiratory phasicity may also be of thromboprophylactic importance. It has been
suggested that the presence of respiratory phasicity in non-pregnant subjects may act
to prevent the formation of DVT by 'washing out' early thrombi forming in venous
valve pockets (Sigel, 1973). The presence of respiratory flow phasicity may be seen
to be beneficial in this regard. Conversely, the presence of cardiac phasicity (that is
fluctuation in venous flow velocity with the cardiac cycle) is rare in healthy non¬
pregnant subjects. It's presence may be associated with haemodynamic pathology
such as cardiac failure (Willeput et al 1984).
The mechanism by which respiration causes phasic changes in venous return and
evident fluctuations in maximum flow velocity have been subject to previous study.
Before the advent of modern non-invasive measurement techniques, venous return to
the heart in the non-pregnant state was thought to increase during inspiration and
decrease during expiration. This was considered to be the result of two factors. The
inspiratory fall in intrathoracic pressure increases the pressure difference between the
periphery and the right atrium, so aspirating blood into the thoracic veins. Secondly,
the descent of the diaphragm compresses visceral organs, propelling splanchnic blood
toward the inferior vena cava. These concepts are, however, derived from canine
experiments involving surgical exposure of the vessels in order to insert flowmeters
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(Brecher & Hubay 1955, Brecher & Mixter 1953). The application of these data to
the human situation has been questioned, since the pattern of inspiratory muscle
contraction is different in dogs and humans; while dogs use parasternal intercostal
muscles to breath in (Road et al 1982), in humans the diaphragm is responsible for
most of the volume change (Sharp et al 1975). Since the veins from the lower
extremities traverse the abdominal cavity and the diaphragm before entering the
thorax, the inferior vena cava may be squeezed by the contracting diaphragm or
collapse as a result of a rise in intrabdominal pressure. In non-pregnant subjects,
Doppler studies have shown that the semi-recumbent position inspiration is
associated with a fall in venous return whereas expiration is associated with an
increase (Willeput et al 1984). There is to the author's knowledge no data indicating
whether this effect is maintained in the standing position. However, it can be
hypothesised that the standing position may result in a head of venous pressure
sufficient to prevent collapse of the IVC which can occur during inspiration. The
patent IVC could then transmit the increased negative intra-thoracic pressure
generated during inspiration to the infra-abdominal venous collecting system, thus
resulting in an increase in venous return, during inspiration compared to expiration.
This effect may be detectable as increased venous flow velocity at the CFV.
The physiological effect of pregnancy on these parameters remains unclear. The aims
of this study were to assess the effects of advancing pregnancy gestation on the
presence or absence of respiratory and cardiac flow phasicity and the phase of
inspiration associated with maximum venous flow velocities. In order to test the
hypothesis stated above regarding the effect of the standing position on the phase of
respiration associated with maximum flow velocity, the studies were carried out in
the semi-supine and upright position.
Duplex Doppler ultrasound was used to assess the common femoral veins (CFV),
superficial femoral veins (SFV) and popliteal veins (POP) of the left and right leg in
the supine and upright position in pregnant subjects from the first trimester until the
42nd postnatal day. In addition to recording the presence and phasicity of respiratory




The same cohort of women studied in the study presented in chapter 8 were
investigated and the data presented below were collected during the same ultrasound
examinations. These 24 women had a viable singleton pregnancy, were aged 18-34
years (median 25 years) of low parity (0-2) and free from any respiratory and
cardiovascular diseases . The mean gestation at which the subjects entered the study
was 12 weeks (8-24). Each subject had a duplex Doppler scan performed at booking
and at approximately monthly intervals thereafter until delivery. Further ultrasound
assessments were carried out on the 4th and 42nd postnatal day. Data were recorded
on the 42nd postnatal day as an approximation to the non-pregnant state.
Prior to each scan, each subject rested in the semi-supine position for 15 minutes. All
the ultrasound examinations were carried out using an Acuson 128 Ultrasound
scanner (Mountain View, Calif.) and 5 MHz tranducer. The subjects were prepared
and positioned by means of the protocol described in Chapter 5. The vessel to be
scrutinised was visualised in the longitudinal axis and the Doppler gate placed across
the middle third of the vessel lumen. A spectral Doppler recording of the flow
waveform was made during a 15 second period of deep breathing during which the
subject was observed for phase of respiration by monitoring chest wall and abdominal
wall excursion. Measurements were carried out at the CFV, SFV and popliteal veins
of the right and left leg in the semi-supine position (head up 15°) and the right CFV
in the upright position. The following observations were made:
a. The presence of respiratory and/or cardiac fluctuations in venous flow.
b. The timing of maximum flow velocity in relation to the phase of the respiratory
cycle.
In order to simplify the analysis of the effect of increasing gestation on flow




8 to 32 weeks gestation.
33 weeks to delivery.
The puerperium up to the 6th postpartum week.
130
Stage 2 was defined to indicate late pregnancy, when any effect of the gravid uterus
was likely to be detected. At gestations prior to this, the effect of the gravid uterus
was considered likely to be of less importance, and thus they were grouped as Stage
1. A total of 155 assessments were made, although technically adequate scans of all
vessels in all postures were only obtained in a total of 142 subject assessments. The
discrepancy was due to cases where the amplitude of phasicity was too low to discern
the relationship with respiratory phase. The categorical data obtained was analysed
using Chi-squared tests for significance.
9.3 Results
In the supine position, respiratory variation in flow velocity was present at the CFV
in 150/155 scans (Plate 9.1). Cardiac variation in flow velocity was also present in 15
scans (Plate 9.2) and was the only form of phasicity of flow in 5/155 scans. Similar
results were obtained at the SFV and popliteal vein (Figure 9a). During deep
breathing, maximal flow velocity through the CFV occurred during expiration in
130/142 of the assessments (Figure 9b), a further 3 showing a biphasic flow pattern
with peak velocities occurring in both inspiration and expiration, 3 showing peak
flow during inspiration and 6 showing no respiratory variation in flow velocity.
Again, similar patterns were observed at the SFV and the popliteal veins. No
significant differences were evident in flow phasicity between the left and right legs.
On adoption of the upright position, 128 of 142 examinations demonstrated
respiratory variation in flow at the CFV (Figure 9c). However, in contrast to the
supine position, maximum flow velocities were observed in inspiration alone during
deep breathing in 102 of 142 examinations (Plate 9.3). A biphasic waveform
demonstrating peak velocities during inspiration and expiration was observed in a
further 8 examinations, and expiration was associated with maximum flow velocities
in 16 examinations. The difference in respiratory phase of peak flow between the
supine and upright position was statistically significant (p<0.02).
The postural effects on flow phasicity described above were stratified for early
pregnancy, late pregnancy and the puerperium. While respiratory phasicity was
almost always present in both the supine and upright positions regardless of stage of
pregnancy, cardiac phasicity appeared to diminish with advancing gestation when
measured in the supine position. Prior to 33 weeks gestation, 10% of assessments of
flow in the right CFV demonstrated cardiac phasicity superimposed on respiratory
fluctuation. This fell to just 3% after 33 weeks gestation, rising to 25% in the
puerperium (Figure 9c). There was no significant change with gestation in the effect
of adopting the upright posture on respiratory phase of maximum venous flow
velocity (Figure 9d).
9.4 Discussion
The present data indicate that in pregnancy and the puerperium, inspiration reduces
the velocity of venous flow through the deep veins of the legs. These findings are
consistent with those of Willeput et al (1984) who used continuous wave Doppler
techniques to measure flow velocity at the CFV in 10 non-pregnant subjects in the
supine position. The presented data, like that of Willeput et al (1984) contrasts with
previous studies such as that of Wexler et al (1968) who used an electromagnetic
transducer positioned in the intrahepatic portion of the inferior vena cava. They
reported increased caval flow velocities during inspiration. This discrepancy may
reflect differences in the pattern of inspiratory muscle use by the subjects examined.
Konno and Mead (1967) have demonstrated the partition of breathing between the
diaphragm and rib cage, and different individuals may engage different components
as the principal means of effecting inspiration. Sharp et al (1975) have shown that
during quiet breathing, most normal subjects are diaphragmatic breathers when
supine and thoracic breathers when upright. If it is accepted that diaphragmatic
excursion tends to cause collapse of the inferior vena cava, whereas thoracic
excursion does not, then their findings would be consistent with our observations.
Advanced gestation did not appear to influence the pattern of respiratory phasicity
observed. However, cardiac pulsations were observed most frequently in the
puerperium, and least frequently in late pregnancy. It might be postulated that the
gravid uterus exerts a dampening effect on the transmission of cardiac pulsations to
the CFV which increases with advancing gestation. After delivery, the return of the
uterus to a size near to its non-pregnant state removes this dampening effect.
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9.5 Conclusion
The present study shows respiratory fluctuation in venous flow through the deep leg
veins to be present throughout pregnancy and demonstrates a reversal in the
respiratory phase of maximal flow velocity when the upright position is adopted, a
phenomenon observed in both the pregnant and non-pregnant state, as indicated by
the measurements taken on the 42 post-natal day. The hypothesis that adoption of the
upright position results in a head of pressure in the abdominal segment of the inferior
vena cava sufficient to resist occlusion by increased intrabdominal pressure during
inspiration is supported by our findings. The presented data also indicate that cardiac
pulsations can be observed in healthy pregnancy but are unusual. Their presence may
indicate an additional degree of haemodynamic disturbance, but further work is
required to determine whether they are more prevalent in pregnancy affected by
additional haemodynamic stress such as that imposed by pre-eclampsia.
Figure 9a
The percentage of assessments demonstrating respiratory, cardiac and both
respiratory and cardiac phasicity, and those assessments where no phasicity of
venous flow was demonstrated, are shown for the right (R) and left (L) common























The percentage of assessments where maximum flow velocity was
demonstrated during expiration, inspiration, both expiration and inspiration
(demonstrating abiphasic waveform), and where no flucuation was observed
with respiration (None). Observations are shown for the right (R) and left (L)
common femoral vein (CFV), superficial femoral vein (SFV) and popliteal
vein (POP) in the supine position.
None








The percentage of assessments demonstrating respiratory, cardiac and both
respiratory and cardiac phasicity, and those assessments where no phasicity of
venous flow was demonstrated, are shown at the right common femoral vein
in the supine and upright positions in early pregnancy (EP), late pregnancy









The percentage of assessments where maximun flow velocity was demonstarted
during expiration, inspiration, both expiration and inspiration (demonstrating a
biphasic waveform), and where no fluctuation was observed with respiration (None).
Observations are shown at the common femoral vein in the supine and upright
positions in early pregnancy (EP), late pregnancy (LP) and the puerperium (PM).
None




Plate 9.1 Respiratory variation in venous flow at the CFV in the supine
position. Maximum flow velocity occurs during expiration.
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Plate 9.3 Respiratory variation demonstrates maximum flow velocity during
inspiration at the CFV in the upright position.
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Chapter 10
Duplex ultrasound screening for deep venous
thrombosis in the puerperium
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Summary
Although the role of duplex Doppler ultrasound as a screening tool for DVT in
asymptomatic patients remains to be established, it is of considerable potential utility
in pregnant and puerperal women. In order to determine whether a significant number
of women at low to moderate risk of developing puerperal DVT had subclinical
thrombosis, the previously described duplex techniques for detecting deep venous
thrombosis in the proximal veins of the leg were applied to 140 such women. No
DVT were detected and all the subjects remained asymptomatic at follow up 6 weeks
later. These findings indicate that there is unlikely to be a large number of subclinical
DVT in this group of women, and are consistent with other data regarding the
incidence of DVT in the puerperium. Current guidelines for thromboprophylaxis in
this group are appropriate.
10.1 Introduction
The puerperium is recognised as a period of increased risk from thromboembolism,
and additional factors known to increase the risk include caesarean section, pre¬
eclampsia, obesity, age over 35 years, and multiparity. While the incidence of
pulmonary embolism in the puerperium is well documented, that of deep venous
thrombosis remains uncertain as no contemporary data based on non-invasive
objective and accurate screening techniques exists. The development of Duplex
doppler ultrasound as a means of diagnosing DVT offers a potential non-invasive
means of screening for DVT in asymptomatic patients deemed to be at risk. In such
patients, particularly those at low to moderate risk, invasive techniques such as
contrast venography would not be acceptable to most patients. However, duplex
Doppler ultrasound screening can only be of value if demonstrated to have sufficient
sensitivity and specificity when compared with a gold standard test such as contrast
venography. As discussed in an earlier chapter, the sensitivity and specificity of
ultrasound in detecting proximal DVT in symptomatic patients has been shown to
approach that of venography, and has replaced it as the first line investigation in many
centres. Less certainty exists as to the accuracy of duplex ultrasound in detecting
DVT in asymptomatic subjects, and no validation studies have been carried out on
pregnant or puerperal patients. The majority of studies designed to assess the
accuracy of Duplex ultrasound as a screening test have been carried out in post¬
operative orthopaedic patients. This prospective screening study of 140 asymptomatic
women who had been delivered four days previously describes the use of duplex
Doppler ultrasound techniques to screen for subclinical deep venous thrombosis in the
early puerperium.
Initial studies suggesting a low sensitivity for the detection of asymptomatic DVT
were hampered by small numbers (Monreal et al, 1989) and selective use of
comparison to confirm positive Duplex tests (White et al, 1990). In a study of 158
post-operative total hip arthroplasty patients, Barnes et al (1991) demonstrated a
sensitivity and specificity for duplex scanning of 79% and 97% respectively against
venography as the gold standard. Cronan et al (1991) were able to achieve 100%
sensitivity and specificity for compression ultrasound against venography in
detecting 12 DVT in 86 patients who had sustained a hip fracture. A meta-analysis of
comparitive studies published between 1982 and 1993 (Wells et al 1995) cast doubt
on the true value of duplex ultrasound in asymptomatic patients however. Analysing
those studies where bias in study design had been minimised, they calculated a
sensitivity of 62% and a specificity of 97% for duplex Doppler against venography,
and suggested that duplex ultrasound may therefore have only a limited role in
screening. In coming to this conclusion they included data from papers that had
employed colour Doppler as the means of screening. Colour Doppler appears of little
value in assessing the asymptomatic patient (Davidson et al, 1992), and some
authorities believe it to be inferior to duplex ultrasound in this role (Camerota, 1993).
The reason for this is unclear, but since colour Doppler renders the examination of
the deep veins easier in most cases, it may encourage a less diligent search in the
asymptomatic patient. Restricting their studies to duplex ultrasound versus
venography, Grady & Benson (1994a) recently assessed duplex ultrasonography in 79
patients who had undergone total knee arthroplasty, and showed 100% sensitivity and
specificity in the detection of proximal DVT against venography. For the detection of
distal thrombosis, the sensitivity of duplex ultrasound fell to 88% with a specificity of
98%. Amongst a cohort of 51 hip arthroplasty patients a sensitivity of 91% and
specificity of 98% was reported by the same authors (1994b). However Jomgbloest et
al (1994) were unable to confirm such impressive figures, reporting a sensitivity of
just 40% in detecting proximal DVT in 13 of 100 patients who had undergone
craniotomy. In the absence of meta-analyses of more recent data, the true value of
duplex ultrasound in screening the asymptomatic at risk patient remains uncertain.
Discrepancies in published results may reflect differing degrees of expertise among
the sonographers. Prior to carrying out this study, the author underwent intensive
training in the technique from experienced experts (see Acknowledgements). While
no formal assessment of the authors expertise was carried out, all DVTs detected by
him in symptomatic patients were subsequently confirmed by venography, and to the
author's best knowledge, no thromboembolic sequelae occured amongst the many
women on whom he reported a negative scan during the period of data collection.
Accepting the limitations of the technique, the published data appears sufficiently
encouraging to merit utilisation of duplex ultrasound as a screening tool among
subjects on whom venography would be difficult to justify. Such a group constitutes
the study group presented in this chapter; asymptomatic woman at low to moderate
risk of postpartum DVT.
In order to ascertain the true incidence of DVT in this group of patients, previous data
would indicate the need for screening study of several hundred patients. The aim of
this study, however was to employ duplex Doppler ultrasound to determine whether a
large number of women at low to moderate risk were sustaining subclinical untreated
DVT prior to discharge from hospital. Thus a study of similar size to those
previously published in the application of other techniques in pregnancy (Bergqvist et
al 1979) was undertaken.
10.2 Methods
The screened population consisted of two groups: 94 women delivered by caesarean
section and 46 delivered vaginally. Although unselected, the presence of additional
risk factors for deep venous thrombosis were recorded, including age older than 35
years, weight over 80 kg at booking, previous history of deep venous thrombosis,
parity greater than four, and pre-eclampsia affecting the index pregnancy.
Each subject was examined in the semi-supine position using an Acuson 128
ultrasound scanner (Mountain View, California, USA) fitted with a 5 MHz linear
array transducer or a Hitachi EUB 415 ultrasound scanner (Tokyo, Japan) fitted with
a 5 MHz curvilinear transducer. The proximal deep vein collecting system of each
leg was examined for evidence of thrombus formation from the ileofemoral vein to
the popliteal vein. Thrombus was excluded if the vein appeared undistended, was
easily compressible and was free of intraluminal echogenic material. Exclusion of
occlusive deep venous thrombosis proximal and distal to the venous segment under
scrutiny respectively required the demonstration of spontaneous respiratory flow
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fluctuation and augmentation of flow on Doppler ultrasound on distal calf
compression. Since direct scrutiny of the superficial femoral vein as it passed
through the adductor canal was not possible in many cases, the latter criteria were
applied to infer patency in this segment.
10.3 Results
One hundred and forty asymptomatic women were screened. Of those delivered by
caesarean section, 21 subjects (22%) had one additional risk factor for deep venous
thrombosis and four (4.3%) had two additional risk factors. Of those delivered
vaginally, ten (22%) had one risk factor and one (2%) had two risk factors. Table
10.1 summarises the risk profile of the screened population. No cases of subclinical
deep venous thrombosis were identified in any of the subjects.
10.4 Discussion
Recently, guidelines on thromboprophylaxis in pregnancy and the puerperium have
been published (THRIFT Consensus Group 1992), but obstetricians remain reluctant
to prescribe prophylaxis in those at risk, partly because of the perceived rarity of
clinical deep venous thrombosis in their practice (Greer & De Swiet 1993). Clinical
diagnosis has estimated the incidence of deep venous thrombosis following vaginal
delivery between 0.08 and 1.2 %, rising to 2.2 to 3.0 % following caesarean section
(Husni et al 1967). However, clinical diagnosis is unreliable (Genton & Turpie
1980). A postpartum study using I-labelled fibrinogen (Friend & Kakkar 1970)
reported an incidence of 2.6 % following vaginal delivery. Most of the cases of deep
venous thrombosis detected were situated in the calf and were of debatable clinical
significance.
The present study found no positive diagnosis in the women studied, although the
majority had either none or only one additional risk factor. While limited by the
relatively low number of women examined, this suggests that the incidence of
proximal deep venous thrombosis is unlikely to be higher, and may even be lower
than previously reported in low risk women. Since previous studies were published,
developments in modern obstetric practice towards shorter admissions and the
encouragement of early ambulation may have contributed to the lower incidence of
deep venous thrombosis suggested by the present results. A more recent study using
plethysmography to screen 169 women following caesarean section found an
incidence of deep venous thrombosis of 1.8 % (Bergqvist et al 1979).
Plethysmography is, however, an indirect means of diagnosis and inferior in
sensitivity and specificity to the traditional diagnostic gold standard, X-ray
venography. The invasive nature of venography and I-labelled fibrinogen scanning,
coupled with the risks of viral transmission and questionable accuracy associated with
the latter (Lensing & Hirsh 1993), render these techniques unsuitable for screening.
Ultrasound techniques have been demonstrated to offer excellent sensitivity and
specificity when measured against venography for the diagnosis of symptomatic
proximal leg vein thrombosis (Aitken & Godden 1987) and have become widely used
for this purpose in pregnancy. As discussed above, however ,in asymptomatic
subjects the sensitivity may be reduced. When considered with the difficulty in
assessing the calf veins, ultrasound appears less attractive as a screening tool. In
pregnancy and the puerperium these limitations may not apply. As is the case with
plethysmography, interpretation of ultrasound findings may be complicated by
pregnancy associated physiological changes and necessitate different criteria for the
diagnosis of deep venous thrombosis. Additionally, in contrast to the nonpregnant
state, obstetric deep venous thrombosis frequently initiate in the common femoral
vein (Bergqvist & Hedner 1983, Polak & Wilkinson, 1991) and poor visualisation of
the calf veins may, therefore, be less important.
Our results are consistent with those of previous indirect noninvasive screening
studies and serve to confirm the perceived low incidence in modern obstetric practice
of subclinical deep venous thrombosis in the early puerperium in women at low to
moderate risk. These data are also compatible with the epidemiological based
incidence. Validation of the techniques as a screening tool in this patient group will
remain difficult, however, given the relatively low incidence of DVT reported
compared to that amongst post-operative orthopaedic patients. The application of this
technique to larger numbers with multiple risk factors may, however be valuable in
the further assessment of ultrasound as a screening tool in pregnancy and the




On the basis of this study, there is no evidence that a large number of subclinical
thromboembolic complications are being missed by not offering routine DVT
screening to women at low to moderate risk. In the absence of data from large
screening studies of women at high risk, and in view of the 10-fold incidence of DVT
reported in those considered under current guidelines to be at risk (see above and
chapter 6) current thrombprophylaxis guidelines (see chapter 1) should not be altered.
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Table 10.1
The number (n) and percentage (%) of subjects screened with none, 1, 2, and 3 risk
factors for deep venous thrombosis (DVT) in addition to their puerperal status are
shown. Delivery by caesarean section is designated an additional risk factor.







Compression stockings and posture:
a comparative study of their effects on the proximal deep
veins of the leg at rest.
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Summary
Graduated compression stockings have been shown to reduce the incidence of deep
venous thrombosis. While they are thought to act primarily by increasing venous flow
velocity, their mode of action remains uncertain. Doppler ultrasound was employed to
study the relative effects of three types of support stocking on the deep venous
diameter, flow velocity and pulsatility in 10 non-pregnant female subjects. In
addition, the effect of altered posture on the same parameters was assessed.
Significant effects of the graduated stockings were found at the level of the popliteal
vein, where a reduction in both the diameter and the amplitude of respiratory
phasicity was recorded (p<0.05). No significant increase in flow velocities was
recorded. Adopting the left lateral position significantly increased flow velocity in the
right common femoral vein (p<0.05). The application of stockings in this position
produced no additional increase in flow velocities, but did alter the amplitude of
respiratory phasicity. These data do not support the widely held view that graduated
compression stockings increase flow velocities at rest. Adopting a lateral recumbent
position significantly increases flow velocity in the non-dependent leg.
11.1 Introduction
Venous thromboembolism remains a major cause of post-operative mortality and
morbidity. Eighty percent of those who die from pulmonary thromboembolism (PTE)
are asymptomatic (Sandler & Martin 1989), and emphasis is therefore placed on
appropriate prophylaxis (Lowe et al 1992). Elasticated stockings are now the most
widely used physical means of preventing DVT.
The use of local compression to increase venous flow through the limbs was first
described by Stanton and colleagues (1949) who observed an increased clearance of
Evans Blue dye from the leg. Later, continuous wave Doppler flow studies
demonstrated that a pressure gradient applied from 18mm Hg at the ankle to 8 mm Hg
at the thigh optimised flow velocity in the proximal veins of the leg (Sigel et al 1975).
Graduated elasticated stockings designed to apply this compression profile have been
shown to prevent post-operative deep venous thrombosis (Holford 1976, Allan et al
1983, Scurr et al 1977) and a recent meta-analysis has confirmed their efficacy in this
regard (Wells et al 1994). Initial studies indicated that compression stockings acted to
increase venous clearance from the limb. However more recently, this mode of action
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has been questioned (Keith et al 1992) and the precise mechanism by which they
achieve their thromboprophylactic effect remains unclear .
The aims of this study were firstly to assess whether the compression stockings used
in our hospital could be demonstrated to exert a measurable effect on venous flow
velocity, and whether any one could be demonstrated to have superior effect. The
second aim of the study was to assess whether adoption of the left lateral position,
recommended in the third trimester to improve venous return, could be shown to have
an effect on venous flow velocity in non-pregnant patients, and to compare any
positional effect on venous flow velocity and vessel diameter with those effects
exerted by compression stockings. Duplex Doppler ultrasound was employed to
measure the diameter and flow velocity within the common femoral and popliteal
veins of non-pregnant subjects. We elected not to extend the study to pregnant
patients for the reasons given below.
The stockings assessed were the T.E.D. Thigh-Length Stocking (Kendall Company,
U.K.), the Brevet TX Anti-Embolism Stocking (Brevet Hospital Products, U.K.) and
the Tubigrip Stocking (Seton Healthcare, U.K.) (Plate 11.1). The T.E.D. stocking
was selected for study as it is the only stocking which objective data shows to be
effective in preventing DVT. The Brevet stocking was studied as it is widely used and
is one of the main competitors to the T.E.D. stocking. Since the Tubigrip stocking is
still widely used in clinical practice it was also subject to the studies presented. The
T.E.D. and Brevet stockings studied provide an ankle to thigh compression gradient
of 30-40 torr, whereas the Tubigrip is worn below the knee and is not graduated.
11.2 Methods
The study protocol required multiple measurements to be made in 3 postures in the
first instance without the application of a support stocking and then 1 hour after the
application of each stocking. To ensure each examination was of acceptable duration
to the subjects measurements for each stocking were made at separate sessions at 2 or
3 day intervals. Compliance of out-patients was expected to be poor, while possible
effects of the varying types and degree of pathology necessitating their admission
rendered in-patient women likely to have confounding factors of a heterogeneous
nature. Given the proposed study period of a week for each subject, gestational
changes in vessel diameter and flow velocity could occur, themselves affecting the
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data obtained. Given the problems associated with standardisation of pregnant
subjects, non-pregnant members of staff were recruited to the study.
Ten fit, non-pregnant pre-menopausal women, with no history of venous disease
volunteered. Initial measurements were made with the subject wearing no stocking
and, in order to limit the duration of each examination, all investigations were
confined to the right lower limb.
All support stockings were fitted one hour before the ultrasound measurements were
made and all fittings were carried out by physiotherapists with expertise in fitting the
correct size of stocking to achieve the intended pressure gradient. The tubigrip
stockings were however not designed to exert a pressure gradient, and were fitted
purely for comfort and adequate compression as judged by the physiotherapist.
The following protocol was followed. Prior to each scan, each subject was allowed to
rest supine for 5 minutes. The ultrasound examinations were carried out using an
Acuson 128 Ultrasound scanner (Acuson, Mountain View, Calif.) equipped with
spectral and colour Doppler facilities, and a 5 MHz linear array transducer. With the
subject lying supine with 15° of head up tilt, the right common femoral vein was
imaged in the longitudinal axis, at a point on the common femoral vein 2 cm below
the junction with the long saphenous vein. The image was frozen after minimising the
transducer pressure near to the point of losing contact. The distance between the
inner aspects of the anterior and posterior vessel walls was recorded and the mean of
three measurements calculated. The Doppler gate was then placed across the middle
third of the vessel lumen, and a spectral Doppler recording of the flow wave form
was made over a period of 15 seconds of quiet respiration. In order to minimise
velocity calculation errors from the Doppler shift, the angle of insonance was
electronically steered to subtend an angle less than 60° to the axis of flow and the
velocities measured were angle corrected by aligning the cursor to the direction of
flow. The wave form recording was then analysed for maximum and minimum flow
velocities, time averaged maximum velocity (TAMV) over 15 seconds, and for the
presence of respiratory and cardiac fluctuation. The degree of flow fluctuation with
respiration was calculated by dividing the difference between maximum and
minimum velocity by the TAMV, giving the Venous Variation Index (VVI).
These measurements were repeated at the superficial femoral vein proximal to its exit
from the adductor canal, and at the popliteal vein, distal to its junction with the short
saphenous tributary. On completion of this protocol, the subject turned to the left
lateral and after a 5 minute period to enable haemodynamic stabilisation, the
measurements were repeated at the common femoral and popliteal vein. The subject
was then invited to adopt the upright position for 5 minutes before the same
measurements were again performed.
Liberal application of sonic gel enabled good imaging through the stockings at the
superficial femoral and popliteal levels without the need for cutting holes which
might have affected the function of the stocking (Mayberry et al 1991).
All the scans were recorded onto video. On screen measurements of vessel diameter
and TAMV were later carried out by an observer who was blinded to which, if any,
stocking was being assessed. The statistical analysis was performed using analysis of
variance with post hoc comparisons using Fishers Protected LSD test. The VVI data
was log transformed prior to analysis.
11.3 Results
The application of elasticated stockings had no significant effect on the diameter of
the common femoral, or superficial femoral vein. At the popliteal vein, the thigh
length T.E.D and Brevet stockings were associated with a significant reduction in
vessel diameter in both the supine and left lateral positions (Table 11.1). However,
no significant increase in flow velocities was demonstrated at this or more proximal
points by the T.E.D., Brevet or Seton stocking (Table 11.2).
In contrast, altering posture was found to affect both the diameter and flow velocity at
the common femoral vein and the popliteal vein. With no stocking applied, adoption
of the left lateral position resulted in a decrease in right common femoral vein
diameter from 8.9±0.9mm to 5.6+0.6mm (p<0.05) and an increase in time averaged
maximum flow velocity at the right common femoral vein from 16±4cm/s to
25±4cm/s (p<0.05). This effect was reproduced on the application of all three
stocking types (Tables 11.1 and 11.2) and two factor analysis of variance
demonstrated no stocking dependent effect. No significant effects of the adoption of
the left lateral position were recorded at the right popliteal vein. As expected,
adoption of an upright posture resulted in a significant increase in the diameter of the
right common femoral vein and right popliteal vein (8.9±0.9mm to 13.3±0.9mm and
5.9+0.5mm to 8.6±0.5mm respectively (p<0.05)). A corresponding fall in time
averaged maximum flow velocity was recorded at both the common femoral and
popliteal veins (16±4cm/s to 6±2cm/s and 6±lcm/s to 4±lcm/s respectively
(p<0.05)). Again, no significant additional effects were noted on the application of
stockings (Tables 11.1 and 11.2). Figure 11a illustrates the combined data relating
posture to right common femoral vein diameter and time averaged maximum flow
velocity.
The amplitude of respiratory variation in flow velocity, expressed as the VVI, was not
altered by posture in the observed limb. However, the application of stockings was
found to alter the VVI at both the common femoral and popliteal vein. In the supine
position, the TED stocking produced a significant reduction in VVI at the popliteal
vein. On adopting the left lateral position this effect was also produced by the Brevet
stocking. Paradoxically, the application of stockings in the left lateral position
produced the opposite effect at the common femoral vein, increasing the VVI (Table
11.3).
11.4 Discussion
Although the efficacy of graduated stockings in preventing DVT has been clearly
demonstrated, uncertainty remains over their mode of action. Early studies on
compression stockings suggested that they acted by increasing the velocity of flow in
the venous system of the leg (Makin et al 1969). Later, Sigel, using continuous wave
Doppler techniques, demonstrated an increased flow velocity proximal to applied
compression stockings (although no measurements were made of flow directly
beneath the stocking) and showed compression to reduce the fluctuation effect of
respiration on venous flow (Sigel et al 1973). Although these reports suggested the
effects were observed at the femoral vein, the techniques employed made distinction
between the femoral vein and adjacent vessels (such as the long saphenous vein)
difficult.
More recent studies have employed photoplethysmography, a technique which has
been shown to yield measurements which correlate with ambulatory venous pressures
(Abramowitz et al, 1979), to assess the effects of graduated compression on venous
refilling time in subjects with venous incompetence. Many stockings appear not to be
effective in improving this parameter of venous function (Cornwall et al, 1987).
Duplex Doppler ultrasound, which enables observation of flow characteristics in
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individual vessels, has become established as an important tool for investigating
venous flow velocity. Recent studies employing duplex ultrasound suggest that
graduated compression does not have a significant effect on peak venous flow
velocity. Keith et al (1992) used duplex ultrasound to assess whether intermittent
pneumatic compression (IPC) and elasticated stockings have additive effects on peak
venous flow velocity showed no independent or additional effect of graduated
compression stockings on flow velocity, which was increased by intermittent
pneumatic compression. Mayberry et al (1991) carrying out a more comprehensive
assessment of the effect of elastic compression stockings on deep venous
haemodynamics, were unable to demonstrate any significant effect of either 30 to 40
or 40 to 50 torr stockings on ambulatory venous pressure, venous refill time,
maximum venous pressure with exercise or amplitude of venous pressure excursion.
Further, no significant effects were observed on duplex derived CFV and popliteal
vein diameter or peak flow velocities, either in normal healthy subjects, or in patients
with chronic deep venous insufficiency. These findings are consistent with our own ,
as we found no significant increase in flow velocity at either the common femoral,
superficial femoral or popliteal levels by the application of any of three stockings
investigated. Only the graduated thigh-length stockings (Kendall and Brevet)
appeared to reduce vessel diameter but this effect reached statistical significance only
at the popliteal vein.
If stockings do not act by increasing peak flow velocity and hence prevent venous
stasis then the proven clinical efficacy of compression stockings and the possible
synergistic thromboprophylactic effect of using both compression stockings and calf
muscle flexion (Scurr et al 1987) demand some other explanation for their effect.
Recent studies have shed light on other possible mechanisms. Passive venous
dilatation has been shown to occur during operative surgery (Camerota et al, 1989),
and may extend to the point where the media can no longer provide support for the
endothelial layer. Tears may occur, ultimately exposing thrombogenic subendothelial
collagen (Stewart et al 1980). Prevention of venous dilatation may be an important
effect of compression, and would explain the adjuvent effect seen when both
compression and calf muscle flexion are applied together as post-operative DVT
prophylaxis (Scurr et al 1987).
Compression stockings may also act at a molecular level to influence thrombogenesis.
Arcleus et al (1995) have shown that application of compression stockings can cause
an increase in circulating levels of tissue factor pathway inhibitor (TFPI). This factor,
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which has been shown to increase up to 4-fold after heparin administration, plays a
key role in the regulation of the extrinsic pathway. Increased activation of the
fibrinolytic system has been demonstrated when intermittent pneumatic compression
is applied (Guyton et al 1985) although no data relating to compression stockings is
available.
Venous valvular incompetence can exacerbate venous stasis and cause venous
dilatation with possible endothelial damage. Sarin et al (1992) using real-time
ultrasound demonstrated that compression stockings can correct valvular dysfunction
possible by allowing coaptation of valvular cusps. However, this effect would not
explain the efficacy of compression stockings in postoperative patients who have no
demonstrable valve incompetence. It may however, be an important mechanism in
pregnancy, since the vessel dilatation which occurs in pregnancy may act to prevent
coaptation of the valve cusps, producing valvular incompetence which might be
corrected by elastic stockings. This possible effect warrants further study.
The data presented here, while consistent with recent studies, may also be compatible
with the seminal studies of Sigel described above. We like other recent workers, have
measured peak flow velocities whereas earlier studies reported effects on mean flow
velocities. Keith et al (1992) have shown significant compressive pressures to be
exerted by elastic stockings on superficial tissues, which may act to divert superficial
blood to deeper vessels. This may cause an increase in mean flow velocity without
necessarily effecting peak velocity values. The fact that recent data indicates no major
effect of compression stockings on peak venous blood flow velocities, however,
indicates that other mechanisms of action are likely to be important in the
thromboprophylactic function of elastic compression stockings.
Posture may also offer an important adjuvent in prophylaxis. Our results show that
adoption of a lateral recumbent position increases flow velocity at the common
femoral vein in the non-dependent limb. Although recognised as an important means
of increasing venous return in late pregnancy (Ueland & Hansen 1969), this
phenomenon has not been previously described in non-pregnant healthy subjects and
may offer a potential additional means of thromboprophylaxis.
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11.5 Conclusion
The presented data are consistent with recent publications which question the
previously held view that compression stockings act to prevent thromboembolism by
increasing flow velocity. In addition the evidence for stasis as a cause of thrombosis
which relates to the proven efficacy of anti-'stasis' stockings needs to be reviewed. In
contrast, flow velocity is shown to be significantly altered by adoption of the lateral
recumbent position. This study has also demonstrated the additional effects of
graduated support stockings on these postural changes in venous flow, suggesting a
potential synergistic role in thromboprophylaxis.
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Figure 11a
The mean diameter of the CFV and the mean time average maximum velocity at the
CFV are shown in the supine (S), left lateral (L) and the upright (U) positions (bars:
SEM). Values are derived from all stocking and 'no stocking' data - see text.
(p = 0.0001)
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Table 11.1 Mean (SEM) vein diameters recorded with varying posture and
stocking.
*p<0.05 compared to 'No Stocking'.
tp<0.05 compared to Supine position.
STOCKING
DIAMETER (mm)
No Stocking TED Brevet Tubigrip
CFV (Supine) 8.9 (±0.9) 8.7 (±0.8) 9.7 (0+9) 9.3 (±0.8)
CFV (Left Lat.) 5.6 (±0.6)t 6.3 (±0.7)t 5.1 (±0.5) 6.4 (±0.4)f
CFV (Upright) 13.3 (±0.6)t 13.3 (±0.5)1* 12.5 (±0.4)t 12.6 (±0.5)t
SFV (Supine) 7.9 (±0.5) 6.8 (±0.5) 7.6 (±0.4) 7.9 (±0.5)
POP (Supine) 5.9 (±0.5) 4.4 (±0.5)* 4.4 (±0.3)* 4.8 (±0.5)
POP (Left Lat.) 5.4 (±0.4) 4.3 (±0.3)* 4.2 (±0.4)* 5.4 (±0.5)
POP (Upright) 8.6 (±0.5)t 8.2 (±0.6)f 9.8 (±0.7)t 7.6 (±0.6)t
Table 11.2 Mean (SEM) venous Time Averaged Mean Velocities (TAMV)
recorded with varying posture and stocking.
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*p<0.05 compared to supine position.
STOCKING
No Stocking TED Brevet Tubigrip
TAMV icm/sl
CFV (Supine) 16(+4) 15 (±2) 23 (±6) 11 (±2)
CFV (Left Lat.) 25 (±4)* 21 (±4)* 37 (±6)* 25 (±5)*
CFV (Upright) 6 (+2)* 4 (±1)* 4 (±1)* 4 (±<1)*
SFV (Supine) 6 (±1) 9 (±2) 6 (±1) 6 (± 1)
POP (Supine) 6 (±1) 9 (±2) 6 (±1) 7(±1)
POP (Left Lat.) 7 (±1) 9 (±1) 8 (±1) 16 (±9)
POP (Upright) 4 (±<1)* 4 (+1)* 3 (+<1)* 4 (±<1)
Table 11.3 Mean (SEM) Venous Variation Index (VVI) recorded with varying
posture and stocking.
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Plate 11.1 The stockings studied were (from left to right), The Brevet
thigh length graduated stocking, the Seton knee length non-
graduated stocking and the Kendal Thromboembolic
Deterrent (T.E.D) graduated thigh length stocking.
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Chapter 12
Conclusions and future research
Summary
In this final chapter the principle findings of the presented work are summarised and
their implications for thromboprophylaxis and the diagnosis of pulmonary
thromboembolism in pregnancy are discussed. Directions for further related research
are then suggested.
12.1 Introduction
While maternal mortality from all causes has fallen dramatically over the past fifty
years, death from thromboembolism has shown a slower reduction, and as a result, is
now a major contributor to maternal mortality statistics. Its increasing importance in
this regard has generated new research interest in the field in relation to pregnancy
after a period of some neglect. Since the early 1960s, little new data on the
physiology of the deep venous circulation of the legs in pregnancy has been
published. Developments in duplex ultrasound technology have offered a non¬
invasive means to further knowledge in this field. Given the now widespread use of
ultrasound as a diagnostic tool for DVT in pregnancy, contemporary information on
the normal deep venous anatomy and blood flow characteristics in pregnancy and the
puerperium as observed with ultrasound imaging is essential to aid not only our
diagnostic ability but also with regard to the physiology and pathology of the deep
venous system. The data presented in this thesis go somewhere to addressing this, and
may aid duplex and colour Doppler ultrasound diagnostic tools for suspected DVT in
pregnancy to move closer to becoming the true 'gold standard' test in pregnancy.
12.2 Summary of Results
A retrospective study of DVT and PTE complicating pregnancy indicated that age
over 35 and emergency caesarean section were major risk factors, together increasing
the risk of postnatal DVT ten fold. A prospective screening study for as asymptomatic
DVT in the puerperium suggested a low incidence in women at low to moderate risk.
Ultrasound studies of deep venous flow in the leg showed spontaneous respiratory
fluctuation to be maintained throughout pregnancy, while venous flow velocity fell
markedly, particularly at the CFV. A corresponding gestational increase in vessel
diameter was observed. Adoption of the left lateral position resulted in a marked
increase in flow velocity in both the left and right CFV. On the right, this effect was
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not confined to late pregnancy. An increase in the amplitude of respiratory fluctuation
of flow was noted in the left lateral position. Significant differences in flow velocity
between the right and left leg were demonstrated. These persisted in the puerperium.
Between the 4th and 42nd postnatal day, the CFV diameter was observed to fall and
the flow velocity to increase. Delivery by caesarean section was associated with a
lower postnatal flow velocity than vaginal delivery. The application of three types of
support stocking in non-pregnant subjects were found to have little detectable effect
on flow velocity within the deep venous system of the leg. Adoption of the left lateral
position resulted in a marked increase in flow velocity in the right CFV in the same
subjects. The above findings have implications for both thromboprophylaxis and
diagnosis of DVT, and these are outlined below.
12.3 Implications for Thromboprophylaxis
In addition to stimulating research, recognition of the importance of thromboembolic
disease as a cause of maternal death has resulted in the means of treatment and, more
importantly, prevention coming under review. The Royal College of Obstetricians
and Gynaecologists has recently published guidelines for the prevention of
thromboembolism in obseterics and gynaecology (RCOG 1995). This and several
other publications have recently come to the attention of practicing obstetricians.
Assuming these guidelines are widely instituted, a fall in maternal mortality and long-
term morbidity might be hoped for in the coming years. The survey of obstetricians
and gynaecologists attitudes to thromboprophylaxis published by Greer and de Swiet
(1993) should be repeated in the coming years in order to test what impact recent
highlighting of the problem and its methods of prevention might have in the future.
Part of the problem in attempting to influence practice with regard to
thromboprophylaxis is the rarity of severe thromboembolic complications as
perceived by individual clinicians. This was highlighted as a reason for many
obstetricians not using thromboprophylaxis in their practice by Greer and de Swiet
(1993). The data presented in chapters 6 and 10 would appear to support this
perception as the incidence as a fraction of the total obstetric population appears low.
However, if the data from chapter 6 are accepted as indicative of the true incidence of
thromboembolic complications in pregnancy and the puerperium, most obstetricians
will expect to encounter at least 3 cases of PTE each year. For these individuals, their
potentially preventable complication may result in death, or more commonly, years of
pain and discomfort arising from chronic venous insufficiency. Although
thromboprophylaxis is not entirely without risk and discomfort, its judicious use may
prevent many of these lifethreatening complications arising. While some clinicians
adopt thromboprophylactic regimens on all their patients, this approach is unusual,
and the data presented in this thesis would tend to support the direction of
thromboprophylaxis to women with recognised risk factors.
The data presented in chapter 6 illustrates the importance of certain risk factors. The
eliciting of such simple information as age and mode of delivery can alone indicate a
ten fold increase in risk of postnatal DVT. The importance demonstrated in chapter 6
of age over 35 as a risk factor for antenatal DVT may help guide the often difficult
clinical decision as to when antenatal thromboprophylaxis should be commenced in
women who have suffered a previous thromboembolic event. The rise in proportion
of women over the age of 35 also demonstrated in chapter 6 might be expected to
impact negatively on mortality statistics from thromboembolism unless appropriate
thromboprophylactic regimens are widely instituted.
Prevention of pathology requires a knowledge of the relevant physiology. While
studies of venous flow in relation to the respiratory and cardiac cycle have been
performed before, the situation in the pregnant subject has not been addressed. The
pregnant uterus has been shown to affect venous flow from the lower extremities. The
data presented in chapter 10 suggest that in addition to reducing venous flow velocity,
the gravid uterus can act to alter the waveform characteristics of venous flow when
the subject lies supine. This observation may have implications for the initiation of
thrombus formation since marked fluctuations in venous flow may serve to dislodge
early thrombi and prevent thrombosis occurring. It was therefore interesting to note
that in the supine position, advancing gestational age and uterine weight was not
associated with either a qualitative or quantitative change (chapter 7) in respiratory
fluctuation of flow.
The adoption of the lateral (decubitus) position is recommended in late pregnancy to
prevent the 'caval syndrome' as the compressive effect of the gravid uterus in late
pregnancy can be removed if the patient adopts a decubitus or left lateral posture.
Chapter 11 presents data which indicate that this effect, the increase in flow velocity
in the deep veins of the leg on adoption of the decubitus posture, is not confined to
late pregnancy. Indeed, a marked effect is demonstrated in non-pregnant women. The
studies presented in chapter 7 show marked increases in flow velocity in both the
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right and left CFV when the left lateral position is adopted, although this effect
appears to occur only after 25 weeks gestation in the left leg. Prior to this, and after
delivery, adoption of the left lateral posture appears to result in a slowing in left CFV
blood flow velocity. It would therefore appear that the gravid uterus has an important
but not a solitary role in producing postural changes in venous flow velocity. The
liver lies on the ascending vena cava and is likely to cause a degree of compression
which may be reduced on adoption of the left lateral position. The influence of
abdominal organs on venous return is likely to be complex, and will vary between
individuals. However, the data presented here provides a clear indication that the left
lateral position results in increased venous flow velocity in the left and right CFV in
mid-late pregnancy, and may therefore prevent DVT forming. A beneficial effect is
also likely to result from adoption of the right lateral position although this was not
investigated. To demonstrate that adopting the decubitus posture when lying down
actually prevents thrombus formation however, would require a very large study
(given the incidence of DVT in pregnancy suggested by the data in chapter 6),
controlled for other means of thromboprophylaxis. The practical difficulties such a
study would present makes it unlikely that it would ever be carried out. However, the
data presented in this thesis provides evidence of the likely benefits of the left lateral
position as a painless, safe and cheap means of thromboprophylaxis.
The findings relating to differences in venous flow velocity and fluctuation between
the left and right leg were consistent with the clinically observed preponderance of
left sided DVT. These data, when considered with the postural effects discussed
above may suggest that any thromboprophylactic effect of the decubitus position
might be enhanced if the right lateral position was adopted as the increase in venous
flow velocity would be more marked in the left CFV, the more common site of
thrombus formation. However, further studies are required to address this.
The puerperium is a period of particular risk. Operative delivery is associated with a
higher incidence of DVT (chapter 8) and this has been thought to be primarily due to
prolonged inactivity and trauma to the vessels. The data presented in chapter 7
suggests that flow velocity may also be reduced after caesarean section. The reason
for this is not clear, but may it may be associated with the lack of muscle pump
activity in women recovering from caesarean delivery. Early mobilisation and the use
of calf compression boots would therefore seem an appropriate way of preventing
DVT in this group. The data presented in chapter 8 has implications for the period for
which postnatal thromboprophylaxis should be used. It would seem that by the 42nd
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day most of the alterations in the deep venous system of the leg observed in
pregnancy have returned to resemble these observations made in early pregnancy. The
current tendency to maintain postpartum thromboprophylaxis for 6 weeks would
appear appropriate.
The work presented in chapter 11 relates to the most important current method of
physical thromboprophylaxis, graduated compression stockings. This study was
limited to non-ambulant, but fit and healthy subjects, and therefore did not assess the
function of stockings within the normal clinical context of their use. Nevertheless,
their moderate effects on venous flow was in marked contrast to those observed on
the adoption of the decubitus posture. As discussed in chapter 11, their mode of
action may relate more to the support they provide to the vessels resulting in an
enhanced muscle pump action during ambulation ore calf muscle exercises in non-
ambulant patients. This hypothesis could be studied by repeating the presented study
during controlled flexion and extension of the foot as can be achieved with passive
calf muscle flexion apparatus normally employed as a means of physical
thromboprophylaxis.
12.4 Implications for Diagnosis
The data relating to gestational changes in vessel diameter presented in chapter 7 may
provide some explanation for the observed tendency in pregnancy for DVT to
originate in the ileofemoral region rather than in the soleal sinuses of the calf, as is
believed to occur outwith pregnancy. The marked increase in CFV diameter, greater
than that observed in more distal vessels has implications for ultrasound diagnosis of
DVT. Duplex Doppler ultrasound is of reduced sensitivity in small vessels such as the
calf veins. While colour Doppler ultrasound makes examination of the calf veins
possible (Baxter et al 1990) the procedure is time consuming and technically difficult.
In practice ultrasound examination is normally confined distally to the popliteal vein.
Even in relatively inexperienced hands, the identification of the CFV is possible with
simple real-time ultrasound alone. The marked enlargement of the CFV demonstrated
with advancing gestation serves to make such an examination easier. However, since
marked dilatation of the CFV is in itself suggestive of acute DVT within, knowledge
of the normal appearances of the vessel in pregnancy is required. Occlusion of vessel
upon application of gentle compression can easily clarify the situation. This simple
technique requires no special expertise. Since many maternity units remain on
separate sites from full radiological services, those training in or practising obstetric
ultrasound should learn these basic techniques, as particularly out of hours, the
decision to withhold or commence anticoagulation in a pregnant woman need not be
deferred unnecessarily.
When doubt remains over the diagnosis, other ultrasound measures such as
augmentation may clarify whether or not occlusion of the vessel is present as
discussed in chapter 1. The presence of respiratory fluctuation in flow can indicate
proximal patency of the vessel, and this may be of particular value when proximal
segments of the ileofemoral system and vena cava are masked by the gravid uterus.
The presented data showing that respiratory fluctuation barely alters through
pregnancy is important in this regard and may aid the accurate diagnosis or exclusion
of DVT in late pregnancy. The enhancing of the amplitude of respiratory fluctuation
demonstrated on adoption of the left lateral position may also be utilised when doubt
remains over the patency of vessels proximal to the segment under scrutiny.
The role of ultrasound in screening for DVT in asymptomatic patients remains
unclear. As discussed in chapter 10, ultrasound is potentially a useful means of
screening because of its safety and noninvasiveness but its accuracy in non-pregnant
subjects is not certain. The screening study presented represents the first such study of
the puerperium to be published. However, in terms of the probable incidence of
postnatal DVT (chapter 6) it is too small to assess the true incidence of subclinical
DVT in women at high risk. A large screening study of high risk subjects may impact
on thromboprophylaxis guidelines if the true incidence of objectively diagnosed DVT
was observed to differ from that derived from the data presented in chapter 6. A full
ultrasound examination is time-consuming and requires a certain degree of expertise,
and the resources required to offer screening to all high risk women are unlikely to
become available.
12.5 Future Research
In addition to those areas already highlighted as meriting further research, certain
other questions should be addressed. The recognition of activated protein C resistance
as a form of thrombophilia has led to the study of its prevalence in subjects who have
sustained a thromboembolic complication. Both in this group and the general
population, it would appear to be the most common inherited thrombophilia. Studies
are now required to assess the incidence of activated protein C resistance in the
pregnant population. Screening studies may identify women at particular risk, and
enable the direction of thromboprophylaxis to a previously unrecognised risk group.
Those screening positive for APC resistance could be offered duplex Doppler
ultrasound screening for DVT in the antenatal and postnatal period, and the incidence
of subclinical DVT in group determined. This study should be carried out as part of a
larger ultrasound screening study of high risk women in the puerperium, as already
described.
The ultrasound studies of venous physiology presented would have benefited from
assessing a larger subject group. Information might be considered lacking as to the
true state of the deep veins of the leg outwith pregnancy, as the presented studies used
subject measurements at 6 postnatal weeks as their own non-pregnant controls.
However, further resolution in the observed changes in the deep venous system may
continue beyond 6 weeks. There is scope therefore, for a repeat of the serial
ultrasound study of pregnancy, with larger numbers, a larger subgroup of patients
with a previous history of DVT, and measurements made at a longer interval after
pregnancy to indicate more clearly the non-pregnant state.
The non-invasive nature of ultrasound studies offer the scope for intrapartum
examination of the deep venous system. Intraoperative venous dilatation is a well
described phenomenon (Camerota et al 1991), and may be demonstrable to varying
degrees in women undergoing spontaneous vaginal, forceps or caesarean delivery.
Intrapartum studies may shed further light on the reasons behind the observed
increase in DVT and PTE in those undergoing operative delivery.
The ultrasound techniques described lend themselves to studies outwith pregnancy.
The development of laparoscopic surgery has been hailed as beneficial to patients in
many ways, not least because they are found to mobilise earlier, with a presumed
reduced risk of postoperative thrombosis. Laparoscopic surgery requires the use of
high intra-abdominal pressures as CO2 is used to lift the anterior abdominal wall off
the organs of surgical interest. These pressures may act to compress the intrabdominal
veins, and thereby impede the velocity of venous flow in the deep leg veins. On the
other hand the moderate elevation of the legs required for laparoscopic surgery may
have a beneficial effect on flow velocity. Ultrasound techniques could readily be
employed to ascertain whether laparoscopic surgery might result in a greater intra¬
operative thrombotic risk than conventional surgery.
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At present, ultrasound techniques for diagnosing DVT continue to be used more
widely in pregnancy. The data presented in this thesis may serve to enhance its utility
in this important aspect of pregnancy care.
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